,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1292762,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,203238,CCDC171,https://ctdbase.org/detail.go?type=gene&acc=203238,,,203238.0,CCDC171,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of CCDC171 mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
1,1292763,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,728621,CCDC30,https://ctdbase.org/detail.go?type=gene&acc=728621,,,728621.0,CCDC30,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of CCDC30 mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
2,1293242,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1196,CLK2,https://ctdbase.org/detail.go?type=gene&acc=1196,,,1196.0,CLK2,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of CLK2 mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
3,1293243,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,9606.0,Homo sapiens (human),Cupric chloride promotes the reaction [CLU protein binds to ATP7B protein]|cupric chloride promotes the reaction [CLU protein binds to ATP7A protein],,,PMID:21242307,https://www.ncbi.nlm.nih.gov/pubmed/21242307,21242307,,
4,1293244,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,10090.0,Mus musculus (house mouse),Cupric chloride results in increased expression of CLU mRNA,,,PMID:17211630,https://www.ncbi.nlm.nih.gov/pubmed/17211630,17211630,,
5,1293245,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,337158,COL1A1A,https://ctdbase.org/detail.go?type=gene&acc=337158,,,337158.0,col1a1a,239089.0,Danio rerio (zebrafish),COL1A1A protein binds to cupric chloride,,,PMID:22699969,https://www.ncbi.nlm.nih.gov/pubmed/22699969,22699969,,
6,1293246,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,562496,COL2A1A,https://ctdbase.org/detail.go?type=gene&acc=562496,,,562496.0,col2a1a,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in increased expression of COL2A1A mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
7,1293247,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,68553,COL6A4,https://ctdbase.org/detail.go?type=gene&acc=68553,,,68553.0,Col6a4,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of COL6A4 mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
8,1293248,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,150684,COMMD1,https://ctdbase.org/detail.go?type=gene&acc=150684,,,150684.0,COMMD1,9606.0,Homo sapiens (human),Cupric chloride results in decreased expression of COMMD1 mrna|cupric chloride results in decreased expression of COMMD1 protein|commd1 protein results in decreased susceptibility to cupric chloride,,,PMID:17211630,https://www.ncbi.nlm.nih.gov/pubmed/17211630,17211630,,
9,1293736,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Cupric chloride results in increased secretion of CXCL8 protein,,,PMID:12865660,https://www.ncbi.nlm.nih.gov/pubmed/12865660,12865660,,
10,1293737,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,79415,CYBC1,https://ctdbase.org/detail.go?type=gene&acc=79415,,,79415.0,CYBC1,9606.0,Homo sapiens (human),Cupric chloride results in increased expression of CYBC1 mRNA,,,PMID:34921933,https://www.ncbi.nlm.nih.gov/pubmed/34921933,34921933,,
11,1294823,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,10056,FARSB,https://ctdbase.org/detail.go?type=gene&acc=10056,,,10056.0,FARSB,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in increased expression of FARSB mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
12,1294824,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in decreased expression of FASLG mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
13,1294825,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606.0,Homo sapiens (human),Cupric chloride results in decreased expression of FASN mRNA,,,PMID:34921933,https://www.ncbi.nlm.nih.gov/pubmed/34921933,34921933,,
14,1294826,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cupric chloride results in increased expression of FASN mRNA,,,PMID:24650576,https://www.ncbi.nlm.nih.gov/pubmed/24650576,24650576,,
15,1294827,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,2219,FCN1,https://ctdbase.org/detail.go?type=gene&acc=2219,,,2219.0,FCN1,157728.0,Saccostrea glomerata,Cupric chloride results in decreased expression of FCN1 mRNA,,,PMID:23545341,https://www.ncbi.nlm.nih.gov/pubmed/23545341,23545341,,
16,1294828,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,9606.0,Homo sapiens (human),Cupric chloride results in decreased expression of FDFT1 mRNA,,,PMID:34921933,https://www.ncbi.nlm.nih.gov/pubmed/34921933,34921933,,
17,1294829,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,2224,FDPS,https://ctdbase.org/detail.go?type=gene&acc=2224,,,2224.0,FDPS,7955.0,Danio rerio (zebrafish),Cupric chloride results in increased expression of FDPS mRNA,,,PMID:19174923,https://www.ncbi.nlm.nih.gov/pubmed/19174923,19174923,,
18,1294830,24014,Comparative Toxicogenomics Database (CTD),Cupric Chloride,C029892,cupric chloride,https://ctdbase.org/detail.go?type=chem&acc=C029892,26998,FETUB,https://ctdbase.org/detail.go?type=gene&acc=26998,,,26998.0,FETUB,10090.0,Mus musculus (house mouse),Cupric chloride results in increased expression of FETUB mRNA,,,PMID:17211630,https://www.ncbi.nlm.nih.gov/pubmed/17211630,17211630,,
19,1292461,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),"[mercuric chloride co-treated with lipopolysaccharide, E. coli O26-B6] results in decreased expression of CXCL8 mRNA",,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
20,1292462,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Mercuric chloride results in decreased expression of CXCL8 mRNA,,,PMID:8560497,https://www.ncbi.nlm.nih.gov/pubmed/8560497,8560497,,
21,1292463,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Mercuric chloride results in increased expression of CXCL8 mRNA,,,PMID:20713136|PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/20713136|https://www.ncbi.nlm.nih.gov/pubmed/29594315,20713136|29594315,,
22,1292464,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Mercuric chloride results in increased expression of CXCL8 protein,,,PMID:26456670,https://www.ncbi.nlm.nih.gov/pubmed/26456670,26456670,,
23,1292465,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Mercuric chloride results in increased secretion of CXCL8 protein,,,PMID:25458486,https://www.ncbi.nlm.nih.gov/pubmed/25458486,25458486,,
24,1292466,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,2833,CXCR3,https://ctdbase.org/detail.go?type=gene&acc=2833,,,2833.0,CXCR3,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in increased expression of CXCR3 protein|mercuric chloride results in increased expression of CXCR3 mRNA,,,PMID:12834626,https://www.ncbi.nlm.nih.gov/pubmed/12834626,12834626,,
25,1292470,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,178926,CYP-14A5,https://ctdbase.org/detail.go?type=gene&acc=178926,,,178926.0,cyp-14A5,6239.0,Caenorhabditis elegans,CYP-14A5 protein results in decreased susceptibility to mercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
26,1292941,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,112597,CYTOR,https://ctdbase.org/detail.go?type=gene&acc=112597,,,112597.0,CYTOR,9606.0,Homo sapiens (human),Mercuric chloride results in increased expression of CYTOR mRNA,,,PMID:24036268,https://www.ncbi.nlm.nih.gov/pubmed/24036268,24036268,,
27,1292942,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,183883,D1005.5,https://ctdbase.org/detail.go?type=gene&acc=183883,,,183883.0,D1005.5,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of D1005.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
28,1292943,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,183913,D1053.3,https://ctdbase.org/detail.go?type=gene&acc=183913,,,183913.0,D1053.3,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of D1053.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
29,1292944,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,183618,D1065.3,https://ctdbase.org/detail.go?type=gene&acc=183618,,,183618.0,D1065.3,6239.0,Caenorhabditis elegans,D1065.3 protein results in increased susceptibility to mercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
30,1292945,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,188350,DACH-1,https://ctdbase.org/detail.go?type=gene&acc=188350,,,188350.0,dach-1,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of DACH-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
31,1292946,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,175410,DAF-2,https://ctdbase.org/detail.go?type=gene&acc=175410,,,175410.0,daf-2,6239.0,Caenorhabditis elegans,DAF-2 protein affects the susceptibility to mercuric chloride,,,PMID:22209111,https://www.ncbi.nlm.nih.gov/pubmed/22209111,22209111,,
32,1293895,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in decreased expression of EGF mRNA,,,PMID:10901180|PMID:8538927,https://www.ncbi.nlm.nih.gov/pubmed/10901180|https://www.ncbi.nlm.nih.gov/pubmed/8538927,10901180|8538927,,
33,1293896,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Mercuric chloride results in increased expression of EGFR mRNA,,,PMID:37172713,https://www.ncbi.nlm.nih.gov/pubmed/37172713,37172713,,
34,1293897,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in increased expression of EGFR mRNA,,,PMID:10901180,https://www.ncbi.nlm.nih.gov/pubmed/10901180,10901180,,
35,1293898,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in increased expression of EGR1 mRNA,,,PMID:16507785,https://www.ncbi.nlm.nih.gov/pubmed/16507785,16507785,,
36,1293899,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301.0,EHBP1,9606.0,Homo sapiens (human),Mercuric chloride results in decreased expression of EHBP1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
37,1293900,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in decreased expression of EHD1 mRNA,,,PMID:16507785,https://www.ncbi.nlm.nih.gov/pubmed/16507785,16507785,,
38,1293901,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in decreased expression of EHHADH mRNA,,,PMID:16507785,https://www.ncbi.nlm.nih.gov/pubmed/16507785,16507785,,
39,1293902,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,100005761,EHMT1A,https://ctdbase.org/detail.go?type=gene&acc=100005761,,,100005761.0,ehmt1a,7955.0,Danio rerio (zebrafish),Mercuric chloride affects the expression of EHMT1A mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
40,1295130,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,174805,F44E5.4,https://ctdbase.org/detail.go?type=gene&acc=174805,,,174805.0,F44E5.4,6239.0,Caenorhabditis elegans,F44E5.4 protein results in increased susceptibility to mercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
41,1295131,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,185758,F44G3.10,https://ctdbase.org/detail.go?type=gene&acc=185758,,,185758.0,F44G3.10,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of F44G3.10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
42,1295132,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,185825,F46A8.9,https://ctdbase.org/detail.go?type=gene&acc=185825,,,185825.0,F46A8.9,6239.0,Caenorhabditis elegans,F46A8.9 protein results in increased susceptibility to mercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
43,1295133,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,185895,F47B8.2,https://ctdbase.org/detail.go?type=gene&acc=185895,,,185895.0,F47B8.2,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of F47B8.2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
44,1295134,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,186061,F49E12.10,https://ctdbase.org/detail.go?type=gene&acc=186061,,,186061.0,F49E12.10,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of F49E12.10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
45,1295135,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,177177,F49F1.7,https://ctdbase.org/detail.go?type=gene&acc=177177,,,177177.0,F49F1.7,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of F49F1.7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
46,1295136,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,186079,F49H6.12,https://ctdbase.org/detail.go?type=gene&acc=186079,,,186079.0,F49H6.12,6239.0,Caenorhabditis elegans,Mercuric chloride results in decreased expression of F49H6.12 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
47,1295137,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,186073,F49H6.5,https://ctdbase.org/detail.go?type=gene&acc=186073,,,186073.0,F49H6.5,6239.0,Caenorhabditis elegans,Mercuric chloride results in increased expression of F49H6.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
48,1293583,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,19428,RASL2-9,https://ctdbase.org/detail.go?type=gene&acc=19428,,,19428.0,Rasl2-9,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RASL2-9 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
49,1293584,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,83593,RASSF5,https://ctdbase.org/detail.go?type=gene&acc=83593,,,83593.0,RASSF5,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RASSF5 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
50,1293585,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,9182,RASSF9,https://ctdbase.org/detail.go?type=gene&acc=9182,,,9182.0,RASSF9,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RASSF9 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
51,1294068,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,5982,RFC2,https://ctdbase.org/detail.go?type=gene&acc=5982,,,5982.0,RFC2,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RFC2 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
52,1294069,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,117584,RFFL,https://ctdbase.org/detail.go?type=gene&acc=117584,,,117584.0,RFFL,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RFFL mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
53,1294070,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,500009,RGD1560872,https://ctdbase.org/detail.go?type=gene&acc=500009,,,500009.0,RGD1560872,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RGD1560872 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
54,1294071,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,500039,RGD1562178,https://ctdbase.org/detail.go?type=gene&acc=500039,,,500039.0,RGD1562178,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RGD1562178 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
55,1294072,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,499084,RGD1564801,https://ctdbase.org/detail.go?type=gene&acc=499084,,,499084.0,RGD1564801,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RGD1564801 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
56,1294073,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,305275,RGD1565048,https://ctdbase.org/detail.go?type=gene&acc=305275,,,305275.0,RGD1565048,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RGD1565048 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
57,1294074,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,5863,RGL2,https://ctdbase.org/detail.go?type=gene&acc=5863,,,5863.0,RGL2,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RGL2 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
58,1294548,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,9610,RIN1,https://ctdbase.org/detail.go?type=gene&acc=9610,,,9610.0,RIN1,10116.0,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of RIN1 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
59,1292313,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,3727,JUND,https://ctdbase.org/detail.go?type=gene&acc=3727,,,3727.0,JUND,10090.0,Mus musculus (house mouse),Tetradecanoylphorbol acetate results in increased expression of JUND protein,,,PMID:11507057|PMID:18755854,https://www.ncbi.nlm.nih.gov/pubmed/11507057|https://www.ncbi.nlm.nih.gov/pubmed/18755854,11507057|18755854,,
60,1292314,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,3728,JUP,https://ctdbase.org/detail.go?type=gene&acc=3728,,,3728.0,JUP,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of JUP mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
61,1294985,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,376132,LRRC10,https://ctdbase.org/detail.go?type=gene&acc=376132,,,376132.0,LRRC10,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of LRRC10 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
62,1294986,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,79442,LRRC2,https://ctdbase.org/detail.go?type=gene&acc=79442,,,79442.0,LRRC2,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of LRRC2 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
63,1294987,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,123355,LRRC28,https://ctdbase.org/detail.go?type=gene&acc=123355,,,123355.0,LRRC28,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of LRRC28 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
64,1294988,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,502201,LRRC29,https://ctdbase.org/detail.go?type=gene&acc=502201,,,502201.0,Lrrc29,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of LRRC29 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
65,1293893,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933.0,SIRT2,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of SIRT2 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
66,1293894,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,23410,SIRT3,https://ctdbase.org/detail.go?type=gene&acc=23410,,,23410.0,SIRT3,9606.0,Homo sapiens (human),SIRT3 affects the susceptibility to chromium hexavalent ion|chromium hexavalent ion results in increased expression of SIRT3 mrna|chromium hexavalent ion results in increased expression of SIRT3 protein|chromium hexavalent ion promotes the reaction [NFE2L2 protein binds to SIRT3 promoter],,,PMID:30715550,https://www.ncbi.nlm.nih.gov/pubmed/30715550,30715550,,
67,1294989,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,692072,SNORD5,https://ctdbase.org/detail.go?type=gene&acc=692072,,,692072.0,SNORD5,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of SNORD5 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
68,1294990,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,692075,SNORD6,https://ctdbase.org/detail.go?type=gene&acc=692075,,,692075.0,SNORD6,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of SNORD6 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
69,1294991,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,347686,SNORD64,https://ctdbase.org/detail.go?type=gene&acc=347686,,,347686.0,SNORD64,9606.0,Homo sapiens (human),Chromium hexavalent ion affects the expression of SNORD64 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
70,1294992,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6628,SNRPB,https://ctdbase.org/detail.go?type=gene&acc=6628,,,6628.0,SNRPB,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of SNRPB mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
71,1294993,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,6632,SNRPD1,https://ctdbase.org/detail.go?type=gene&acc=6632,,,6632.0,SNRPD1,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of SNRPD1 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
72,1292146,31229,Comparative Toxicogenomics Database (CTD),Phenyl acetate,C570634,phenyl acetate,https://ctdbase.org/detail.go?type=chem&acc=C570634,5446,PON3,https://ctdbase.org/detail.go?type=gene&acc=5446,,,5446.0,PON3,9606.0,Homo sapiens (human),PON3 gene SNP affects the hydrolysis of phenyl acetate,,,PMID:20839225,https://www.ncbi.nlm.nih.gov/pubmed/20839225,20839225,,
73,1292147,31229,Comparative Toxicogenomics Database (CTD),Phenyl acetate,C570634,phenyl acetate,https://ctdbase.org/detail.go?type=chem&acc=C570634,55607,PPP1R9A,https://ctdbase.org/detail.go?type=gene&acc=55607,,,55607.0,PPP1R9A,9606.0,Homo sapiens (human),PPP1R9A 3' UTR SNP affects the hydrolysis of phenyl acetate,,,PMID:20839225,https://www.ncbi.nlm.nih.gov/pubmed/20839225,20839225,,
74,1292148,31236,Comparative Toxicogenomics Database (CTD),Phenoxyethanol,C005398,phenoxyethanol,https://ctdbase.org/detail.go?type=chem&acc=C005398,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,8355.0,Xenopus laevis (African clawed frog),Phenoxyethanol binds to AR protein,,,PMID:29205417,https://www.ncbi.nlm.nih.gov/pubmed/29205417,29205417,,
75,1292149,31236,Comparative Toxicogenomics Database (CTD),Phenoxyethanol,C005398,phenoxyethanol,https://ctdbase.org/detail.go?type=chem&acc=C005398,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,8355.0,Xenopus laevis (African clawed frog),Phenoxyethanol binds to PGR protein,,,PMID:29205417,https://www.ncbi.nlm.nih.gov/pubmed/29205417,29205417,,
76,1292150,31236,Drug Gene Interaction database (DGIdb),Phenoxyethanol,,PHENOXYETHANOL,https://www.dgidb.org/drugs/rxcui:89552,,RXRA,https://www.dgidb.org/genes/hgnc:10477,,,6256.0,RXRA,9606.0,Homo sapiens (human),,,,,,,,
77,1292151,31244,Comparative Toxicogenomics Database (CTD),p-Anisaldehyde,C024896,4-anisaldehyde,https://ctdbase.org/detail.go?type=chem&acc=C024896,8989,TRPA1,https://ctdbase.org/detail.go?type=gene&acc=8989,,,8989.0,TRPA1,9606.0,Homo sapiens (human),4-anisaldehyde results in increased activity of TRPA1 protein,,,PMID:21591660,https://www.ncbi.nlm.nih.gov/pubmed/21591660,21591660,,
78,1292152,31307,Drug Gene Interaction database (DGIdb),Triamcinolone,,TRIAMCINOLONE,https://www.dgidb.org/drugs/rxcui:10759,,GLCCI1,https://www.dgidb.org/genes/hgnc:18713,,,113263.0,GLCCI1,9606.0,Homo sapiens (human),,,,,,,,
79,1292764,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,353189,SLCO4C1,https://ctdbase.org/detail.go?type=gene&acc=353189,,,353189.0,SLCO4C1,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SLCO4C1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
80,1292765,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,20555,SLFN1,https://ctdbase.org/detail.go?type=gene&acc=20555,,,20555.0,Slfn1,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SLFN1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
81,1292766,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,20556,SLFN2,https://ctdbase.org/detail.go?type=gene&acc=20556,,,20556.0,Slfn2,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of SLFN2 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
82,1292767,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,79811,SLTM,https://ctdbase.org/detail.go?type=gene&acc=79811,,,79811.0,SLTM,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of SLTM mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
83,1292768,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6597,SMARCA4,https://ctdbase.org/detail.go?type=gene&acc=6597,,,6597.0,SMARCA4,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of SMARCA4 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
84,1292769,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,10051,SMC4,https://ctdbase.org/detail.go?type=gene&acc=10051,,,10051.0,SMC4,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of SMC4 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
85,1292770,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,23347,SMCHD1,https://ctdbase.org/detail.go?type=gene&acc=23347,,,23347.0,SMCHD1,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of SMCHD1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
86,1293239,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,6491,STIL,https://ctdbase.org/detail.go?type=gene&acc=6491,,,6491.0,STIL,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of STIL mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
87,1293240,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,340061,STING1,https://ctdbase.org/detail.go?type=gene&acc=340061,,,340061.0,STING1,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of STING1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
88,1293241,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,9262,STK17B,https://ctdbase.org/detail.go?type=gene&acc=9262,,,9262.0,STK17B,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of STK17B mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
89,1294684,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,29089,UBE2T,https://ctdbase.org/detail.go?type=gene&acc=29089,,,29089.0,UBE2T,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of UBE2T mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
90,1294685,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,7337,UBE3A,https://ctdbase.org/detail.go?type=gene&acc=7337,,,7337.0,UBE3A,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of UBE3A mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
91,1294686,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,29855,UBN1,https://ctdbase.org/detail.go?type=gene&acc=29855,,,29855.0,UBN1,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of UBN1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
92,1294687,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,254048,UBN2,https://ctdbase.org/detail.go?type=gene&acc=254048,,,254048.0,UBN2,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of UBN2 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
93,1294688,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,127733,UBXN10,https://ctdbase.org/detail.go?type=gene&acc=127733,,,127733.0,UBXN10,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of UBXN10 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
94,1294689,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,23190,UBXN4,https://ctdbase.org/detail.go?type=gene&acc=23190,,,23190.0,UBXN4,10116.0,Rattus norvegicus (Norway rat),Chloroprene results in increased expression of UBXN4 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
95,1294690,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,7345,UCHL1,https://ctdbase.org/detail.go?type=gene&acc=7345,,,7345.0,UCHL1,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of UCHL1 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
96,1294691,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351.0,UCP2,10090.0,Mus musculus (house mouse),Chloroprene results in increased expression of UCP2 mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
97,1294692,31369,Comparative Toxicogenomics Database (CTD),Chloroprene,D002737,Chloroprene,https://ctdbase.org/detail.go?type=chem&acc=D002737,7357,UGCG,https://ctdbase.org/detail.go?type=gene&acc=7357,,,7357.0,UGCG,10090.0,Mus musculus (house mouse),Chloroprene results in decreased expression of UGCG mRNA,,,PMID:23125180,https://www.ncbi.nlm.nih.gov/pubmed/23125180,23125180,,
98,1292306,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606.0,Homo sapiens (human),Ursodeoxycholic acid promotes the reaction [EP300 protein binds to SLC4A2 promoter]|[ursodeoxycholic acid co-treated with dexamethasone] promotes the reaction [EP300 protein binds to NR3C1 protein binds to HNF1A protein binds to SLC4A2 promoter alternative form]|[ursodeoxycholic acid co-treated with dexamethasone] promotes the reaction [EP300 protein binds to SLC4A2 promoter]|[ursodeoxycholic acid co-treated with dexamethasone] promotes the reaction [HNF1B protein binds to NR3C1 protein binds to EP300 protein binds to SLC4A2 promoter alternative form]|[ursodeoxycholic acid co-treated with dexamethasone] promotes the reaction [EP300 protein binds to SLC4A2 promoter alternative form],,,PMID:18188457,https://www.ncbi.nlm.nih.gov/pubmed/18188457,18188457,,
99,1292307,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,79956,ERMP1,https://ctdbase.org/detail.go?type=gene&acc=79956,,,79956.0,ERMP1,9606.0,Homo sapiens (human),Ursodeoxycholic acid affects the expression of ERMP1 mRNA,,,PMID:18422935,https://www.ncbi.nlm.nih.gov/pubmed/18422935,18422935,,
100,1292308,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9606.0,Homo sapiens (human),Ursodeoxycholic acid results in decreased expression of FABP4 mRNA,,,PMID:24312631,https://www.ncbi.nlm.nih.gov/pubmed/24312631,24312631,,
101,1292309,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,2172,FABP6,https://ctdbase.org/detail.go?type=gene&acc=2172,,,2172.0,FABP6,9606.0,Homo sapiens (human),Ursodeoxycholic acid inhibits the reaction [chenodeoxycholic acid results in increased expression of FABP6 mrna]|ursodeoxycholic acid results in increased expression of FABP6 mRNA,,,PMID:15935148,https://www.ncbi.nlm.nih.gov/pubmed/15935148,15935148,,
102,1292310,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,2172,FABP6,https://ctdbase.org/detail.go?type=gene&acc=2172,,,2172.0,FABP6,10090.0,Mus musculus (house mouse),Ursodeoxycholic acid results in increased expression of FABP6 mRNA,,,PMID:25582706,https://www.ncbi.nlm.nih.gov/pubmed/25582706,25582706,,
103,1292311,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),Ursodeoxycholic acid inhibits the reaction [tretinoin results in decreased expression of MMP2 mrna],,,PMID:21274875,https://www.ncbi.nlm.nih.gov/pubmed/21274875,21274875,,
104,1292312,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10090.0,Mus musculus (house mouse),Ursodeoxycholic acid results in decreased activity of MPO protein,,,PMID:17888421,https://www.ncbi.nlm.nih.gov/pubmed/17888421,17888421,,
105,1294241,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,220323,OAF,https://ctdbase.org/detail.go?type=gene&acc=220323,,,220323.0,OAF,9606.0,Homo sapiens (human),Ursodeoxycholic acid affects the expression of OAF mRNA,,,PMID:18422935,https://www.ncbi.nlm.nih.gov/pubmed/18422935,18422935,,
106,1294242,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,26873,OPLAH,https://ctdbase.org/detail.go?type=gene&acc=26873,,,26873.0,OPLAH,10116.0,Rattus norvegicus (Norway rat),Ursodeoxycholic acid results in decreased expression of OPLAH mRNA,,,PMID:15885361,https://www.ncbi.nlm.nih.gov/pubmed/15885361,15885361,,
107,1294243,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,5005,ORM2,https://ctdbase.org/detail.go?type=gene&acc=5005,,,5005.0,ORM2,9606.0,Homo sapiens (human),Ursodeoxycholic acid affects the expression of ORM2 mRNA,,,PMID:18422935,https://www.ncbi.nlm.nih.gov/pubmed/18422935,18422935,,
108,1294244,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,5009,OTC,https://ctdbase.org/detail.go?type=gene&acc=5009,,,5009.0,OTC,10116.0,Rattus norvegicus (Norway rat),Ursodeoxycholic acid results in decreased expression of OTC mRNA,,,PMID:15885361,https://www.ncbi.nlm.nih.gov/pubmed/15885361,15885361,,
109,1294245,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|ursodeoxycholic acid results in increased cleavage of PARP1 protein|ripk1 mutant form inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|tnfrsf10b mutant form inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|fadd mutant form inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein]|methyl-beta-cyclodextrin inhibits the reaction [ursodeoxycholic acid results in increased cleavage of PARP1 protein],,,PMID:21362627,https://www.ncbi.nlm.nih.gov/pubmed/21362627,21362627,,
110,1294246,31401,Comparative Toxicogenomics Database (CTD),Ursodiol,D014580,Ursodeoxycholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014580,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[oxaliplatin co-treated with ursodeoxycholic acid] results in increased cleavage of PARP1 protein,,,PMID:19728331,https://www.ncbi.nlm.nih.gov/pubmed/19728331,19728331,,
111,1292598,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,10090.0,Mus musculus (house mouse),Doxorubicin results in increased expression of CCND3 mRNA,,,PMID:25896364,https://www.ncbi.nlm.nih.gov/pubmed/25896364,25896364,,
112,1292599,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,10090.0,Mus musculus (house mouse),[zoledronic acid co-treated with doxorubicin] results in decreased expression of CCND3 protein,,,PMID:19789217,https://www.ncbi.nlm.nih.gov/pubmed/19789217,19789217,,
113,1292600,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),SETD7 protein promotes the reaction [doxorubicin inhibits the reaction [HDAC2 protein binds to CCNE1 promoter]]|doxorubicin promotes the reaction [E2F1 protein binds to CCNE1 promoter]|setd7 protein promotes the reaction [doxorubicin results in increased expression of CCNE1 mrna]|setd7 protein promotes the reaction [doxorubicin results in increased expression of CCNE1 protein]|doxorubicin inhibits the reaction [HDAC2 protein binds to CCNE1 promoter]|doxorubicin results in increased expression of CCNE1 mrna|setd7 protein promotes the reaction [doxorubicin promotes the reaction [E2F1 protein binds to CCNE1 promoter]]|doxorubicin results in increased expression of CCNE1 protein|e2f1 protein promotes the reaction [doxorubicin results in increased expression of CCNE1 protein],,,PMID:25124555,https://www.ncbi.nlm.nih.gov/pubmed/25124555,25124555,,
114,1292601,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CCNE1 protein,,,PMID:16036217,https://www.ncbi.nlm.nih.gov/pubmed/16036217,16036217,,
115,1292602,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,10090.0,Mus musculus (house mouse),[zoledronic acid co-treated with doxorubicin] results in decreased expression of CCNE1 protein,,,PMID:19789217,https://www.ncbi.nlm.nih.gov/pubmed/19789217,19789217,,
116,1292603,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,10116.0,Rattus norvegicus (Norway rat),Doxorubicin promotes the reaction [TAF1 protein results in increased expression of CCNE1 protein],,,PMID:15124910,https://www.ncbi.nlm.nih.gov/pubmed/15124910,15124910,,
117,1292604,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),CCNE1 protein results in decreased susceptibility to doxorubicin,,,PMID:19385967,https://www.ncbi.nlm.nih.gov/pubmed/19385967,19385967,,
118,1292605,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CCNG1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
119,1293091,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,23607,CD2AP,https://ctdbase.org/detail.go?type=gene&acc=23607,,,23607.0,CD2AP,10116.0,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of CD2AP mrna|tretinoin affects the reaction [doxorubicin results in increased expression of CD2AP mrna]|tretinoin inhibits the reaction [doxorubicin results in increased expression of CD2AP protein]|doxorubicin results in increased expression of CD2AP protein|prednisone inhibits the reaction [doxorubicin results in increased expression of CD2AP protein]|prednisone affects the reaction [doxorubicin results in increased expression of CD2AP mrna]|lisinopril inhibits the reaction [doxorubicin results in increased expression of CD2AP protein],,,PMID:16636307,https://www.ncbi.nlm.nih.gov/pubmed/16636307,16636307,,
120,1293092,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,9936,CD302,https://ctdbase.org/detail.go?type=gene&acc=9936,,,9936.0,CD302,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CD302 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
121,1293093,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,51293,CD320,https://ctdbase.org/detail.go?type=gene&acc=51293,,,51293.0,CD320,9606.0,Homo sapiens (human),Doxorubicin results in increased expression of CD320 mrna|doxorubicin affects the expression of CD320 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
122,1293094,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CD34 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
123,1293095,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,10090.0,Mus musculus (house mouse),Doxorubicin results in decreased expression of CD34 protein|resveratrol affects the reaction [doxorubicin results in decreased expression of CD34 protein],,,PMID:36925030,https://www.ncbi.nlm.nih.gov/pubmed/36925030,36925030,,
124,1293577,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8556,CDC14A,https://ctdbase.org/detail.go?type=gene&acc=8556,,,8556.0,CDC14A,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CDC14A mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
125,1293578,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8555,CDC14B,https://ctdbase.org/detail.go?type=gene&acc=8555,,,8555.0,CDC14B,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CDC14B mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
126,1293579,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8881,CDC16,https://ctdbase.org/detail.go?type=gene&acc=8881,,,8881.0,CDC16,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CDC16 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
127,1293580,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,991,CDC20,https://ctdbase.org/detail.go?type=gene&acc=991,,,991.0,CDC20,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CDC20 mRNA,,,PMID:29803840|PMID:30031762,https://www.ncbi.nlm.nih.gov/pubmed/29803840|https://www.ncbi.nlm.nih.gov/pubmed/30031762,29803840|30031762,,
128,1293581,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,991,CDC20,https://ctdbase.org/detail.go?type=gene&acc=991,,,991.0,CDC20,10090.0,Mus musculus (house mouse),Doxorubicin results in increased expression of CDC20 mRNA,,,PMID:36227756,https://www.ncbi.nlm.nih.gov/pubmed/36227756,36227756,,
129,1293582,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,8697,CDC23,https://ctdbase.org/detail.go?type=gene&acc=8697,,,8697.0,CDC23,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of CDC23 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
130,1294066,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Acetaminophen inhibits the reaction [doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:17526808,https://www.ncbi.nlm.nih.gov/pubmed/17526808,17526808,,
131,1294067,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),[AKR1B10 protein results in decreased susceptibility to doxorubicin] which results in increased phosphorylation of MAPK1 protein,,,PMID:25686905,https://www.ncbi.nlm.nih.gov/pubmed/25686905,25686905,,
132,1294398,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),CDK2 protein affects the susceptibility to doxorubicin,,,PMID:16036217|PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16036217|https://www.ncbi.nlm.nih.gov/pubmed/16217747,16036217|16217747,,
133,1294399,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),[doxorubicin co-treated with TNF protein] results in increased activity of CDK2 protein|cdk2 protein results in increased susceptibility to doxorubicin,,,PMID:15823547,https://www.ncbi.nlm.nih.gov/pubmed/15823547,15823547,,
134,1294400,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),Doxorubicin affects the activity of CDK2 protein,,,PMID:16036217,https://www.ncbi.nlm.nih.gov/pubmed/16036217,16036217,,
135,1294401,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),TP53 protein inhibits the reaction [doxorubicin results in decreased activity of CDK2 protein]|doxorubicin results in decreased activity of CDK2 protein|setd7 protein inhibits the reaction [doxorubicin results in decreased activity of CDK2 protein],,,PMID:25124555,https://www.ncbi.nlm.nih.gov/pubmed/25124555,25124555,,
136,1294402,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090.0,Mus musculus (house mouse),Doxorubicin promotes the reaction [AZD 6244 results in decreased expression of CDK2 protein],,,PMID:17876044,https://www.ncbi.nlm.nih.gov/pubmed/17876044,17876044,,
137,1294403,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090.0,Mus musculus (house mouse),Doxorubicin promotes the reaction [CDK2 protein binds to FOXO1 protein]|doxorubicin promotes the reaction [CDK2 protein binds to FOXO1 protein modified form],,,PMID:32075913,https://www.ncbi.nlm.nih.gov/pubmed/32075913,32075913,,
138,1294404,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090.0,Mus musculus (house mouse),PARP1 gene mutant form inhibits the reaction [doxorubicin results in increased phosphorylation of CDK2 protein]|doxorubicin results in increased phosphorylation of CDK2 protein,,,PMID:15861398,https://www.ncbi.nlm.nih.gov/pubmed/15861398,15861398,,
139,1294405,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10090.0,Mus musculus (house mouse),[zoledronic acid co-treated with doxorubicin] results in decreased expression of CDK2 protein,,,PMID:19789217,https://www.ncbi.nlm.nih.gov/pubmed/19789217,19789217,,
140,1294406,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116.0,Rattus norvegicus (Norway rat),[roscovitine results in decreased activity of CDK2 protein] inhibits the reaction [TAF1 protein results in decreased susceptibility to doxorubicin]|taf1 protein mutant form inhibits the reaction [doxorubicin results in increased activity of CDK2 protein]|doxorubicin results in increased activity of CDK2 protein|cdk2 protein results in decreased susceptibility to doxorubicin|taf1 protein promotes the reaction [doxorubicin results in increased activity of CDK2 protein],,,PMID:15124910,https://www.ncbi.nlm.nih.gov/pubmed/15124910,15124910,,
141,1294540,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein,,,PMID:15843167|PMID:16687611|PMID:18373386,https://www.ncbi.nlm.nih.gov/pubmed/15843167|https://www.ncbi.nlm.nih.gov/pubmed/16687611|https://www.ncbi.nlm.nih.gov/pubmed/18373386,15843167|16687611|18373386,,
142,1294541,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Doxorubicin results in increased phosphorylation of MAPK1 protein,,,PMID:17384285|PMID:17384286|PMID:22155320|PMID:29087013|PMID:31010378|PMID:35843304,https://www.ncbi.nlm.nih.gov/pubmed/17384285|https://www.ncbi.nlm.nih.gov/pubmed/17384286|https://www.ncbi.nlm.nih.gov/pubmed/22155320|https://www.ncbi.nlm.nih.gov/pubmed/29087013|https://www.ncbi.nlm.nih.gov/pubmed/31010378|https://www.ncbi.nlm.nih.gov/pubmed/35843304,17384285|17384286|22155320|29087013|31010378|35843304,,
143,1294542,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Galangin inhibits the reaction [doxorubicin results in increased phosphorylation of MAPK1 protein],,,PMID:35843304,https://www.ncbi.nlm.nih.gov/pubmed/35843304,35843304,,
144,1294543,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Kaempferol inhibits the reaction [doxorubicin results in increased phosphorylation of MAPK1 protein],,,PMID:22155320,https://www.ncbi.nlm.nih.gov/pubmed/22155320,22155320,,
145,1294544,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Pifithrin inhibits the reaction [doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:16687611,https://www.ncbi.nlm.nih.gov/pubmed/16687611,16687611,,
146,1294545,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),RTKI cpd inhibits the reaction [doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein]|u 0126 inhibits the reaction [doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:15843167,https://www.ncbi.nlm.nih.gov/pubmed/15843167,15843167,,
147,1294546,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5602,MAPK10,https://ctdbase.org/detail.go?type=gene&acc=5602,,,5602.0,MAPK10,9606.0,Homo sapiens (human),Doxorubicin results in decreased expression of MAPK10 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
148,1294547,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5602,MAPK10,https://ctdbase.org/detail.go?type=gene&acc=5602,,,5602.0,MAPK10,10116.0,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of MAPK10 mRNA,,,PMID:32289291,https://www.ncbi.nlm.nih.gov/pubmed/32289291,32289291,,
149,1293388,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0004640,Carboxypeptidase Q,http://www.t3db.ca/biodb/bio_entities/BE0004640,Q9Y646,Carboxypeptidase Q,10404.0,CPQ,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
150,1293389,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0000822,Formimidoyltransferase-cyclodeaminase,http://www.t3db.ca/biodb/bio_entities/BE0000822,O95954,Formimidoyltransferase-cyclodeaminase,10841.0,FTCD,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:9837973,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/9837973,17139284|17016423|9837973,,
151,1293738,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0002244,Glutamine-dependent NAD(+) synthetase,http://www.t3db.ca/biodb/bio_entities/BE0002244,Q6IA69,Glutamine-dependent NAD(+) synthetase,55191.0,NADSYN1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
152,1293739,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0002237,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002237,O75879,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",5188.0,GATB,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
153,1293740,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0002162,Kynurenine--oxoglutarate transaminase 3,http://www.t3db.ca/biodb/bio_entities/BE0002162,Q6YP21,Kynurenine--oxoglutarate transaminase 3,56267.0,KYAT3,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
154,1293741,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0002273,Lengsin,http://www.t3db.ca/biodb/bio_entities/BE0002273,Q5TDP6,Lengsin,51557.0,LGSN,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
155,1293742,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0005571,Metabotropic glutamate receptor 6,http://www.t3db.ca/biodb/bio_entities/BE0005571,O15303,Metabotropic glutamate receptor 6,2916.0,GRM6,9606.0,Homo sapiens (human),,,,PMID:9131252|PMID:10893301,https://www.ncbi.nlm.nih.gov/pubmed/9131252|https://www.ncbi.nlm.nih.gov/pubmed/10893301,9131252|10893301,,
156,1293743,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0000834,Metabotropic glutamate receptor 7,http://www.t3db.ca/biodb/bio_entities/BE0000834,Q14831,Metabotropic glutamate receptor 7,2917.0,GRM7,9606.0,Homo sapiens (human),,,,PMID:17360958|PMID:10893301,https://www.ncbi.nlm.nih.gov/pubmed/17360958|https://www.ncbi.nlm.nih.gov/pubmed/10893301,17360958|10893301,,
157,1293744,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0002276,Mitochondrial glutamate carrier 1,http://www.t3db.ca/biodb/bio_entities/BE0002276,Q9H936,Mitochondrial glutamate carrier 1,79751.0,SLC25A22,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
158,1293745,33032,Toxin and Toxin Target Database (T3DB),Glutamic Acid,T3D4296,L-Glutamic acid,http://www.t3db.ca/toxins/T3D4296,BE0002275,Mitochondrial glutamate carrier 2,http://www.t3db.ca/biodb/bio_entities/BE0002275,Q9H1K4,Mitochondrial glutamate carrier 2,83733.0,SLC25A18,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
159,1294237,36314,Drug Gene Interaction database (DGIdb),Paclitaxel,,PACLITAXEL,https://www.dgidb.org/drugs/rxcui:56946,,PIK3CA,https://www.dgidb.org/genes/hgnc:8975,,,5290.0,PIK3CA,9606.0,Homo sapiens (human),,,,,,,,
160,1294238,36314,Drug Gene Interaction database (DGIdb),Paclitaxel,,PACLITAXEL,https://www.dgidb.org/drugs/rxcui:56946,,CHEK1,https://www.dgidb.org/genes/hgnc:1925,,,1111.0,CHEK1,9606.0,Homo sapiens (human),,,,,,,,
161,1294239,36314,Drug Gene Interaction database (DGIdb),Paclitaxel,,PACLITAXEL,https://www.dgidb.org/drugs/rxcui:56946,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
162,1294240,36314,Drug Gene Interaction database (DGIdb),Paclitaxel,,PACLITAXEL,https://www.dgidb.org/drugs/rxcui:56946,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606.0,Homo sapiens (human),,,,,,,,
163,1292606,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,166793,ZBTB49,https://ctdbase.org/detail.go?type=gene&acc=166793,,,166793.0,ZBTB49,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB49 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
164,1293096,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,147841,SPC24,https://ctdbase.org/detail.go?type=gene&acc=147841,,,147841.0,SPC24,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPC24 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
165,1293097,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,57405,SPC25,https://ctdbase.org/detail.go?type=gene&acc=57405,,,57405.0,SPC25,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPC25 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
166,1293098,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,9789,SPCS2,https://ctdbase.org/detail.go?type=gene&acc=9789,,,9789.0,SPCS2,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPCS2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
167,1293099,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,54908,SPDL1,https://ctdbase.org/detail.go?type=gene&acc=54908,,,54908.0,SPDL1,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPDL1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
168,1294821,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,160418,TMTC3,https://ctdbase.org/detail.go?type=gene&acc=160418,,,160418.0,TMTC3,10090.0,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMTC3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
169,1294822,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,3371,TNC,https://ctdbase.org/detail.go?type=gene&acc=3371,,,3371.0,TNC,9606.0,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of TNC mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
170,1411098,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,8339,H2BC8,https://ctdbase.org/detail.go?type=gene&acc=8339,,,8339.0,H2BC8,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of H2BC8 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
171,1411099,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,8345,H2BC9,https://ctdbase.org/detail.go?type=gene&acc=8345,,,8345.0,H2BC9,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of H2BC9 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
172,1411100,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,337875,H2BP1,https://ctdbase.org/detail.go?type=gene&acc=337875,,,337875.0,H2BP1,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in decreased expression of H2BP1 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
173,1411101,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,8350,H3C1,https://ctdbase.org/detail.go?type=gene&acc=8350,,,8350.0,H3C1,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of H3C1 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
174,1411102,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,8354,H3C11,https://ctdbase.org/detail.go?type=gene&acc=8354,,,8354.0,H3C11,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in decreased expression of H3C11 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
175,1411103,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,8356,H3C12,https://ctdbase.org/detail.go?type=gene&acc=8356,,,8356.0,H3C12,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in decreased expression of H3C12 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
176,1412114,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of JUN mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
177,1412115,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,3726,JUNB,https://ctdbase.org/detail.go?type=gene&acc=3726,,,3726.0,JUNB,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of JUNB mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
178,1412116,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,84541,KBTBD8,https://ctdbase.org/detail.go?type=gene&acc=84541,,,84541.0,KBTBD8,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of KBTBD8 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
179,1412117,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759.0,KCNJ2,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of KCNJ2 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
180,1412118,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,3775,KCNK1,https://ctdbase.org/detail.go?type=gene&acc=3775,,,3775.0,KCNK1,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of KCNK1 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
181,1412119,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,27345,KCNMB4,https://ctdbase.org/detail.go?type=gene&acc=27345,,,27345.0,KCNMB4,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of KCNMB4 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
182,1412120,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,10984,KCNQ1OT1,https://ctdbase.org/detail.go?type=gene&acc=10984,,,10984.0,KCNQ1OT1,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of KCNQ1OT1 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
183,1413761,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,100616258,MIR4516,https://ctdbase.org/detail.go?type=gene&acc=100616258,,,100616258.0,MIR4516,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of MIR4516 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
184,1413762,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,100616406,MIR4521,https://ctdbase.org/detail.go?type=gene&acc=100616406,,,100616406.0,MIR4521,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of MIR4521 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
185,1413763,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,100616196,MIR4525,https://ctdbase.org/detail.go?type=gene&acc=100616196,,,100616196.0,MIR4525,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of MIR4525 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
186,1413764,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,100616114,MIR4668,https://ctdbase.org/detail.go?type=gene&acc=100616114,,,100616114.0,MIR4668,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in decreased expression of MIR4668 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
187,1414394,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in decreased expression of NFKBIA protein,,,PMID:29110394,https://www.ncbi.nlm.nih.gov/pubmed/29110394,29110394,,
188,1414395,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,64332,NFKBIZ,https://ctdbase.org/detail.go?type=gene&acc=64332,,,64332.0,NFKBIZ,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of NFKBIZ mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
189,1414396,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,374354,NHLRC2,https://ctdbase.org/detail.go?type=gene&acc=374354,,,374354.0,NHLRC2,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in decreased expression of NHLRC2 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
190,1414397,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,4824,NKX3-1,https://ctdbase.org/detail.go?type=gene&acc=4824,,,4824.0,NKX3-1,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of NKX3-1 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
191,1414398,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,25819,NOCT,https://ctdbase.org/detail.go?type=gene&acc=25819,,,25819.0,NOCT,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of NOCT mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
192,1414399,39800,Comparative Toxicogenomics Database (CTD),2-Methyl-4-isothiazolin-3-one,C011506,2-methyl-4-isothiazolin-3-one,https://ctdbase.org/detail.go?type=chem&acc=C011506,51491,NOP16,https://ctdbase.org/detail.go?type=gene&acc=51491,,,51491.0,NOP16,9606.0,Homo sapiens (human),2-methyl-4-isothiazolin-3-one results in increased expression of NOP16 mRNA,,,PMID:31629900,https://www.ncbi.nlm.nih.gov/pubmed/31629900,31629900,,
193,1292947,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,5225,PGC,https://ctdbase.org/detail.go?type=gene&acc=5225,,,5225.0,PGC,10116.0,Rattus norvegicus (Norway rat),"2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PGC mRNA",,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
194,1292948,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,9749,PHACTR2,https://ctdbase.org/detail.go?type=gene&acc=9749,,,9749.0,PHACTR2,10090.0,Mus musculus (house mouse),"2,3,7,8-tetrachlorodibenzofuran affects the expression of PHACTR2 mRNA",,,PMID:20702594,https://www.ncbi.nlm.nih.gov/pubmed/20702594,20702594,,
195,1292949,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,5245,PHB1,https://ctdbase.org/detail.go?type=gene&acc=5245,,,5245.0,PHB1,10090.0,Mus musculus (house mouse),"2,3,7,8-tetrachlorodibenzofuran affects the expression of PHB1 mRNA",,,PMID:20702594,https://www.ncbi.nlm.nih.gov/pubmed/20702594,20702594,,
196,1295138,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,57589,RIC1,https://ctdbase.org/detail.go?type=gene&acc=57589,,,57589.0,RIC1,10116.0,Rattus norvegicus (Norway rat),"2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RIC1 mRNA",,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
197,1295139,39929,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzofuran",C014211,"2,3,7,8-tetrachlorodibenzofuran",https://ctdbase.org/detail.go?type=chem&acc=C014211,284485,RIIAD1,https://ctdbase.org/detail.go?type=gene&acc=284485,,,284485.0,RIIAD1,10116.0,Rattus norvegicus (Norway rat),"2,3,7,8-tetrachlorodibenzofuran results in increased expression of RIIAD1 mRNA",,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
198,1410798,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of GPX7 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
199,1410799,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,493869,GPX8,https://ctdbase.org/detail.go?type=gene&acc=493869,,,493869.0,GPX8,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of GPX8 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
200,1410800,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,57476,GRAMD1B,https://ctdbase.org/detail.go?type=gene&acc=57476,,,57476.0,GRAMD1B,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of GRAMD1B mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
201,1412428,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3015,H2AZ1,https://ctdbase.org/detail.go?type=gene&acc=3015,,,3015.0,H2AZ1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2AZ1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
202,1412429,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,94239,H2AZ2,https://ctdbase.org/detail.go?type=gene&acc=94239,,,94239.0,H2AZ2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2AZ2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
203,1412430,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2BC12 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
204,1412431,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8340,H2BC13,https://ctdbase.org/detail.go?type=gene&acc=8340,,,8340.0,H2BC13,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2BC13 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
205,1412432,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8349,H2BC21,https://ctdbase.org/detail.go?type=gene&acc=8349,,,8349.0,H2BC21,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2BC21 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
206,1412433,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3018,H2BC3,https://ctdbase.org/detail.go?type=gene&acc=3018,,,3018.0,H2BC3,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2BC3 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
207,1412434,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8347,H2BC4,https://ctdbase.org/detail.go?type=gene&acc=8347,,,8347.0,H2BC4,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2BC4 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
208,1412435,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,8339,H2BC8,https://ctdbase.org/detail.go?type=gene&acc=8339,,,8339.0,H2BC8,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of H2BC8 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
209,1412436,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,14964,H2-D1,https://ctdbase.org/detail.go?type=gene&acc=14964,,,14964.0,H2-D1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of H2-D1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
210,1413032,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54801,HAUS6,https://ctdbase.org/detail.go?type=gene&acc=54801,,,54801.0,HAUS6,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HAUS6 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
211,1413033,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,93323,HAUS8,https://ctdbase.org/detail.go?type=gene&acc=93323,,,93323.0,HAUS8,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HAUS8 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
212,1413034,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,84868,HAVCR2,https://ctdbase.org/detail.go?type=gene&acc=84868,,,84868.0,HAVCR2,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HAVCR2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
213,1413035,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,10456,HAX1,https://ctdbase.org/detail.go?type=gene&acc=10456,,,10456.0,HAX1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HAX1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
214,1413036,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,10456,HAX1,https://ctdbase.org/detail.go?type=gene&acc=10456,,,10456.0,HAX1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HAX1 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
215,1413037,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,15126,HBA-X,https://ctdbase.org/detail.go?type=gene&acc=15126,,,15126.0,Hba-x,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HBA-X mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
216,1413038,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,15132,HBB-BH1,https://ctdbase.org/detail.go?type=gene&acc=15132,,,15132.0,Hbb-bh1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HBB-BH1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
217,1413039,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,15135,HBB-Y,https://ctdbase.org/detail.go?type=gene&acc=15135,,,15135.0,Hbb-y,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HBB-Y mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
218,1413040,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,1839,HBEGF,https://ctdbase.org/detail.go?type=gene&acc=1839,,,1839.0,HBEGF,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HBEGF mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
219,1414063,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,23119,HIC2,https://ctdbase.org/detail.go?type=gene&acc=23119,,,23119.0,HIC2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HIC2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
220,1414064,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,283987,HID1,https://ctdbase.org/detail.go?type=gene&acc=283987,,,283987.0,HID1,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HID1 mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
221,1414065,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HIF1A mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
222,1414066,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of HIF1A mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
223,1414067,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in increased expression of HIF1A mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
224,1414068,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,55662,HIF1AN,https://ctdbase.org/detail.go?type=gene&acc=55662,,,55662.0,HIF1AN,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HIF1AN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
225,1414568,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of HMGCR mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
226,1414569,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of HMGCR mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
227,1414570,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCR mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
228,1414571,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
229,1414572,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of HMGCS1 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
230,1414573,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of HMGCS1 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
231,1414693,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3161,HMMR,https://ctdbase.org/detail.go?type=gene&acc=3161,,,3161.0,HMMR,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HMMR mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
232,1414694,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,93934.0,Coturnix japonica (Japanese quail),Decamethrin results in decreased expression of HMOX1 protein|decamethrin results in decreased expression of HMOX1 mRNA,,,PMID:34216712,https://www.ncbi.nlm.nih.gov/pubmed/34216712,34216712,,
233,1414695,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HMOX1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
234,1415555,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,9951,HS3ST4,https://ctdbase.org/detail.go?type=gene&acc=9951,,,9951.0,HS3ST4,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HS3ST4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
235,1415556,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,64711,HS3ST6,https://ctdbase.org/detail.go?type=gene&acc=64711,,,64711.0,HS3ST6,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HS3ST6 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
236,1415795,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3298,HSF2,https://ctdbase.org/detail.go?type=gene&acc=3298,,,3298.0,HSF2,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSF2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
237,1415796,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3298,HSF2,https://ctdbase.org/detail.go?type=gene&acc=3298,,,3298.0,HSF2,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
238,1415797,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3298,HSF2,https://ctdbase.org/detail.go?type=gene&acc=3298,,,3298.0,HSF2,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of HSF2 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
239,1415798,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3298,HSF2,https://ctdbase.org/detail.go?type=gene&acc=3298,,,3298.0,HSF2,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of HSF2 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
240,1415799,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3299,HSF4,https://ctdbase.org/detail.go?type=gene&acc=3299,,,3299.0,HSF4,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HSF4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
241,1415800,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,84941,HSH2D,https://ctdbase.org/detail.go?type=gene&acc=84941,,,84941.0,HSH2D,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSH2D mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
242,1415801,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,39078,HSP27,https://ctdbase.org/detail.go?type=gene&acc=39078,,,39078.0,Hsp27,10116.0,Rattus norvegicus (Norway rat),Decamethrin results in increased expression of HSP27 mRNA,,,PMID:19017407,https://www.ncbi.nlm.nih.gov/pubmed/19017407,19017407,,
243,1415802,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,403612,HSP70,https://ctdbase.org/detail.go?type=gene&acc=403612,,,403612.0,HSP70,304456.0,Channa punctata (spotted snakehead),Decamethrin results in increased expression of HSP70 protein,,,PMID:21801715,https://www.ncbi.nlm.nih.gov/pubmed/21801715,21801715,,
244,1415803,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSP90AA1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
245,1415918,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184.0,HSP90B1,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of HSP90B1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
246,1415919,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,116835,HSPA12B,https://ctdbase.org/detail.go?type=gene&acc=116835,,,116835.0,HSPA12B,10090.0,Mus musculus (house mouse),Decamethrin affects the expression of HSPA12B mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
247,1415920,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6782,HSPA13,https://ctdbase.org/detail.go?type=gene&acc=6782,,,6782.0,HSPA13,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HSPA13 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
248,1415921,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,51182,HSPA14,https://ctdbase.org/detail.go?type=gene&acc=51182,,,51182.0,HSPA14,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSPA14 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
249,1415922,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HSPA1A mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
250,1415923,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3308,HSPA4,https://ctdbase.org/detail.go?type=gene&acc=3308,,,3308.0,HSPA4,10116.0,Rattus norvegicus (Norway rat),Decamethrin results in increased expression of HSPA4 mRNA,,,PMID:22889898|PMID:23076637,https://www.ncbi.nlm.nih.gov/pubmed/22889898|https://www.ncbi.nlm.nih.gov/pubmed/23076637,22889898|23076637,,
251,1415924,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3308,HSPA4,https://ctdbase.org/detail.go?type=gene&acc=3308,,,3308.0,HSPA4,10116.0,Rattus norvegicus (Norway rat),Lycopene inhibits the reaction [decamethrin results in increased expression of HSPA4 mrna],,,PMID:23076637,https://www.ncbi.nlm.nih.gov/pubmed/23076637,23076637,,
252,1415925,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,22824,HSPA4L,https://ctdbase.org/detail.go?type=gene&acc=22824,,,22824.0,HSPA4L,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSPA4L mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
253,1416048,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26353,HSPB8,https://ctdbase.org/detail.go?type=gene&acc=26353,,,26353.0,HSPB8,10090.0,Mus musculus (house mouse),Decamethrin results in increased expression of HSPB8 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
254,1416049,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,79663,HSPBAP1,https://ctdbase.org/detail.go?type=gene&acc=79663,,,79663.0,HSPBAP1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSPBAP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
255,1416050,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,23640,HSPBP1,https://ctdbase.org/detail.go?type=gene&acc=23640,,,23640.0,HSPBP1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSPBP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
256,1416051,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSPD1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
257,1416052,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,10090.0,Mus musculus (house mouse),Decamethrin results in decreased expression of HSPE1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
258,1410601,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of G0S2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
259,1410602,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of G6PC1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
260,1410603,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,14381,G6PDX,https://ctdbase.org/detail.go?type=gene&acc=14381,,,14381.0,G6pdx,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of G6PDX mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
261,1410604,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,11337,GABARAP,https://ctdbase.org/detail.go?type=gene&acc=11337,,,11337.0,GABARAP,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GABARAP mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
262,1410605,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2550,GABBR1,https://ctdbase.org/detail.go?type=gene&acc=2550,,,2550.0,GABBR1,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of GABBR1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
263,1410606,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9568,GABBR2,https://ctdbase.org/detail.go?type=gene&acc=9568,,,9568.0,GABBR2,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GABBR2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
264,1411104,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,347862,GATD1,https://ctdbase.org/detail.go?type=gene&acc=347862,,,347862.0,GATD1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GATD1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
265,1411105,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,8729,GBF1,https://ctdbase.org/detail.go?type=gene&acc=8729,,,8729.0,GBF1,10090.0,Mus musculus (house mouse),Triptonide affects the expression of GBF1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
266,1411355,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GFAP mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
267,1411356,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9945,GFPT2,https://ctdbase.org/detail.go?type=gene&acc=9945,,,9945.0,GFPT2,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GFPT2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
268,1411357,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2676,GFRA3,https://ctdbase.org/detail.go?type=gene&acc=2676,,,2676.0,GFRA3,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GFRA3 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
269,1411358,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,199720,GGN,https://ctdbase.org/detail.go?type=gene&acc=199720,,,199720.0,GGN,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GGN mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
270,1411359,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GGT1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
271,1411360,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,14599,GH,https://ctdbase.org/detail.go?type=gene&acc=14599,,,14599.0,Gh,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of GH mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
272,1413765,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,8339,H2BC8,https://ctdbase.org/detail.go?type=gene&acc=8339,,,8339.0,H2BC8,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of H2BC8 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
273,1413766,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,14964,H2-D1,https://ctdbase.org/detail.go?type=gene&acc=14964,,,14964.0,H2-D1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of H2-D1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
274,1413767,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,14998,H2-DMA,https://ctdbase.org/detail.go?type=gene&acc=14998,,,14998.0,H2-DMa,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of H2-DMA mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
275,1413768,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,14969,H2-EB1,https://ctdbase.org/detail.go?type=gene&acc=14969,,,14969.0,H2-Eb1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of H2-EB1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
276,1413769,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,14972,H2-K1,https://ctdbase.org/detail.go?type=gene&acc=14972,,,14972.0,H2-K1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of H2-K1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
277,1414400,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,220296,HEPACAM,https://ctdbase.org/detail.go?type=gene&acc=220296,,,220296.0,HEPACAM,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HEPACAM mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
278,1414401,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,253012,HEPACAM2,https://ctdbase.org/detail.go?type=gene&acc=253012,,,253012.0,HEPACAM2,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HEPACAM2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
279,1414402,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9843,HEPH,https://ctdbase.org/detail.go?type=gene&acc=9843,,,9843.0,HEPH,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HEPH mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
280,1415029,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,3188,HNRNPH2,https://ctdbase.org/detail.go?type=gene&acc=3188,,,3188.0,HNRNPH2,10090.0,Mus musculus (house mouse),Triptonide affects the expression of HNRNPH2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
281,1415030,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,3190,HNRNPK,https://ctdbase.org/detail.go?type=gene&acc=3190,,,3190.0,HNRNPK,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HNRNPK mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
282,1415031,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,3191,HNRNPL,https://ctdbase.org/detail.go?type=gene&acc=3191,,,3191.0,HNRNPL,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HNRNPL mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
283,1415032,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,92906,HNRNPLL,https://ctdbase.org/detail.go?type=gene&acc=92906,,,92906.0,HNRNPLL,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HNRNPLL mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
284,1415033,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,4670,HNRNPM,https://ctdbase.org/detail.go?type=gene&acc=4670,,,4670.0,HNRNPM,10090.0,Mus musculus (house mouse),Triptonide affects the expression of HNRNPM mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
285,1415034,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,10236,HNRNPR,https://ctdbase.org/detail.go?type=gene&acc=10236,,,10236.0,HNRNPR,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HNRNPR mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
286,1415035,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,11100,HNRNPUL1,https://ctdbase.org/detail.go?type=gene&acc=11100,,,11100.0,HNRNPUL1,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HNRNPUL1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
287,1415036,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,112817,HOGA1,https://ctdbase.org/detail.go?type=gene&acc=112817,,,112817.0,HOGA1,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HOGA1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
288,1415284,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,3270,HRC,https://ctdbase.org/detail.go?type=gene&acc=3270,,,3270.0,HRC,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HRC mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
289,1415285,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,11255,HRH3,https://ctdbase.org/detail.go?type=gene&acc=11255,,,11255.0,HRH3,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HRH3 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
290,1415286,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,59340,HRH4,https://ctdbase.org/detail.go?type=gene&acc=59340,,,59340.0,HRH4,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HRH4 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
291,1415287,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9957,HS3ST1,https://ctdbase.org/detail.go?type=gene&acc=9957,,,9957.0,HS3ST1,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HS3ST1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
292,1415288,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9955,HS3ST3A1,https://ctdbase.org/detail.go?type=gene&acc=9955,,,9955.0,HS3ST3A1,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HS3ST3A1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
293,1415289,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,64711,HS3ST6,https://ctdbase.org/detail.go?type=gene&acc=64711,,,64711.0,HS3ST6,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HS3ST6 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
294,1415290,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9394,HS6ST1,https://ctdbase.org/detail.go?type=gene&acc=9394,,,9394.0,HS6ST1,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HS6ST1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
295,1415410,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,11077,HSF2BP,https://ctdbase.org/detail.go?type=gene&acc=11077,,,11077.0,HSF2BP,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HSF2BP mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
296,1415411,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,84941,HSH2D,https://ctdbase.org/detail.go?type=gene&acc=84941,,,84941.0,HSH2D,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HSH2D mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
297,1415412,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,3305,HSPA1L,https://ctdbase.org/detail.go?type=gene&acc=3305,,,3305.0,HSPA1L,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HSPA1L mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
298,1415413,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,3306,HSPA2,https://ctdbase.org/detail.go?type=gene&acc=3306,,,3306.0,HSPA2,10090.0,Mus musculus (house mouse),Triptonide results in increased expression of HSPA2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
299,1415414,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,22824,HSPA4L,https://ctdbase.org/detail.go?type=gene&acc=22824,,,22824.0,HSPA4L,10090.0,Mus musculus (house mouse),Triptonide results in decreased expression of HSPA4L mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
300,1411670,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,84617,TUBB6,https://ctdbase.org/detail.go?type=gene&acc=84617,,,84617.0,TUBB6,10116.0,Rattus norvegicus (Norway rat),Nonylphenol results in decreased expression of TUBB6 protein,,,PMID:19260726,https://www.ncbi.nlm.nih.gov/pubmed/19260726,19260726,,
301,1411671,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,7284,TUFM,https://ctdbase.org/detail.go?type=gene&acc=7284,,,7284.0,TUFM,10116.0,Rattus norvegicus (Norway rat),Nonylphenol results in increased expression of TUFM protein,,,PMID:19260726,https://www.ncbi.nlm.nih.gov/pubmed/19260726,19260726,,
302,1411672,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,7332,UBE2L3,https://ctdbase.org/detail.go?type=gene&acc=7332,,,7332.0,UBE2L3,8355.0,Xenopus laevis (African clawed frog),Nonylphenol affects the expression of UBE2L3 mRNA,,,PMID:15364205,https://www.ncbi.nlm.nih.gov/pubmed/15364205,15364205,,
303,1411673,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,7335,UBE2V1,https://ctdbase.org/detail.go?type=gene&acc=7335,,,7335.0,UBE2V1,8022.0,Oncorhynchus mykiss (rainbow trout),Nonylphenol results in decreased expression of UBE2V1 mRNA,,,PMID:22982499,https://www.ncbi.nlm.nih.gov/pubmed/22982499,22982499,,
304,1411674,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,56893,UBQLN4,https://ctdbase.org/detail.go?type=gene&acc=56893,,,56893.0,UBQLN4,8022.0,Oncorhynchus mykiss (rainbow trout),Nonylphenol results in increased expression of UBQLN4 mRNA,,,PMID:22982499,https://www.ncbi.nlm.nih.gov/pubmed/22982499,22982499,,
305,1411675,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351.0,UCP2,10090.0,Mus musculus (house mouse),Nonylphenol results in decreased expression of UCP2 mRNA,,,PMID:32645552,https://www.ncbi.nlm.nih.gov/pubmed/32645552,32645552,,
306,1411676,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351.0,UCP2,10116.0,Rattus norvegicus (Norway rat),Nonylphenol results in increased expression of UCP2 mRNA,,,PMID:22946080,https://www.ncbi.nlm.nih.gov/pubmed/22946080,22946080,,
307,1411677,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,105218533,UGT1,https://ctdbase.org/detail.go?type=gene&acc=105218533,,,105218533.0,,8030.0,Salmo salar (Atlantic salmon),Nonylphenol results in increased expression of UGT1 mRNA,,,PMID:32373476,https://www.ncbi.nlm.nih.gov/pubmed/32373476,32373476,,
308,1411678,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,71773,UGT2B1,https://ctdbase.org/detail.go?type=gene&acc=71773,,,71773.0,Ugt2b1,10116.0,Rattus norvegicus (Norway rat),UGT2B1 protein results in increased glucuronidation of nonylphenol,,,PMID:11836149,https://www.ncbi.nlm.nih.gov/pubmed/11836149,11836149,,
309,1412437,67636,Comparative Toxicogenomics Database (CTD),Perfluorodecane sulfonic acid,C000720114,perfluorodecanesulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C000720114,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,9606.0,Homo sapiens (human),Perfluorodecanesulfonic acid results in increased expression of GSTA5 mRNA,,,PMID:33772556,https://www.ncbi.nlm.nih.gov/pubmed/33772556,33772556,,
310,1414204,67944,Therapeutic Target Database (TTD),"1,3-Benzothiazole-2-sulfonamide",D0XL5K,Benzothiazole-2-sulfonic acid amide,https://idrblab.net/ttd/data/drug/details/D0XL5K,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
311,1414205,68176,Toxin and Toxin Target Database (T3DB),Thionyl bromide,T3D1764,Thionyl bromide,http://www.t3db.ca/toxins/T3D1764,BE0005290,Chloride channel protein 1,http://www.t3db.ca/biodb/bio_entities/BE0005290,P35523,Chloride channel protein 1,1180.0,CLCN1,9606.0,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
312,1414206,68176,Toxin and Toxin Target Database (T3DB),Thionyl bromide,T3D1764,Thionyl bromide,http://www.t3db.ca/toxins/T3D1764,BE0002376,Chloride channel protein ClC-Ka,http://www.t3db.ca/biodb/bio_entities/BE0002376,P51800,Chloride channel protein ClC-Ka,1187.0,CLCNKA,9606.0,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
313,1414207,68176,Toxin and Toxin Target Database (T3DB),Thionyl bromide,T3D1764,Thionyl bromide,http://www.t3db.ca/toxins/T3D1764,BE0005283,Chloride channel protein ClC-Kb,http://www.t3db.ca/biodb/bio_entities/BE0005283,P51801,Chloride channel protein ClC-Kb ,1188.0,CLCNKB,9606.0,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
314,1414208,68176,Toxin and Toxin Target Database (T3DB),Thionyl bromide,T3D1764,Thionyl bromide,http://www.t3db.ca/toxins/T3D1764,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
315,1414209,68176,Toxin and Toxin Target Database (T3DB),Thionyl bromide,T3D1764,Thionyl bromide,http://www.t3db.ca/toxins/T3D1764,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0002345,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
316,1414210,68176,Toxin and Toxin Target Database (T3DB),Thionyl bromide,T3D1764,Thionyl bromide,http://www.t3db.ca/toxins/T3D1764,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,http://www.t3db.ca/biodb/bio_entities/BE0003592,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
317,1416053,68740,Comparative Toxicogenomics Database (CTD),Zoledronic acid,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,9283,GPR37L1,https://ctdbase.org/detail.go?type=gene&acc=9283,,,9283.0,GPR37L1,9606.0,Homo sapiens (human),Zoledronic acid results in increased expression of GPR37L1 mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,
318,1416054,68740,Comparative Toxicogenomics Database (CTD),Zoledronic acid,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,9052,GPRC5A,https://ctdbase.org/detail.go?type=gene&acc=9052,,,9052.0,GPRC5A,9606.0,Homo sapiens (human),Zoledronic acid results in decreased expression of GPRC5A mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,
319,1416055,68740,Comparative Toxicogenomics Database (CTD),Zoledronic acid,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,2888,GRB14,https://ctdbase.org/detail.go?type=gene&acc=2888,,,2888.0,GRB14,9606.0,Homo sapiens (human),Zoledronic acid results in decreased expression of GRB14 mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,
320,1416056,68740,Comparative Toxicogenomics Database (CTD),Zoledronic acid,D000077211,Zoledronic Acid,https://ctdbase.org/detail.go?type=chem&acc=D000077211,80852,GRIP2,https://ctdbase.org/detail.go?type=gene&acc=80852,,,80852.0,GRIP2,9606.0,Homo sapiens (human),Zoledronic acid results in increased expression of GRIP2 mRNA,,,PMID:24714768,https://www.ncbi.nlm.nih.gov/pubmed/24714768,24714768,,
321,1293390,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116.0,Rattus norvegicus (Norway rat),Ceric oxide results in decreased expression of SPP1 mRNA,,,PMID:29463257,https://www.ncbi.nlm.nih.gov/pubmed/29463257,29463257,,
322,1293391,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,6901,TAFAZZIN,https://ctdbase.org/detail.go?type=gene&acc=6901,,,6901.0,TAFAZZIN,9606.0,Homo sapiens (human),Ceric oxide analog results in decreased expression of TAFAZZIN mRNA,,,PMID:24821434,https://www.ncbi.nlm.nih.gov/pubmed/24821434,24821434,,
323,1293392,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,114609,TIRAP,https://ctdbase.org/detail.go?type=gene&acc=114609,,,114609.0,TIRAP,9606.0,Homo sapiens (human),Ceric oxide analog results in decreased expression of TIRAP mRNA,,,PMID:24821434,https://www.ncbi.nlm.nih.gov/pubmed/24821434,24821434,,
324,1293393,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,10333,TLR6,https://ctdbase.org/detail.go?type=gene&acc=10333,,,10333.0,TLR6,9606.0,Homo sapiens (human),Ceric oxide analog results in decreased expression of TLR6 mRNA,,,PMID:24821434,https://www.ncbi.nlm.nih.gov/pubmed/24821434,24821434,,
325,1293394,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Ceric oxide results in increased expression of TNF protein,,,PMID:27693598,https://www.ncbi.nlm.nih.gov/pubmed/27693598,27693598,,
326,1293395,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Ceric oxide results in increased expression of TNF protein,,,PMID:21624445,https://www.ncbi.nlm.nih.gov/pubmed/21624445,21624445,,
327,1293396,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,7292,TNFSF4,https://ctdbase.org/detail.go?type=gene&acc=7292,,,7292.0,TNFSF4,10116.0,Rattus norvegicus (Norway rat),Ceric oxide affects the expression of TNFSF4 mRNA,,,PMID:29463257,https://www.ncbi.nlm.nih.gov/pubmed/29463257,29463257,,
328,1293397,73963,Comparative Toxicogenomics Database (CTD),Ceric oxide,C030583,ceric oxide,https://ctdbase.org/detail.go?type=chem&acc=C030583,54472,TOLLIP,https://ctdbase.org/detail.go?type=gene&acc=54472,,,54472.0,TOLLIP,9606.0,Homo sapiens (human),Ceric oxide analog results in decreased expression of TOLLIP mRNA,,,PMID:24821434,https://www.ncbi.nlm.nih.gov/pubmed/24821434,24821434,,
329,1381164,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596.0,GAP43,10090.0,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of GAP43 protein,,,PMID:19211617,https://www.ncbi.nlm.nih.gov/pubmed/19211617,19211617,,
330,1515458,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276.0,TTR,7955.0,Danio rerio (zebrafish),"[perchlorate co-treated with 2,2',4,4'-tetrabromodiphenyl ether] results in decreased expression of TTR mrna|[perchlorate co-treated with 2,2',4,4'-tetrabromodiphenyl ether] results in decreased expression of TTR protein",,,PMID:24177579,https://www.ncbi.nlm.nih.gov/pubmed/24177579,24177579,,
331,1515459,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276.0,TTR,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog binds to TTR protein",,,PMID:20804816,https://www.ncbi.nlm.nih.gov/pubmed/20804816,20804816,,
332,1515460,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276.0,TTR,9606.0,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [thyroxine binds to TTR protein]|2,2',4,4'-tetrabromodiphenyl ether analog inhibits the reaction [thyroxine binds to TTR protein]",,,PMID:16601080,https://www.ncbi.nlm.nih.gov/pubmed/16601080,16601080,,
333,1412889,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [fludioxonil results in increased expression of CCNE1 protein],,,PMID:27539251,https://www.ncbi.nlm.nih.gov/pubmed/27539251,27539251,,
334,1415169,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,57019,CIAPIN1,https://ctdbase.org/detail.go?type=gene&acc=57019,,,57019.0,CIAPIN1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of CIAPIN1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
335,1415170,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10519,CIB1,https://ctdbase.org/detail.go?type=gene&acc=10519,,,10519.0,CIB1,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of CIB1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
336,1415171,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,642924,CIBAR1-DT,https://ctdbase.org/detail.go?type=gene&acc=642924,,,642924.0,CIBAR1-DT,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of CIBAR1-DT gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
337,1415172,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,113746,CIMAP1A,https://ctdbase.org/detail.go?type=gene&acc=113746,,,113746.0,CIMAP1A,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of CIMAP1A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
338,1415173,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,163747,CIMAP2,https://ctdbase.org/detail.go?type=gene&acc=163747,,,163747.0,CIMAP2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of CIMAP2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
339,1415174,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,339778,CIMIP2C,https://ctdbase.org/detail.go?type=gene&acc=339778,,,339778.0,CIMIP2C,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of CIMIP2C gene|fulvestrant results in increased methylation of CIMIP2C gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
340,1415175,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10370,CITED2,https://ctdbase.org/detail.go?type=gene&acc=10370,,,10370.0,CITED2,9606.0,Homo sapiens (human),Estradiol inhibits the reaction [fulvestrant results in increased expression of CITED2 mrna]|fulvestrant results in increased expression of CITED2 mRNA,,,PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/31646340,31646340,,
341,1415176,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,1152,CKB,https://ctdbase.org/detail.go?type=gene&acc=1152,,,1152.0,CKB,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in decreased expression of CKB mrna]|fulvestrant results in increased expression of CKB mRNA,,,PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/31646340,31646340,,
342,1513883,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7474,WNT5A,https://ctdbase.org/detail.go?type=gene&acc=7474,,,7474.0,WNT5A,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of WNT5A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
343,1513884,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,81029,WNT5B,https://ctdbase.org/detail.go?type=gene&acc=81029,,,81029.0,WNT5B,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of WNT5B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
344,1513885,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7476,WNT7A,https://ctdbase.org/detail.go?type=gene&acc=7476,,,7476.0,WNT7A,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in decreased expression of WNT7A mrna],,,PMID:16534752,https://www.ncbi.nlm.nih.gov/pubmed/16534752,16534752,,
345,1513886,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7490,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490.0,WT1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of WT1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
346,1513887,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7490,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490.0,WT1,9606.0,Homo sapiens (human),WT1 protein results in decreased susceptibility to fulvestrant,,,PMID:20204298,https://www.ncbi.nlm.nih.gov/pubmed/20204298,20204298,,
347,1513888,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23286,WWC1,https://ctdbase.org/detail.go?type=gene&acc=23286,,,23286.0,WWC1,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of WWC1 mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
348,1513889,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of WWOX gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
349,1513890,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7494,XBP1,https://ctdbase.org/detail.go?type=gene&acc=7494,,,7494.0,XBP1,7955.0,Danio rerio (zebrafish),Fulvestrant inhibits the reaction [bavachin results in increased expression of XBP1 mrna]|fulvestrant results in decreased expression of XBP1 mRNA,,,PMID:37586115,https://www.ncbi.nlm.nih.gov/pubmed/37586115,37586115,,
350,1514358,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7535,ZAP70,https://ctdbase.org/detail.go?type=gene&acc=7535,,,7535.0,ZAP70,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ZAP70 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
351,1514359,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7704,ZBTB16,https://ctdbase.org/detail.go?type=gene&acc=7704,,,7704.0,ZBTB16,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of ZBTB16 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
352,1514360,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,7709,ZBTB17,https://ctdbase.org/detail.go?type=gene&acc=7709,,,7709.0,ZBTB17,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of ZBTB17 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
353,1514361,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10472,ZBTB18,https://ctdbase.org/detail.go?type=gene&acc=10472,,,10472.0,ZBTB18,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ZBTB18 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
354,1515452,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,25850,ZNF345,https://ctdbase.org/detail.go?type=gene&acc=25850,,,25850.0,ZNF345,9606.0,Homo sapiens (human),Fulvestrant results in decreased methylation of ZNF345 gene|[bisphenol A co-treated with fulvestrant] results in decreased methylation of ZNF345 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
355,1515453,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23567,ZNF346,https://ctdbase.org/detail.go?type=gene&acc=23567,,,23567.0,ZNF346,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ZNF346 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
356,1515454,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,84671,ZNF347,https://ctdbase.org/detail.go?type=gene&acc=84671,,,84671.0,ZNF347,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ZNF347 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
357,1515455,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,59348,ZNF350,https://ctdbase.org/detail.go?type=gene&acc=59348,,,59348.0,ZNF350,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of ZNF350 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
358,1515456,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,22891,ZNF365,https://ctdbase.org/detail.go?type=gene&acc=22891,,,22891.0,ZNF365,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ZNF365 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
359,1515457,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,151126,ZNF385B,https://ctdbase.org/detail.go?type=gene&acc=151126,,,151126.0,ZNF385B,9606.0,Homo sapiens (human),Fulvestrant results in decreased methylation of ZNF385B gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of ZNF385B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
360,1519469,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,64773,PCED1A,https://ctdbase.org/detail.go?type=gene&acc=64773,,,64773.0,PCED1A,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PCED1A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
361,1519470,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10336,PCGF3,https://ctdbase.org/detail.go?type=gene&acc=10336,,,10336.0,PCGF3,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of PCGF3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
362,1519471,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9768,PCLAF,https://ctdbase.org/detail.go?type=gene&acc=9768,,,9768.0,PCLAF,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PCLAF mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
363,1519472,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),"[fulvestrant co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in decreased expression of PCNA protein|2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [fulvestrant inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of PCNA protein]]|fulvestrant inhibits the reaction [estradiol results in increased expression of PCNA protein]|2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [fulvestrant inhibits the reaction [estradiol results in increased expression of PCNA protein]]|fulvestrant promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of PCNA protein]]|fulvestrant inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of PCNA protein]",,,PMID:33484789,https://www.ncbi.nlm.nih.gov/pubmed/33484789,33484789,,
364,1519473,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PCNA gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
365,1519474,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),[fulvestrant co-treated with sirolimus] results in decreased expression of PCNA mRNA,,,PMID:19016759,https://www.ncbi.nlm.nih.gov/pubmed/19016759,19016759,,
366,1519475,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PCNA mRNA,,,PMID:15072547|PMID:16202921|PMID:19016759,https://www.ncbi.nlm.nih.gov/pubmed/15072547|https://www.ncbi.nlm.nih.gov/pubmed/16202921|https://www.ncbi.nlm.nih.gov/pubmed/19016759,15072547|16202921|19016759,,
367,1520201,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,57107,PDSS2,https://ctdbase.org/detail.go?type=gene&acc=57107,,,57107.0,PDSS2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PDSS2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
368,1520202,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,3651,PDX1,https://ctdbase.org/detail.go?type=gene&acc=3651,,,3651.0,PDX1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PDX1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
369,1520203,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23037,PDZD2,https://ctdbase.org/detail.go?type=gene&acc=23037,,,23037.0,PDZD2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PDZD2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
370,1520204,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [cadmium results in increased expression of PDZK1 mrna]|fulvestrant inhibits the reaction [arsenite results in increased expression of PDZK1 mrna],,,PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/31646340,31646340,,
371,1520205,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of PDZK1 mrna],,,PMID:14605097|PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/14605097|https://www.ncbi.nlm.nih.gov/pubmed/31646340,14605097|31646340,,
372,1520206,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PDZK1 mRNA,,,PMID:26865669|PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/26865669|https://www.ncbi.nlm.nih.gov/pubmed/31646340,26865669|31646340,,
373,1520207,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10158,PDZK1IP1,https://ctdbase.org/detail.go?type=gene&acc=10158,,,10158.0,PDZK1IP1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PDZK1IP1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
374,1523699,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,25833,POU2F3,https://ctdbase.org/detail.go?type=gene&acc=25833,,,25833.0,POU2F3,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of POU2F3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
375,1523700,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of POU5F1 mrna],,,PMID:22132214,https://www.ncbi.nlm.nih.gov/pubmed/22132214,22132214,,
376,1523701,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),PPARG protein affects the reaction [fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of glucose]]]|fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mrna],,,PMID:32623698,https://www.ncbi.nlm.nih.gov/pubmed/32623698,32623698,,
377,1523702,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [diazinon results in increased expression of PPARG protein]|fulvestrant inhibits the reaction [terbufos results in increased expression of PPARG protein]|fulvestrant inhibits the reaction [tolclofos-methyl results in increased expression of PPARG protein]|fulvestrant inhibits the reaction [phoxim results in increased expression of PPARG protein],,,PMID:33872936,https://www.ncbi.nlm.nih.gov/pubmed/33872936,33872936,,
378,1523703,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [diethylstilbestrol results in increased activity of PPARG protein],,,PMID:22710028,https://www.ncbi.nlm.nih.gov/pubmed/22710028,22710028,,
379,1523875,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Fulvestrant inhibits the reaction [diosgenin results in decreased expression of PPARG mrna],,,PMID:26408789,https://www.ncbi.nlm.nih.gov/pubmed/26408789,26408789,,
380,1523876,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606.0,Homo sapiens (human),[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of PPARGC1A gene|[bisphenol A co-treated with fulvestrant] affects the methylation of PPARGC1A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
381,1523877,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [TGFB1 protein promotes the reaction [FSHB protein promotes the reaction [ESR1 protein binds to PPARGC1A protein]]]|fulvestrant inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] promotes the reaction [PPARGC1A protein binds to CYP11A1 gene]]|fulvestrant inhibits the reaction [FSHB protein promotes the reaction [ESR1 protein binds to PPARGC1A protein]]|fulvestrant inhibits the reaction [[FSHB protein co-treated with TGFB1 protein] promotes the reaction [PPARGC1A protein binds to HSD3B gene]],,,PMID:18511507,https://www.ncbi.nlm.nih.gov/pubmed/18511507,18511507,,
382,1523878,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,8495,PPFIBP2,https://ctdbase.org/detail.go?type=gene&acc=8495,,,8495.0,PPFIBP2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PPFIBP2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
383,1523879,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,51645,PPIL1,https://ctdbase.org/detail.go?type=gene&acc=51645,,,51645.0,PPIL1,9606.0,Homo sapiens (human),Fulvestrant results in increased methylation of PPIL1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
384,1523880,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5493,PPL,https://ctdbase.org/detail.go?type=gene&acc=5493,,,5493.0,PPL,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PPL gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
385,1523881,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5495,PPM1B,https://ctdbase.org/detail.go?type=gene&acc=5495,,,5495.0,PPM1B,9606.0,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of PPM1B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
386,1523882,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,8493,PPM1D,https://ctdbase.org/detail.go?type=gene&acc=8493,,,8493.0,PPM1D,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PPM1D mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
387,1526117,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5799,PTPRN2,https://ctdbase.org/detail.go?type=gene&acc=5799,,,5799.0,PTPRN2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of PTPRN2 gene|[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in decreased methylation of PTPRN2 gene|fulvestrant results in increased methylation of PTPRN2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
388,1526118,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5800,PTPRO,https://ctdbase.org/detail.go?type=gene&acc=5800,,,5800.0,PTPRO,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PTPRO gene|fulvestrant results in increased methylation of PTPRO gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
389,1526119,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,374462,PTPRQ,https://ctdbase.org/detail.go?type=gene&acc=374462,,,374462.0,PTPRQ,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PTPRQ gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
390,1526120,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5801,PTPRR,https://ctdbase.org/detail.go?type=gene&acc=5801,,,5801.0,PTPRR,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of PTPRR gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
391,1526121,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5802,PTPRS,https://ctdbase.org/detail.go?type=gene&acc=5802,,,5802.0,PTPRS,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of PTPRS gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
392,1526122,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,9606.0,Homo sapiens (human),[fulvestrant co-treated with sirolimus] results in decreased expression of PTTG1 mRNA,,,PMID:19016759,https://www.ncbi.nlm.nih.gov/pubmed/19016759,19016759,,
393,1526123,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,9606.0,Homo sapiens (human),Fulvestrant results in decreased expression of PTTG1 mRNA,,,PMID:18984771|PMID:19016759,https://www.ncbi.nlm.nih.gov/pubmed/18984771|https://www.ncbi.nlm.nih.gov/pubmed/19016759,18984771|19016759,,
394,1526921,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [arsenite results in increased expression of RARA mrna]|fulvestrant inhibits the reaction [cadmium results in increased expression of RARA mrna]|fulvestrant results in decreased expression of RARA mrna|fulvestrant inhibits the reaction [estradiol results in increased expression of RARA mrna],,,PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/31646340,31646340,,
395,1526922,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5919,RARRES2,https://ctdbase.org/detail.go?type=gene&acc=5919,,,5919.0,RARRES2,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [tetrabromobisphenol A results in decreased expression of and results in decreased secretion of RARRES2 protein]|fulvestrant inhibits the reaction [bisphenol A results in decreased expression of and results in decreased secretion of RARRES2 protein]|fulvestrant inhibits the reaction [tetrachlorodian results in decreased expression of and results in decreased secretion of RARRES2 protein],,,PMID:29653259,https://www.ncbi.nlm.nih.gov/pubmed/29653259,29653259,,
396,1526923,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5921,RASA1,https://ctdbase.org/detail.go?type=gene&acc=5921,,,5921.0,RASA1,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of RASA1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
397,1526924,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,5922,RASA2,https://ctdbase.org/detail.go?type=gene&acc=5922,,,5922.0,RASA2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RASA2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
398,1526925,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,22821,RASA3,https://ctdbase.org/detail.go?type=gene&acc=22821,,,22821.0,RASA3,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] affects the methylation of RASA3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
399,1526926,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,100271927,RASA4B,https://ctdbase.org/detail.go?type=gene&acc=100271927,,,100271927.0,RASA4B,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of RASA4B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
400,1526927,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9462,RASAL2,https://ctdbase.org/detail.go?type=gene&acc=9462,,,9462.0,RASAL2,9606.0,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RASAL2 gene|[bisphenol F co-treated with fulvestrant] results in increased methylation of RASAL2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
401,1415177,104745,BindingDB,Propionate,50257201,CHEMBL500826,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50257201,10875,Carbonic anhydrase [110-330],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10875,P46510,Carbonic anhydrase,,,4224.0,Flaveria bidentis,,Ki (nM),91000,PMID:23895630|DOI:10.3109/14756366.2013.813942,https://www.ncbi.nlm.nih.gov/pubmed/23895630|https://doi.org/10.3109/14756366.2013.813942,23895630,10.3109/14756366.2013.813942,
402,1415291,104748,BindingDB,Hydrogen sulfite,26991,CHEMBL1689285,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26991,10929,Carbonic anhydrase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10929,,,,,,,,Ki (nM),>200000000,PMID:27283786|DOI:10.1016/j.bmc.2016.05.029,https://www.ncbi.nlm.nih.gov/pubmed/27283786|https://doi.org/10.1016/j.bmc.2016.05.029,27283786,10.1016/j.bmc.2016.05.029,
403,1415292,104748,BindingDB,Hydrogen sulfite,26991,CHEMBL1689285,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26991,10930,Gamma carbonic anhydrase family protein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10930,,,,,,,,Ki (nM),>200000000,PMID:27283786|DOI:10.1016/j.bmc.2016.05.029,https://www.ncbi.nlm.nih.gov/pubmed/27283786|https://doi.org/10.1016/j.bmc.2016.05.029,27283786,10.1016/j.bmc.2016.05.029,
404,1415415,104764,Comparative Toxicogenomics Database (CTD),Dehydromonocrotaline,C014114,monocrotaline pyrrole,https://ctdbase.org/detail.go?type=chem&acc=C014114,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Monocrotaline pyrrole affects the localization of NFE2L2 protein,,,PMID:20695460,https://www.ncbi.nlm.nih.gov/pubmed/20695460,20695460,,
405,1415416,104766,IUPHAR/BPS Guide to PHARMACOLOGY,"(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid",1365,"(1S,3R)-ACPD",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1365,295,mGlu7 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=295,Q14831,Metabotropic glutamate receptor 7,2917.0,GRM7,9606.0,Homo sapiens (human),Full agonist,pKi,3,PMID:11138847,https://www.ncbi.nlm.nih.gov/pubmed/11138847,11138847,,
406,1415417,104766,IUPHAR/BPS Guide to PHARMACOLOGY,"(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid",1365,"(1S,3R)-ACPD",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1365,295,mGlu7 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=295,Q14831,Metabotropic glutamate receptor 7,2917.0,GRM7,9606.0,Homo sapiens (human),Full agonist,pKi,3.1,PMID:11138847,https://www.ncbi.nlm.nih.gov/pubmed/11138847,11138847,,
407,1415418,104766,IUPHAR/BPS Guide to PHARMACOLOGY,"(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid",1365,"(1S,3R)-ACPD",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1365,296,mGlu8 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=296,P70579,Metabotropic glutamate receptor 8,60590.0,Grm8,10116.0,Rattus norvegicus (Norway rat),Full agonist,pEC50,4.3,PMID:9016353,https://www.ncbi.nlm.nih.gov/pubmed/9016353,9016353,,
408,1411826,104769,ChEMBL,Esmolol Hydrochloride,CHEMBL1201115,ESMOLOL HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201115/,CHEMBL210,Beta-2 adrenergic receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL210/,P07550,Beta-2 adrenergic receptor,154.0,ADRB2,9606.0,Homo sapiens (human),Beta-2 adrenergic receptor antagonist,,,,,,,
409,1516679,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] results in increased expression of and results in increased cleavage of CDKN1A protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
410,1517365,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] affects the localization of CYCS protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
411,1517366,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),[perifosine co-treated with butyrates] affects the localization of CYCS protein,,,PMID:15781658,https://www.ncbi.nlm.nih.gov/pubmed/15781658,15781658,,
412,1517367,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),[azacitidine co-treated with butyrates] inhibits the reaction [chromium inhibits the reaction [benzo(a)pyrene promotes the reaction [AHR protein binds to CYP1A1 promoter]]]|butyrates inhibits the reaction [chromium inhibits the reaction [benzo(a)pyrene results in increased expression of CYP1A1 mrna]]|[azacitidine co-treated with butyrates] inhibits the reaction [chromium inhibits the reaction [benzo(a)pyrene results in increased expression of CYP1A1 mrna]]|butyrates inhibits the reaction [chromium inhibits the reaction [benzo(a)pyrene promotes the reaction [AHR protein binds to CYP1A1 promoter]]],,,PMID:17682057,https://www.ncbi.nlm.nih.gov/pubmed/17682057,17682057,,
413,1517368,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin inhibits the reaction [butyrates results in increased expression of CYP1A2 mrna]|butyrates results in increased expression of CYP1A2 mRNA,,,PMID:15252868,https://www.ncbi.nlm.nih.gov/pubmed/15252868,15252868,,
414,1517369,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,10114.0,Rattus,Butyrates results in decreased expression of CYP51 mRNA,,,PMID:14674679,https://www.ncbi.nlm.nih.gov/pubmed/14674679,14674679,,
415,1517370,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,1612,DAPK1,https://ctdbase.org/detail.go?type=gene&acc=1612,,,1612.0,DAPK1,9606.0,Homo sapiens (human),Butyrates results in increased expression of DAPK1 mRNA,,,PMID:16042588,https://www.ncbi.nlm.nih.gov/pubmed/16042588,16042588,,
416,1518238,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,14869,GSTP2,https://ctdbase.org/detail.go?type=gene&acc=14869,,,14869.0,Gstp2,10114.0,Rattus,Butyrates results in increased expression of GSTP2 mRNA,,,PMID:14674679,https://www.ncbi.nlm.nih.gov/pubmed/14674679,14674679,,
417,1518239,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10114.0,Rattus,Butyrates results in increased expression of GSTT1 mRNA,,,PMID:14674679,https://www.ncbi.nlm.nih.gov/pubmed/14674679,14674679,,
418,1518240,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,2953,GSTT2,https://ctdbase.org/detail.go?type=gene&acc=2953,,,2953.0,GSTT2,9606.0,Homo sapiens (human),Butyrates results in decreased expression of GSTT2 protein,,,PMID:19800383,https://www.ncbi.nlm.nih.gov/pubmed/19800383,19800383,,
419,1518241,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,2953,GSTT2,https://ctdbase.org/detail.go?type=gene&acc=2953,,,2953.0,GSTT2,9606.0,Homo sapiens (human),Butyrates results in increased expression of GSTT2 mRNA,,,PMID:15746163,https://www.ncbi.nlm.nih.gov/pubmed/15746163,15746163,,
420,1518242,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,11036,GTF2A1L,https://ctdbase.org/detail.go?type=gene&acc=11036,,,11036.0,GTF2A1L,9606.0,Homo sapiens (human),Butyrates results in decreased expression of GTF2A1L protein,,,PMID:16646664,https://www.ncbi.nlm.nih.gov/pubmed/16646664,16646664,,
421,1518243,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,3005,H1-0,https://ctdbase.org/detail.go?type=gene&acc=3005,,,3005.0,H1-0,9606.0,Homo sapiens (human),Butyrates results in increased expression of H1-0 protein,,,PMID:16006241,https://www.ncbi.nlm.nih.gov/pubmed/16006241,16006241,,
422,1518244,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,8290,H3-4,https://ctdbase.org/detail.go?type=gene&acc=8290,,,8290.0,H3-4,9606.0,Homo sapiens (human),Butyrates results in increased acetylation of H3-4 protein,,,PMID:12130515|PMID:15476886|PMID:17431121|PMID:20201064,https://www.ncbi.nlm.nih.gov/pubmed/12130515|https://www.ncbi.nlm.nih.gov/pubmed/15476886|https://www.ncbi.nlm.nih.gov/pubmed/17431121|https://www.ncbi.nlm.nih.gov/pubmed/20201064,12130515|15476886|17431121|20201064,,
423,1518245,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,382523,H3F4,https://ctdbase.org/detail.go?type=gene&acc=382523,,,382523.0,H3f4,10090.0,Mus musculus (house mouse),[butyrates co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased acetylation of H3F4 protein,,,PMID:16256798,https://www.ncbi.nlm.nih.gov/pubmed/16256798,16256798,,
424,1518246,104775,Comparative Toxicogenomics Database (CTD),Butyrate,D002087,Butyrates,https://ctdbase.org/detail.go?type=chem&acc=D002087,121504,H4C16,https://ctdbase.org/detail.go?type=gene&acc=121504,,,121504.0,H4C16,9606.0,Homo sapiens (human),Butyrates results in increased acetylation of H4C16 protein,,,PMID:12130515,https://www.ncbi.nlm.nih.gov/pubmed/12130515,12130515,,
425,1411827,104781,Comparative Toxicogenomics Database (CTD),tert-Butylbicyclophosphorothionate,C037476,tert-butylbicyclophosphorothionate,https://ctdbase.org/detail.go?type=chem&acc=C037476,2554,GABRA1,https://ctdbase.org/detail.go?type=gene&acc=2554,,,2554.0,GABRA1,9606.0,Homo sapiens (human),Tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]|alpha-hexachlorocyclohexane inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]|delta-hexachlorocyclohexane inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]|hexachlorocyclohexane inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]],,,PMID:9316872,https://www.ncbi.nlm.nih.gov/pubmed/9316872,9316872,,
426,1411828,104781,Comparative Toxicogenomics Database (CTD),tert-Butylbicyclophosphorothionate,C037476,tert-butylbicyclophosphorothionate,https://ctdbase.org/detail.go?type=chem&acc=C037476,2554,GABRA1,https://ctdbase.org/detail.go?type=gene&acc=2554,,,2554.0,GABRA1,9606.0,Homo sapiens (human),"Dieldrin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|picrotoxin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]",,,PMID:14637376,https://www.ncbi.nlm.nih.gov/pubmed/14637376,14637376,,
427,1411829,104781,Comparative Toxicogenomics Database (CTD),tert-Butylbicyclophosphorothionate,C037476,tert-butylbicyclophosphorothionate,https://ctdbase.org/detail.go?type=chem&acc=C037476,2555,GABRA2,https://ctdbase.org/detail.go?type=gene&acc=2555,,,2555.0,GABRA2,9606.0,Homo sapiens (human),"Tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]",,,PMID:14637376,https://www.ncbi.nlm.nih.gov/pubmed/14637376,14637376,,
428,1411830,104781,Comparative Toxicogenomics Database (CTD),tert-Butylbicyclophosphorothionate,C037476,tert-butylbicyclophosphorothionate,https://ctdbase.org/detail.go?type=chem&acc=C037476,2561,GABRB2,https://ctdbase.org/detail.go?type=gene&acc=2561,,,2561.0,GABRB2,9606.0,Homo sapiens (human),"Dieldrin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|picrotoxin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]|tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]|tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]",,,PMID:14637376,https://www.ncbi.nlm.nih.gov/pubmed/14637376,14637376,,
429,1411831,104781,Comparative Toxicogenomics Database (CTD),tert-Butylbicyclophosphorothionate,C037476,tert-butylbicyclophosphorothionate,https://ctdbase.org/detail.go?type=chem&acc=C037476,2562,GABRB3,https://ctdbase.org/detail.go?type=gene&acc=2562,,,2562.0,GABRB3,9606.0,Homo sapiens (human),Tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]|alpha-hexachlorocyclohexane inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]|delta-hexachlorocyclohexane inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]|hexachlorocyclohexane inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]],,,PMID:9316872,https://www.ncbi.nlm.nih.gov/pubmed/9316872,9316872,,
430,1522467,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,9606.0,Homo sapiens (human),S-nitrosoglutathione results in increased activity of SP1 protein,,,PMID:14766015,https://www.ncbi.nlm.nih.gov/pubmed/14766015,14766015,,
431,1522468,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,6670,SP3,https://ctdbase.org/detail.go?type=gene&acc=6670,,,6670.0,SP3,9606.0,Homo sapiens (human),S-nitrosoglutathione results in decreased activity of SP3 protein|s-nitrosoglutathione results in increased activity of SP3 protein,,,PMID:14766015,https://www.ncbi.nlm.nih.gov/pubmed/14766015,14766015,,
432,1522469,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),S-nitrosoglutathione results in increased secretion of TNF protein,,,PMID:13678430,https://www.ncbi.nlm.nih.gov/pubmed/13678430,13678430,,
433,1522470,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),S-nitrosoglutathione inhibits the reaction [PRKN protein binds to TP53 promoter]|[s-nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein binds to TP53 promoter]|s-nitrosoglutathione inhibits the reaction [PRKN protein results in decreased expression of TP53 protein]|s-nitrosoglutathione inhibits the reaction [PRKN protein results in decreased expression of TP53 mrna]|[s-nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 protein]|[s-nitrosoglutathione results in increased nitrosation of PRKN protein] inhibits the reaction [PRKN protein results in decreased expression of TP53 mrna],,,PMID:23985028,https://www.ncbi.nlm.nih.gov/pubmed/23985028,23985028,,
434,1522471,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),[S-nitrosoglutathione results in increased abundance of nitric oxide] which results in increased expression of TP53 protein,,,PMID:8982730,https://www.ncbi.nlm.nih.gov/pubmed/8982730,8982730,,
435,1522472,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116.0,Rattus norvegicus (Norway rat),ABCC2 affects the transport of S-nitrosoglutathione,,,PMID:20683964,https://www.ncbi.nlm.nih.gov/pubmed/20683964,20683964,,
436,1522473,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,128,ADH5,https://ctdbase.org/detail.go?type=gene&acc=128,,,128.0,ADH5,9606.0,Homo sapiens (human),ADH5 protein results in increased reduction of S-nitrosoglutathione,,,PMID:19038239|PMID:19428350,https://www.ncbi.nlm.nih.gov/pubmed/19038239|https://www.ncbi.nlm.nih.gov/pubmed/19428350,19038239|19428350,,
437,1522474,104858,Comparative Toxicogenomics Database (CTD),S-nitrosoglutathione,D026422,S-Nitrosoglutathione,https://ctdbase.org/detail.go?type=chem&acc=D026422,873,CBR1,https://ctdbase.org/detail.go?type=gene&acc=873,,,873.0,CBR1,9606.0,Homo sapiens (human),"[S-nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1,4-naphthoquinone]|[s-nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 2,3-hexanedione]|[s-nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of daunorubicin]|s-nitrosoglutathione binds to and results in decreased activity of CBR1 protein|s-nitrosoglutathione binds to and results in increased activity of CBR1 protein|[s-nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 4-benzoylpyridine]|[s-nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of vitamin K 3]|[S-nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 9,10-phenanthrenequinone]|[s-nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of isatin]|[s-nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1,2-naphthoquinone]",,,PMID:23295225,https://www.ncbi.nlm.nih.gov/pubmed/23295225,23295225,,
438,1415662,104954,Comparative Toxicogenomics Database (CTD),"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C060533,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",https://ctdbase.org/detail.go?type=chem&acc=C060533,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),"[[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,,PMID:16167840,https://www.ncbi.nlm.nih.gov/pubmed/16167840,16167840,,
439,1415663,104954,Comparative Toxicogenomics Database (CTD),"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C060533,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",https://ctdbase.org/detail.go?type=chem&acc=C060533,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),"[tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine|[cyp1a1 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,,PMID:17052995,https://www.ncbi.nlm.nih.gov/pubmed/17052995,17052995,,
440,1415664,104954,Comparative Toxicogenomics Database (CTD),"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",C060533,"2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",https://ctdbase.org/detail.go?type=chem&acc=C060533,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),"[[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased chemical synthesis of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",,,PMID:16167840,https://www.ncbi.nlm.nih.gov/pubmed/16167840,16167840,,
441,1410950,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,7955.0,Danio rerio (zebrafish),Beta-N-methylamino-L-alanine results in decreased expression of GAPDH protein,,,PMID:27404450,https://www.ncbi.nlm.nih.gov/pubmed/27404450,27404450,,
442,1410951,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,26330,GAPDHS,https://ctdbase.org/detail.go?type=gene&acc=26330,,,26330.0,GAPDHS,7955.0,Danio rerio (zebrafish),Beta-N-methylamino-L-alanine results in decreased expression of GAPDHS protein,,,PMID:27404450,https://www.ncbi.nlm.nih.gov/pubmed/27404450,27404450,,
443,1410952,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,10090.0,Mus musculus (house mouse),Beta-N-methylamino-L-alanine results in decreased expression of GARS1 protein,,,PMID:28837265,https://www.ncbi.nlm.nih.gov/pubmed/28837265,28837265,,
444,1410953,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,78997,GDAP1L1,https://ctdbase.org/detail.go?type=gene&acc=78997,,,78997.0,GDAP1L1,10090.0,Mus musculus (house mouse),Beta-N-methylamino-L-alanine results in increased expression of GDAP1L1 protein,,,PMID:28837265,https://www.ncbi.nlm.nih.gov/pubmed/28837265,28837265,,
445,1410954,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,439,GET3,https://ctdbase.org/detail.go?type=gene&acc=439,,,439.0,GET3,10090.0,Mus musculus (house mouse),Beta-N-methylamino-L-alanine results in increased expression of GET3 protein,,,PMID:28837265,https://www.ncbi.nlm.nih.gov/pubmed/28837265,28837265,,
446,1410955,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10116.0,Rattus norvegicus (Norway rat),Beta-N-methylamino-L-alanine results in increased expression of GFAP protein,,,PMID:27956354|PMID:30090328,https://www.ncbi.nlm.nih.gov/pubmed/27956354|https://www.ncbi.nlm.nih.gov/pubmed/30090328,27956354|30090328,,
447,1410956,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,2799,GNS,https://ctdbase.org/detail.go?type=gene&acc=2799,,,2799.0,GNS,10090.0,Mus musculus (house mouse),Beta-N-methylamino-L-alanine results in increased expression of GNS protein,,,PMID:28837265,https://www.ncbi.nlm.nih.gov/pubmed/28837265,28837265,,
448,1410957,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824.0,GPM6B,10116.0,Rattus norvegicus (Norway rat),Beta-N-methylamino-L-alanine results in increased expression of GPM6B protein,,,PMID:25797319,https://www.ncbi.nlm.nih.gov/pubmed/25797319,25797319,,
449,1410958,105089,Comparative Toxicogenomics Database (CTD),beta-N-Methylamino-L-alanine,C001824,beta-N-methylamino-L-alanine,https://ctdbase.org/detail.go?type=chem&acc=C001824,84706,GPT2,https://ctdbase.org/detail.go?type=gene&acc=84706,,,84706.0,GPT2,9606.0,Homo sapiens (human),"[beta-N-methylamino-L-alanine co-treated with 2,4-diaminobutyric acid] results in increased expression of GPT2 mRNA",,,PMID:28634653,https://www.ncbi.nlm.nih.gov/pubmed/28634653,28634653,,
450,1411832,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,643418,LIPN,https://ctdbase.org/detail.go?type=gene&acc=643418,,,643418.0,LIPN,10090.0,Mus musculus (house mouse),Glucose results in increased expression of LIPN mRNA,,,PMID:31525975,https://www.ncbi.nlm.nih.gov/pubmed/31525975,31525975,,
451,1411833,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10116.0,Rattus norvegicus (Norway rat),"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[glucose co-treated with INS1 protein] results in increased secretion of LEP protein]|[[glucose co-treated with INS1 protein] results in increased abundance of adenosine triphosphate] which results in increased secretion of LEP protein|[glucose co-treated with INS1 protein] results in increased secretion of LEP protein|diazoxide inhibits the reaction [[glucose co-treated with INS1 protein] results in increased secretion of LEP protein]|ins1 protein promotes the reaction [glucose results in increased secretion of LEP protein]|glucose results in increased secretion of LEP protein|glucose results in increased expression of LEP mrna|nickel chloride inhibits the reaction [[glucose co-treated with INS1 protein] results in increased secretion of LEP protein]|calcium deficiency inhibits the reaction [[glucose co-treated with INS1 protein] results in increased secretion of LEP protein]|ins1 protein promotes the reaction [glucose results in increased expression of LEP mrna]",,,PMID:10780946,https://www.ncbi.nlm.nih.gov/pubmed/10780946,10780946,,
452,1411834,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10116.0,Rattus norvegicus (Norway rat),Argan oil inhibits the reaction [glucose results in increased expression of LEP protein]|corn oil inhibits the reaction [glucose results in increased expression of LEP protein],,,PMID:29165388,https://www.ncbi.nlm.nih.gov/pubmed/29165388,29165388,,
453,1411835,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10116.0,Rattus norvegicus (Norway rat),Glucose results in increased expression of LEP protein,,,PMID:18627777|PMID:24399619|PMID:29165388,https://www.ncbi.nlm.nih.gov/pubmed/18627777|https://www.ncbi.nlm.nih.gov/pubmed/24399619|https://www.ncbi.nlm.nih.gov/pubmed/29165388,18627777|24399619|29165388,,
454,1411970,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,80774,LIMD2,https://ctdbase.org/detail.go?type=gene&acc=80774,,,80774.0,LIMD2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of LIMD2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
455,1411971,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,55679,LIMS2,https://ctdbase.org/detail.go?type=gene&acc=55679,,,55679.0,LIMS2,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of LIMS2 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
456,1411972,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,64130,LIN7B,https://ctdbase.org/detail.go?type=gene&acc=64130,,,64130.0,LIN7B,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of LIN7B mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
457,1411973,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,101055671,LIPO2,https://ctdbase.org/detail.go?type=gene&acc=101055671,,,101055671.0,Lipo2,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of LIPO2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
458,1411974,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,135927,LLCFC1,https://ctdbase.org/detail.go?type=gene&acc=135927,,,135927.0,LLCFC1,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of LLCFC1 mrna|[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of LLCFC1 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
459,1412592,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,256691,MAMDC2,https://ctdbase.org/detail.go?type=gene&acc=256691,,,256691.0,MAMDC2,10090.0,Mus musculus (house mouse),Glucose results in decreased expression of MAMDC2 mRNA,,,PMID:31525975|PMID:33448797,https://www.ncbi.nlm.nih.gov/pubmed/31525975|https://www.ncbi.nlm.nih.gov/pubmed/33448797,31525975|33448797,,
460,1412593,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9794,MAML1,https://ctdbase.org/detail.go?type=gene&acc=9794,,,9794.0,MAML1,9606.0,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of MAML1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
461,1412594,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4129,MAOB,https://ctdbase.org/detail.go?type=gene&acc=4129,,,4129.0,MAOB,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of MAOB mrna|[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of MAOB mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
462,1412595,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),Glucose deficiency results in increased expression of MAP1LC3B protein modified form|u 0126 inhibits the reaction [glucose deficiency results in increased expression of MAP1LC3B protein modified form]|glucose deficiency results in increased expression of MAP1LC3B protein,,,PMID:34580807,https://www.ncbi.nlm.nih.gov/pubmed/34580807,34580807,,
463,1412596,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4504,MT3,https://ctdbase.org/detail.go?type=gene&acc=4504,,,4504.0,MT3,9606.0,Homo sapiens (human),Glucose results in decreased expression of MT3 mRNA,,,PMID:32942007,https://www.ncbi.nlm.nih.gov/pubmed/32942007,32942007,,
464,1413327,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"Fulvestrant inhibits the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]]|euk-134 inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]|4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]",,,PMID:20962025,https://www.ncbi.nlm.nih.gov/pubmed/20962025,20962025,,
465,1413466,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Catechin inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]|rutin inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]|quercetin inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]|luteolin inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein]|epigallocatechin gallate inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein],,,PMID:19557821,https://www.ncbi.nlm.nih.gov/pubmed/19557821,19557821,,
466,1413467,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Tetradecanoylphorbol acetate inhibits the reaction [glucose deficiency results in increased activity of MAPK3 protein]|cat inhibits the reaction [glucose deficiency results in increased activity of MAPK3 protein]|glucose deficiency results in increased activity of MAPK3 protein,,,PMID:17309078,https://www.ncbi.nlm.nih.gov/pubmed/17309078,17309078,,
467,1413468,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Glucose deficiency results in increased expression of and results in increased phosphorylation of MAPK3 protein,,,PMID:34580807,https://www.ncbi.nlm.nih.gov/pubmed/34580807,34580807,,
468,1413469,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Glucose promotes the reaction [bupivacaine results in increased phosphorylation of MAPK3 protein],,,PMID:34060177,https://www.ncbi.nlm.nih.gov/pubmed/34060177,34060177,,
469,1413470,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Glucose results in decreased phosphorylation of MAPK3 protein,,,PMID:20200188,https://www.ncbi.nlm.nih.gov/pubmed/20200188,20200188,,
470,1413471,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein,,,PMID:22162761,https://www.ncbi.nlm.nih.gov/pubmed/22162761,22162761,,
471,1413472,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Glucose results in increased phosphorylation of MAPK3 protein,,,PMID:18057711|PMID:19557821|PMID:20962025|PMID:23690508|PMID:38000455,https://www.ncbi.nlm.nih.gov/pubmed/18057711|https://www.ncbi.nlm.nih.gov/pubmed/19557821|https://www.ncbi.nlm.nih.gov/pubmed/20962025|https://www.ncbi.nlm.nih.gov/pubmed/23690508|https://www.ncbi.nlm.nih.gov/pubmed/38000455,18057711|19557821|20962025|23690508|38000455,,
472,1413473,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Heparin analog inhibits the reaction [glucose results in increased phosphorylation of MAPK3 protein],,,PMID:18057711,https://www.ncbi.nlm.nih.gov/pubmed/18057711,18057711,,
473,1413474,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]|glucose results in increased phosphorylation of and results in increased activity of MAPK3 protein,,,PMID:18310510,https://www.ncbi.nlm.nih.gov/pubmed/18310510,18310510,,
474,1414853,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,406983,MIR200A,https://ctdbase.org/detail.go?type=gene&acc=406983,,,406983.0,MIR200A,10090.0,Mus musculus (house mouse),Glucose results in decreased expression of MIR200A mRNA,,,PMID:23776576,https://www.ncbi.nlm.nih.gov/pubmed/23776576,23776576,,
475,1414854,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,406984,MIR200B,https://ctdbase.org/detail.go?type=gene&acc=406984,,,406984.0,MIR200B,10090.0,Mus musculus (house mouse),Glucose results in decreased expression of MIR200B mRNA,,,PMID:23776576,https://www.ncbi.nlm.nih.gov/pubmed/23776576,23776576,,
476,1414855,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314.0,MMP3,9606.0,Homo sapiens (human),[oxygen deficiency co-treated with glucose deficiency] results in increased expression of mmp3|resveratrol inhibits the reaction [[oxygen deficiency co-treated with glucose deficiency] results in increased expression of MMP3],,,PMID:24840287,https://www.ncbi.nlm.nih.gov/pubmed/24840287,24840287,,
477,1414856,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,10090.0,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of MMP7 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
478,1514492,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0002189,Glutathione S-transferase A2,http://www.t3db.ca/biodb/bio_entities/BE0002189,P09210,Glutathione S-transferase A2,2939.0,GSTA2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
479,1514493,107720,Toxin and Toxin Target Database (T3DB),Indoxacarb,T3D3864,Indoxacarb,http://www.t3db.ca/toxins/T3D3864,BE0000215,Peroxisome proliferator-activated receptor gamma,http://www.t3db.ca/biodb/bio_entities/BE0000215,P37231,Peroxisome proliferator-activated receptor gamma,5468.0,PPARG,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
480,1514494,107744,Drug Gene Interaction database (DGIdb),Aldophosphamide,,ALDOPHOSPHAMIDE,https://www.dgidb.org/drugs/chembl:CHEMBL1593,,ALDH1A1,https://www.dgidb.org/genes/hgnc:402,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),,,,,,,,
481,1524496,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),CNR1 mutant form inhibits the reaction [HU 211 results in increased phosphorylation of PTK2 protein],,,PMID:12163181,https://www.ncbi.nlm.nih.gov/pubmed/12163181,12163181,,
482,1524497,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),CNR1 protein affects the reaction [HU 211 results in decreased expression of TH mrna],,,PMID:17540007,https://www.ncbi.nlm.nih.gov/pubmed/17540007,17540007,,
483,1524498,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [HU 211 binds to and results in increased activity of CNR1 protein]|hu 211 binds to and results in increased activity of CNR1 protein,,,PMID:18536748,https://www.ncbi.nlm.nih.gov/pubmed/18536748,18536748,,
484,1524499,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10116.0,Rattus norvegicus (Norway rat),HU 211 results in decreased expression of CNR1 protein|am 251 inhibits the reaction [HU 211 results in decreased expression of CNR1 protein],,,PMID:31199905,https://www.ncbi.nlm.nih.gov/pubmed/31199905,31199905,,
485,1524500,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10116.0,Rattus norvegicus (Norway rat),HU 211 binds to and results in increased activity of CNR1 protein,,,PMID:11558437,https://www.ncbi.nlm.nih.gov/pubmed/11558437,11558437,,
486,1524501,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10116.0,Rattus norvegicus (Norway rat),HU 211 results in decreased expression of CNR1 mRNA,,,PMID:12968131,https://www.ncbi.nlm.nih.gov/pubmed/12968131,12968131,,
487,1524502,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,9606.0,Homo sapiens (human),HU 211 binds to and results in increased activity of CNR1 protein,,,PMID:10570211|PMID:15085199,https://www.ncbi.nlm.nih.gov/pubmed/10570211|https://www.ncbi.nlm.nih.gov/pubmed/15085199,10570211|15085199,,
488,1524503,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1272,CNTN1,https://ctdbase.org/detail.go?type=gene&acc=1272,,,1272.0,CNTN1,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of CNTN1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
489,1524504,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,1381,CRABP1,https://ctdbase.org/detail.go?type=gene&acc=1381,,,1381.0,CRABP1,10116.0,Rattus norvegicus (Norway rat),HU 211 results in increased expression of CRABP1 mrna|[poly I-C co-treated with HU 211] results in increased expression of CRABP1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
490,1527163,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,6274,S100A3,https://ctdbase.org/detail.go?type=gene&acc=6274,,,6274.0,S100A3,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in increased expression of S100A3 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
491,1527164,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,80031,SEMA6D,https://ctdbase.org/detail.go?type=gene&acc=80031,,,80031.0,SEMA6D,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of SEMA6D mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
492,1528222,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,85453,TSPYL5,https://ctdbase.org/detail.go?type=gene&acc=85453,,,85453.0,TSPYL5,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of TSPYL5 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
493,1528223,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,7267,TTC3,https://ctdbase.org/detail.go?type=gene&acc=7267,,,7267.0,TTC3,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of TTC3 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
494,1528224,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,57045,TWSG1,https://ctdbase.org/detail.go?type=gene&acc=57045,,,57045.0,TWSG1,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of TWSG1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
495,1528225,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,8266,UBL4A,https://ctdbase.org/detail.go?type=gene&acc=8266,,,8266.0,UBL4A,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of UBL4A mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
496,1528226,107778,Comparative Toxicogenomics Database (CTD),Dexanabinol,C062018,HU 211,https://ctdbase.org/detail.go?type=chem&acc=C062018,197131,UBR1,https://ctdbase.org/detail.go?type=gene&acc=197131,,,197131.0,UBR1,10116.0,Rattus norvegicus (Norway rat),[poly I-C co-treated with HU 211] results in decreased expression of UBR1 mRNA,,,PMID:26923065,https://www.ncbi.nlm.nih.gov/pubmed/26923065,26923065,,
497,1514658,107807,Therapeutic Target Database (TTD),Perindopril,D03KYG,Perindopril,https://idrblab.net/ttd/data/drug/details/D03KYG,T82577,Angiotensin-converting enzyme (ACE),https://idrblab.net/ttd/data/target/details/T82577,P12821,Angiotensin-converting enzyme ,1636.0,ACE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
498,1411523,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Grape seed proanthocyanidins inhibits the reaction [lead results in decreased expression of BCL2 protein],,,PMID:29630945,https://www.ncbi.nlm.nih.gov/pubmed/29630945,29630945,,
499,1411524,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10090.0,Mus musculus (house mouse),Grape seed proanthocyanidins results in increased expression of BCL2L1,,,PMID:11330834,https://www.ncbi.nlm.nih.gov/pubmed/11330834,11330834,,
500,1411525,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116.0,Rattus norvegicus (Norway rat),Grape seed proanthocyanidins inhibits the reaction [lead results in decreased expression of BCL2L1 protein],,,PMID:29630945,https://www.ncbi.nlm.nih.gov/pubmed/29630945,29630945,,
501,1411526,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,497258,BDNF-AS,https://ctdbase.org/detail.go?type=gene&acc=497258,,,497258.0,BDNF-AS,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of BDNF-AS mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
502,1411527,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,27319,BHLHE22,https://ctdbase.org/detail.go?type=gene&acc=27319,,,27319.0,BHLHE22,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of BHLHE22 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
503,1411528,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,23074,BLTP3B,https://ctdbase.org/detail.go?type=gene&acc=23074,,,23074.0,BLTP3B,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of BLTP3B mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
504,1411529,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,2972,BRF1,https://ctdbase.org/detail.go?type=gene&acc=2972,,,2972.0,BRF1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of BRF1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
505,1411530,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,54014,BRWD1,https://ctdbase.org/detail.go?type=gene&acc=54014,,,54014.0,BRWD1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of BRWD1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
506,1411531,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,55108,BSDC1,https://ctdbase.org/detail.go?type=gene&acc=55108,,,55108.0,BSDC1,9606.0,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of BSDC1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
507,1517158,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,9606.0,Homo sapiens (human),Proanthocyanidins results in decreased expression of NANOG protein|lithium chloride inhibits the reaction [proanthocyanidins results in decreased expression of NANOG protein],,,PMID:37551626,https://www.ncbi.nlm.nih.gov/pubmed/37551626,37551626,,
508,1517159,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9823.0,Sus scrofa (pig),Proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NFE2L2 mrna]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NFE2L2 protein]]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NQO1 protein]]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NQO1 mrna]]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of HMOX1 mrna]]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of HMOX1 protein]]|proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NFE2L2 protein],,,PMID:35489465,https://www.ncbi.nlm.nih.gov/pubmed/35489465,35489465,,
509,1517160,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9823.0,Sus scrofa (pig),[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NFE2L2 mrna]],,,PMID:35489465,https://www.ncbi.nlm.nih.gov/pubmed/35489465,35489465|35489465,,
510,1517161,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9823.0,Sus scrofa (pig),Proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NQO1 protein]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NQO1 mrna]]|proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NQO1 mrna]|[heterocyclic compounds results in decreased activity of NFE2L2 protein] inhibits the reaction [proanthocyanidins inhibits the reaction [zearalenone results in decreased expression of NQO1 protein]],,,PMID:35489465,https://www.ncbi.nlm.nih.gov/pubmed/35489465,35489465,,
511,1517162,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164.0,NR4A1,9606.0,Homo sapiens (human),Proanthocyanidins inhibits the reaction [quinocetone metabolite affects the expression of NR4A1 mrna],,,PMID:26802905,https://www.ncbi.nlm.nih.gov/pubmed/26802905,26802905,,
512,1517163,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,4929,NR4A2,https://ctdbase.org/detail.go?type=gene&acc=4929,,,4929.0,NR4A2,9606.0,Homo sapiens (human),Proanthocyanidins inhibits the reaction [quinocetone metabolite results in decreased expression of NR4A2 mrna],,,PMID:26802905,https://www.ncbi.nlm.nih.gov/pubmed/26802905,26802905,,
513,1517164,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,2516,NR5A1,https://ctdbase.org/detail.go?type=gene&acc=2516,,,2516.0,NR5A1,9606.0,Homo sapiens (human),Proanthocyanidins inhibits the reaction [quinocetone metabolite affects the expression of NR5A1 mrna],,,PMID:26802905,https://www.ncbi.nlm.nih.gov/pubmed/26802905,26802905,,
514,1517165,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,D044945,Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=D044945,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10090.0,Mus musculus (house mouse),Proanthocyanidins inhibits the reaction [3-chloroperbenzoic acid results in increased activity of ODC1 protein],,,PMID:7653998,https://www.ncbi.nlm.nih.gov/pubmed/7653998,7653998,,
515,1514659,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9120,SLC16A6,https://ctdbase.org/detail.go?type=gene&acc=9120,,,9120.0,SLC16A6,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC16A6 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
516,1514660,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9194,SLC16A7,https://ctdbase.org/detail.go?type=gene&acc=9194,,,9194.0,SLC16A7,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC16A7 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
517,1514661,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,10050,SLC17A4,https://ctdbase.org/detail.go?type=gene&acc=10050,,,10050.0,SLC17A4,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC17A4 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
518,1514662,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,26503,SLC17A5,https://ctdbase.org/detail.go?type=gene&acc=26503,,,26503.0,SLC17A5,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC17A5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
519,1514663,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,246213,SLC17A8,https://ctdbase.org/detail.go?type=gene&acc=246213,,,246213.0,SLC17A8,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC17A8 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
520,1514664,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6573,SLC19A1,https://ctdbase.org/detail.go?type=gene&acc=6573,,,6573.0,SLC19A1,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC19A1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
521,1514665,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6506,SLC1A2,https://ctdbase.org/detail.go?type=gene&acc=6506,,,6506.0,SLC1A2,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of SLC1A2 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
522,1514975,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,114789,SLC25A25,https://ctdbase.org/detail.go?type=gene&acc=114789,,,114789.0,SLC25A25,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC25A25 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
523,1514976,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,253512,SLC25A30,https://ctdbase.org/detail.go?type=gene&acc=253512,,,253512.0,SLC25A30,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC25A30 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
524,1514977,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,83447,SLC25A31,https://ctdbase.org/detail.go?type=gene&acc=83447,,,83447.0,SLC25A31,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC25A31 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
525,1514978,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,399512,SLC25A35,https://ctdbase.org/detail.go?type=gene&acc=399512,,,399512.0,SLC25A35,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC25A35 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
526,1514979,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51312,SLC25A37,https://ctdbase.org/detail.go?type=gene&acc=51312,,,51312.0,SLC25A37,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of SLC25A37 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
527,1515319,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,10999,SLC27A4,https://ctdbase.org/detail.go?type=gene&acc=10999,,,10999.0,SLC27A4,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC27A4 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
528,1515320,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9153,SLC28A2,https://ctdbase.org/detail.go?type=gene&acc=9153,,,9153.0,SLC28A2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC28A2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
529,1515321,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,381417,SLC28A2B,https://ctdbase.org/detail.go?type=gene&acc=381417,,,381417.0,Slc28a2b,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC28A2B mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
530,1515322,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC2A1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
531,1515323,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,81031,SLC2A10,https://ctdbase.org/detail.go?type=gene&acc=81031,,,81031.0,SLC2A10,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLC2A10 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
532,1515324,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6518,SLC2A5,https://ctdbase.org/detail.go?type=gene&acc=6518,,,6518.0,SLC2A5,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC2A5 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
533,1516206,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,23315,SLC9A8,https://ctdbase.org/detail.go?type=gene&acc=23315,,,23315.0,SLC9A8,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLC9A8 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
534,1516207,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28248,SLCO1A1,https://ctdbase.org/detail.go?type=gene&acc=28248,,,28248.0,Slco1a1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLCO1A1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
535,1516208,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28250,SLCO1A4,https://ctdbase.org/detail.go?type=gene&acc=28250,,,28250.0,Slco1a4,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLCO1A4 mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
536,1516209,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SLCO2B1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
537,1516210,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,28232,SLCO3A1,https://ctdbase.org/detail.go?type=gene&acc=28232,,,28232.0,SLCO3A1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLCO3A1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
538,1516211,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,237886,SLFN9,https://ctdbase.org/detail.go?type=gene&acc=237886,,,237886.0,Slfn9,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLFN9 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
539,1516212,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,81892,SLIRP,https://ctdbase.org/detail.go?type=gene&acc=81892,,,81892.0,SLIRP,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SLIRP mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
540,1516213,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6585,SLIT1,https://ctdbase.org/detail.go?type=gene&acc=6585,,,6585.0,SLIT1,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of SLIT1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
541,1517157,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,3431,SP110,https://ctdbase.org/detail.go?type=gene&acc=3431,,,3431.0,SP110,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SP110 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
542,1518074,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,24067,SRP54A,https://ctdbase.org/detail.go?type=gene&acc=24067,,,24067.0,Srp54a,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRP54A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
543,1518075,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6726,SRP9,https://ctdbase.org/detail.go?type=gene&acc=6726,,,6726.0,SRP9,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRP9 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
544,1518076,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6734,SRPRA,https://ctdbase.org/detail.go?type=gene&acc=6734,,,6734.0,SRPRA,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRPRA mRNA,,,PMID:22334560,https://www.ncbi.nlm.nih.gov/pubmed/22334560,22334560,,
545,1518077,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,58477,SRPRB,https://ctdbase.org/detail.go?type=gene&acc=58477,,,58477.0,SRPRB,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SRPRB mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
546,1518078,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,84530,SRRM4,https://ctdbase.org/detail.go?type=gene&acc=84530,,,84530.0,SRRM4,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SRRM4 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
547,1519476,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,126074,SWSAP1,https://ctdbase.org/detail.go?type=gene&acc=126074,,,126074.0,SWSAP1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of SWSAP1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
548,1519477,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,256126,SYCE2,https://ctdbase.org/detail.go?type=gene&acc=256126,,,256126.0,SYCE2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of SYCE2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
549,1519904,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6901,TAFAZZIN,https://ctdbase.org/detail.go?type=gene&acc=6901,,,6901.0,TAFAZZIN,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TAFAZZIN mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
550,1519905,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6887,TAL2,https://ctdbase.org/detail.go?type=gene&acc=6887,,,6887.0,TAL2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TAL2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
551,1519906,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,128989,TANGO2,https://ctdbase.org/detail.go?type=gene&acc=128989,,,128989.0,TANGO2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TANGO2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
552,1519907,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,9344,TAOK2,https://ctdbase.org/detail.go?type=gene&acc=9344,,,9344.0,TAOK2,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TAOK2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
553,1519908,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6892,TAPBP,https://ctdbase.org/detail.go?type=gene&acc=6892,,,6892.0,TAPBP,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TAPBP mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
554,1519909,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6894,TARBP1,https://ctdbase.org/detail.go?type=gene&acc=6894,,,6894.0,TARBP1,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TARBP1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
555,1519910,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of TARS1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
556,1519911,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,123283,TARS3,https://ctdbase.org/detail.go?type=gene&acc=123283,,,123283.0,TARS3,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TARS3 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
557,1519912,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,80835,TAS1R1,https://ctdbase.org/detail.go?type=gene&acc=80835,,,80835.0,TAS1R1,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of TAS1R1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
558,1520506,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,158931,TCEAL6,https://ctdbase.org/detail.go?type=gene&acc=158931,,,158931.0,TCEAL6,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TCEAL6 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
559,1520507,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51186,TCEAL9,https://ctdbase.org/detail.go?type=gene&acc=51186,,,51186.0,TCEAL9,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TCEAL9 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
560,1520508,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,170082,TCEANC,https://ctdbase.org/detail.go?type=gene&acc=170082,,,170082.0,TCEANC,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TCEANC mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
561,1520509,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,127428,TCEANC2,https://ctdbase.org/detail.go?type=gene&acc=127428,,,127428.0,TCEANC2,10090.0,Mus musculus (house mouse),Epoxiconazole affects the expression of TCEANC2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
562,1520510,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,6934,TCF7L2,https://ctdbase.org/detail.go?type=gene&acc=6934,,,6934.0,TCF7L2,10090.0,Mus musculus (house mouse),Epoxiconazole results in increased expression of TCF7L2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
563,1520511,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,56892,TCIM,https://ctdbase.org/detail.go?type=gene&acc=56892,,,56892.0,TCIM,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TCIM mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
564,1520512,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,10312,TCIRG1,https://ctdbase.org/detail.go?type=gene&acc=10312,,,10312.0,TCIRG1,10090.0,Mus musculus (house mouse),Epoxiconazole results in decreased expression of TCIRG1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
565,1517557,107918,Comparative Toxicogenomics Database (CTD),Oligoadenylate,C023505,"2',5'-oligoadenylate",https://ctdbase.org/detail.go?type=chem&acc=C023505,4938,OAS1,https://ctdbase.org/detail.go?type=gene&acc=4938,,,4938.0,OAS1,9606.0,Homo sapiens (human),"[[poly I-C co-treated with interferon-alpha] results in increased activity of OAS1 protein] which results in increased abundance of 2',5'-oligoadenylate",,,PMID:26055709,https://www.ncbi.nlm.nih.gov/pubmed/26055709,26055709,,
566,1517558,107918,Comparative Toxicogenomics Database (CTD),Oligoadenylate,C023505,"2',5'-oligoadenylate",https://ctdbase.org/detail.go?type=chem&acc=C023505,4939,OAS2,https://ctdbase.org/detail.go?type=gene&acc=4939,,,4939.0,OAS2,9606.0,Homo sapiens (human),"[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased expression of OAS2 mRNA",,,PMID:24651439,https://www.ncbi.nlm.nih.gov/pubmed/24651439,24651439,,
567,1517559,107918,Comparative Toxicogenomics Database (CTD),Oligoadenylate,C023505,"2',5'-oligoadenylate",https://ctdbase.org/detail.go?type=chem&acc=C023505,201626,PDE12,https://ctdbase.org/detail.go?type=gene&acc=201626,,,201626.0,PDE12,9606.0,Homo sapiens (human),"[antiviral agents binds to and results in decreased activity of PDE12 protein] which results in increased abundance of 2',5'-oligoadenylate|pde12 gene mutant form results in increased abundance of 2',5'-oligoadenylate",,,PMID:26055709,https://www.ncbi.nlm.nih.gov/pubmed/26055709,26055709,,
568,1517560,107918,Comparative Toxicogenomics Database (CTD),Oligoadenylate,C023505,"2',5'-oligoadenylate",https://ctdbase.org/detail.go?type=chem&acc=C023505,6041,RNASEL,https://ctdbase.org/detail.go?type=gene&acc=6041,,,6041.0,RNASEL,9606.0,Homo sapiens (human),"2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein",,,PMID:26055709,https://www.ncbi.nlm.nih.gov/pubmed/26055709,26055709,,
569,1517561,107918,Comparative Toxicogenomics Database (CTD),Oligoadenylate,C023505,"2',5'-oligoadenylate",https://ctdbase.org/detail.go?type=chem&acc=C023505,6041,RNASEL,https://ctdbase.org/detail.go?type=gene&acc=6041,,,6041.0,RNASEL,9606.0,Homo sapiens (human),"[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased expression of TLR3 mrna|[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased expression of OAS1 mrna|[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased expression of SOD2 mrna|[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased expression of OAS2 mrna|[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased uptake of glucose|2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein|[2',5'-oligoadenylate binds to and results in increased activity of RNASEL protein] which results in increased expression of SOD2 protein",,,PMID:24651439,https://www.ncbi.nlm.nih.gov/pubmed/24651439,24651439,,
570,1517733,107953,Comparative Toxicogenomics Database (CTD),"3,3',4,4'-Tetrabromobiphenyl",C036685,"3,3',4,4'-tetrabromobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C036685,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),"3,3',4,4'-tetrabromobiphenyl results in increased expression of CYP11A1 mRNA",,,PMID:17447562,https://www.ncbi.nlm.nih.gov/pubmed/17447562,17447562,,
571,1517734,107953,Comparative Toxicogenomics Database (CTD),"3,3',4,4'-Tetrabromobiphenyl",C036685,"3,3',4,4'-tetrabromobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C036685,1585,CYP11B2,https://ctdbase.org/detail.go?type=gene&acc=1585,,,1585.0,CYP11B2,9606.0,Homo sapiens (human),"3,3',4,4'-tetrabromobiphenyl results in increased expression of CYP11B2 mRNA",,,PMID:17447562,https://www.ncbi.nlm.nih.gov/pubmed/17447562,17447562,,
572,1414857,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [triptolide affects the expression of BCL2 protein]|triptolide affects the expression of BCL2 protein,,,PMID:26277538,https://www.ncbi.nlm.nih.gov/pubmed/26277538,26277538,,
573,1414858,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Triptolide results in decreased expression of BCL2 protein,,,PMID:25169008|PMID:30009776|PMID:30926361,https://www.ncbi.nlm.nih.gov/pubmed/25169008|https://www.ncbi.nlm.nih.gov/pubmed/30009776|https://www.ncbi.nlm.nih.gov/pubmed/30926361,25169008|30009776|30926361,,
574,1414859,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,570772,BCL2A,https://ctdbase.org/detail.go?type=gene&acc=570772,,,570772.0,bcl2a,7955.0,Danio rerio (zebrafish),Triptolide results in decreased expression of BCL2A mRNA,,,PMID:31321794,https://www.ncbi.nlm.nih.gov/pubmed/31321794,31321794,,
575,1414860,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10090.0,Mus musculus (house mouse),Triptolide results in decreased expression of BCL2L1 protein|pifithrin inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein]|trp53 gene mutant form inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein],,,PMID:30009776,https://www.ncbi.nlm.nih.gov/pubmed/30009776,30009776,,
576,1414861,107985,Comparative Toxicogenomics Database (CTD),Triptolide,C001899,triptolide,https://ctdbase.org/detail.go?type=chem&acc=C001899,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10090.0,Mus musculus (house mouse),Triptolide results in increased expression of BCL2L1 protein,,,PMID:26990902,https://www.ncbi.nlm.nih.gov/pubmed/26990902,26990902,,
577,1529601,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,151887,CCDC80,https://ctdbase.org/detail.go?type=gene&acc=151887,,,151887.0,CCDC80,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CCDC80 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
578,1529602,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CCL5 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
579,1529603,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CCNG1 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
580,1529604,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,915,CD3D,https://ctdbase.org/detail.go?type=gene&acc=915,,,915.0,CD3D,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CD3D mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
581,1529605,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,917,CD3G,https://ctdbase.org/detail.go?type=gene&acc=917,,,917.0,CD3G,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CD3G mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
582,1529606,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,968,CD68,https://ctdbase.org/detail.go?type=gene&acc=968,,,968.0,CD68,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CD68 mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
583,1529607,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CDH1 mRNA,,,PMID:25663515,https://www.ncbi.nlm.nih.gov/pubmed/25663515,25663515,,
584,1529608,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,8837,CFLAR,https://ctdbase.org/detail.go?type=gene&acc=8837,,,8837.0,CFLAR,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CFLAR mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
585,1529609,108168,Comparative Toxicogenomics Database (CTD),Aristolochic acid II,C042310,aristolochic acid II,https://ctdbase.org/detail.go?type=chem&acc=C042310,43690,CHP,https://ctdbase.org/detail.go?type=gene&acc=43690,,,43690.0,chp,10116.0,Rattus norvegicus (Norway rat),[aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CHP mRNA,,,PMID:23912714,https://www.ncbi.nlm.nih.gov/pubmed/23912714,23912714,,
586,1519122,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Deoxyglucose inhibits the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in decreased expression of SQSTM1 mrna]|[bafilomycin A co-treated with deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] affects the expression of SQSTM1 protein|[bafilomycin A co-treated with deoxyglucose] affects the expression of SQSTM1 protein|deoxyglucose promotes the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in decreased expression of SQSTM1 mrna],,,PMID:26079942,https://www.ncbi.nlm.nih.gov/pubmed/26079942,26079942,,
587,1519123,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10090.0,Mus musculus (house mouse),Deoxyglucose results in increased expression of SREBF1 mRNA,,,PMID:10913129,https://www.ncbi.nlm.nih.gov/pubmed/10913129,10913129,,
588,1519124,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [TNF protein inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose]]|tnf protein inhibits the reaction [INS1 protein results in increased uptake of deoxyglucose],,,PMID:23439570,https://www.ncbi.nlm.nih.gov/pubmed/23439570,23439570,,
589,1519125,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,2,A2M,https://ctdbase.org/detail.go?type=gene&acc=2,,,2.0,A2M,9606.0,Homo sapiens (human),A2M protein modified form results in increased uptake of deoxyglucose|hspa5 protein affects the reaction [A2M protein modified form results in increased uptake of deoxyglucose],,,PMID:25720493,https://www.ncbi.nlm.nih.gov/pubmed/25720493,25720493,,
590,1519126,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Deoxyglucose inhibits the reaction [ABCB1 protein results in increased export of diazinon],,,PMID:16221533,https://www.ncbi.nlm.nih.gov/pubmed/16221533,16221533,,
591,1519127,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,10060,ABCC9,https://ctdbase.org/detail.go?type=gene&acc=10060,,,10060.0,ABCC9,10090.0,Mus musculus (house mouse),Glyburide inhibits the reaction [[oligomycins co-treated with deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]]|[oligomycins co-treated with deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein],,,PMID:28842488,https://www.ncbi.nlm.nih.gov/pubmed/28842488,28842488,,
592,1519128,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,137735,ABRA,https://ctdbase.org/detail.go?type=gene&acc=137735,,,137735.0,ABRA,10116.0,Rattus norvegicus (Norway rat),CCG 1423 promotes the reaction [INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of deoxyglucose]]|ins1 protein promotes the reaction [ABRA mutant form results in increased uptake of deoxyglucose]|ccg 1423 promotes the reaction [ABRA mutant form promotes the reaction [INS1 protein results in increased uptake of deoxyglucose]]|ccg 1423 promotes the reaction [ABRA mutant form results in increased uptake of deoxyglucose]|abra mutant form results in increased uptake of deoxyglucose,,,PMID:21393865,https://www.ncbi.nlm.nih.gov/pubmed/21393865,21393865,,
593,1519129,108223,Comparative Toxicogenomics Database (CTD),2-deoxy-D-glucose,D003847,Deoxyglucose,https://ctdbase.org/detail.go?type=chem&acc=D003847,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Indinavir inhibits the reaction [ADIPOQ protein modified form results in increased uptake of deoxyglucose]|adipoq protein modified form results in increased uptake of deoxyglucose,,,PMID:29991592,https://www.ncbi.nlm.nih.gov/pubmed/29991592,29991592,,
594,1523704,119406,Comparative Toxicogenomics Database (CTD),2-(4-methoxy-1H-indol-3-yl)acetonitrile,C500823,arvelexin,https://ctdbase.org/detail.go?type=chem&acc=C500823,9536,PTGES,https://ctdbase.org/detail.go?type=gene&acc=9536,,,9536.0,PTGES,10090.0,Mus musculus (house mouse),Arvelexin analog inhibits the reaction [carrageenan results in increased expression of PTGES protein]|arvelexin analog results in decreased stability of PTGES mrna|arvelexin analog inhibits the reaction [lipopolysaccharides results in increased expression of PTGES mrna]|arvelexin analog inhibits the reaction [lipopolysaccharides results in increased expression of PTGES protein],,,PMID:25451575,https://www.ncbi.nlm.nih.gov/pubmed/25451575,25451575,,
595,1523705,119406,Comparative Toxicogenomics Database (CTD),2-(4-methoxy-1H-indol-3-yl)acetonitrile,C500823,arvelexin,https://ctdbase.org/detail.go?type=chem&acc=C500823,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Arvelexin analog inhibits the reaction [lipopolysaccharides affects the localization of RELA protein],,,PMID:25451575,https://www.ncbi.nlm.nih.gov/pubmed/25451575,25451575,,
596,1523706,119406,Comparative Toxicogenomics Database (CTD),2-(4-methoxy-1H-indol-3-yl)acetonitrile,C500823,arvelexin,https://ctdbase.org/detail.go?type=chem&acc=C500823,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Arvelexin analog inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein]|arvelexin analog inhibits the reaction [lipopolysaccharides results in increased expression of TNF mrna],,,PMID:25451575,https://www.ncbi.nlm.nih.gov/pubmed/25451575,25451575,,
597,1523707,119461,Therapeutic Target Database (TTD),6-Isopropoxy-9-oxoxanthene-2-carboxylic acid,D0J9PG,AH6809,https://idrblab.net/ttd/data/drug/details/D0J9PG,T15497,Prostaglandin E2 receptor EP1 (PTGER1),https://idrblab.net/ttd/data/target/details/T15497,P34995,Prostaglandin E2 receptor EP1 subtype,5731.0,PTGER1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
598,1524039,119584,ChEMBL,Mosapride,CHEMBL60889,MOSAPRIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL60889/,CHEMBL2094132,Serotonin 3 (5-HT3) receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094132/,Q8WXA8,5-hydroxytryptamine receptor 3C,170572.0,HTR3C,9606.0,Homo sapiens (human),Serotonin 3 (5-HT3) receptor antagonist,,,PMID:9692698,https://www.ncbi.nlm.nih.gov/pubmed/9692698,9692698,,
599,1524040,119584,ChEMBL,Mosapride,CHEMBL60889,MOSAPRIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL60889/,CHEMBL1875,Serotonin 4 (5-HT4) receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1875/,Q13639,5-hydroxytryptamine receptor 4,3360.0,HTR4,9606.0,Homo sapiens (human),Serotonin 4 (5-HT4) receptor agonist,,,PMID:9692698,https://www.ncbi.nlm.nih.gov/pubmed/9692698,9692698,,
600,1524041,119607,IUPHAR/BPS Guide to PHARMACOLOGY,Valdecoxib,2894,valdecoxib,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2894,1376,COX-2 ,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1376,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibition,pIC50,8.3,PMID:10715145,https://www.ncbi.nlm.nih.gov/pubmed/10715145,10715145,,
601,1524042,121850,Comparative Toxicogenomics Database (CTD),"2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole",C072125,BRL 44408,https://ctdbase.org/detail.go?type=chem&acc=C072125,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,9986.0,Oryctolagus cuniculus (rabbit),BRL 44408 binds to and results in decreased activity of ADRA2A protein,,,PMID:8397342,https://www.ncbi.nlm.nih.gov/pubmed/8397342,8397342,,
602,1524043,121850,Comparative Toxicogenomics Database (CTD),"2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole",C072125,BRL 44408,https://ctdbase.org/detail.go?type=chem&acc=C072125,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,10116.0,Rattus norvegicus (Norway rat),[BRL 44408 binds to and results in decreased activity of ADRA2A protein] inhibits the reaction [xylazine inhibits the reaction [potassium results in increased secretion of norepinephrine]],,,PMID:11312645,https://www.ncbi.nlm.nih.gov/pubmed/11312645,11312645,,
603,1524044,121850,Comparative Toxicogenomics Database (CTD),"2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole",C072125,BRL 44408,https://ctdbase.org/detail.go?type=chem&acc=C072125,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,10116.0,Rattus norvegicus (Norway rat),[BRL 44408 binds to and results in decreased activity of ADRA2A protein] which results in decreased susceptibility to oxcarbazepine,,,PMID:17959985,https://www.ncbi.nlm.nih.gov/pubmed/17959985,17959985,,
604,1524045,121850,Comparative Toxicogenomics Database (CTD),"2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole",C072125,BRL 44408,https://ctdbase.org/detail.go?type=chem&acc=C072125,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,9606.0,Homo sapiens (human),BRL 44408 binds to and results in decreased activity of ADRA2A protein,,,PMID:11312645|PMID:15265636|PMID:19429072,https://www.ncbi.nlm.nih.gov/pubmed/11312645|https://www.ncbi.nlm.nih.gov/pubmed/15265636|https://www.ncbi.nlm.nih.gov/pubmed/19429072,11312645|15265636|19429072,,
605,1524046,121850,Comparative Toxicogenomics Database (CTD),"2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole",C072125,BRL 44408,https://ctdbase.org/detail.go?type=chem&acc=C072125,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),BRL 44408 inhibits the reaction [clonidine inhibits the reaction [zymosan results in increased expression of IFNG protein]],,,PMID:16192389,https://www.ncbi.nlm.nih.gov/pubmed/16192389,16192389,,
606,1524047,121850,Comparative Toxicogenomics Database (CTD),"2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole",C072125,BRL 44408,https://ctdbase.org/detail.go?type=chem&acc=C072125,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10116.0,Rattus norvegicus (Norway rat),BRL 44408 inhibits the reaction [clonidine inhibits the reaction [zymosan results in increased expression of IL1A protein]],,,PMID:16192389,https://www.ncbi.nlm.nih.gov/pubmed/16192389,16192389,,
607,1525194,122623,Comparative Toxicogenomics Database (CTD),Z-Pro-prolinal,C038541,N-benzyloxycarbonylprolylprolinal,https://ctdbase.org/detail.go?type=chem&acc=C038541,26286,ARFGAP3,https://ctdbase.org/detail.go?type=gene&acc=26286,,,26286.0,ARFGAP3,9606.0,Homo sapiens (human),N-benzyloxycarbonylprolylprolinal results in increased expression of ARFGAP3 mRNA,,,PMID:21487212,https://www.ncbi.nlm.nih.gov/pubmed/21487212,21487212,,
608,1525195,122623,Comparative Toxicogenomics Database (CTD),Z-Pro-prolinal,C038541,N-benzyloxycarbonylprolylprolinal,https://ctdbase.org/detail.go?type=chem&acc=C038541,55152,DALRD3,https://ctdbase.org/detail.go?type=gene&acc=55152,,,55152.0,DALRD3,9606.0,Homo sapiens (human),N-benzyloxycarbonylprolylprolinal results in increased expression of DALRD3 mRNA,,,PMID:21487212,https://www.ncbi.nlm.nih.gov/pubmed/21487212,21487212,,
609,1525196,122623,Comparative Toxicogenomics Database (CTD),Z-Pro-prolinal,C038541,N-benzyloxycarbonylprolylprolinal,https://ctdbase.org/detail.go?type=chem&acc=C038541,1612,DAPK1,https://ctdbase.org/detail.go?type=gene&acc=1612,,,1612.0,DAPK1,9606.0,Homo sapiens (human),N-benzyloxycarbonylprolylprolinal results in decreased expression of DAPK1 mRNA,,,PMID:21487212,https://www.ncbi.nlm.nih.gov/pubmed/21487212,21487212,,
610,1525197,122623,Comparative Toxicogenomics Database (CTD),Z-Pro-prolinal,C038541,N-benzyloxycarbonylprolylprolinal,https://ctdbase.org/detail.go?type=chem&acc=C038541,1785,DNM2,https://ctdbase.org/detail.go?type=gene&acc=1785,,,1785.0,DNM2,9606.0,Homo sapiens (human),N-benzyloxycarbonylprolylprolinal results in increased expression of DNM2 mRNA,,,PMID:21487212,https://www.ncbi.nlm.nih.gov/pubmed/21487212,21487212,,
611,1525198,122623,Comparative Toxicogenomics Database (CTD),Z-Pro-prolinal,C038541,N-benzyloxycarbonylprolylprolinal,https://ctdbase.org/detail.go?type=chem&acc=C038541,1936,EEF1D,https://ctdbase.org/detail.go?type=gene&acc=1936,,,1936.0,EEF1D,9606.0,Homo sapiens (human),N-benzyloxycarbonylprolylprolinal results in increased expression of EEF1D mRNA,,,PMID:21487212,https://www.ncbi.nlm.nih.gov/pubmed/21487212,21487212,,
612,1525912,123278,Toxin and Toxin Target Database (T3DB),Plumbane,T3D1329,Plumbane,http://www.t3db.ca/toxins/T3D1329,BE0000732,Sodium/potassium-transporting ATPase subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000732,P05023,Sodium/potassium-transporting ATPase subunit alpha-1 ,476.0,ATP1A1,9606.0,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
613,1525913,123278,Toxin and Toxin Target Database (T3DB),Plumbane,T3D1329,Plumbane,http://www.t3db.ca/toxins/T3D1329,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0005034,P50993,Sodium/potassium-transporting ATPase subunit alpha-2,477.0,ATP1A2,9606.0,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
614,1525914,123278,Toxin and Toxin Target Database (T3DB),Plumbane,T3D1329,Plumbane,http://www.t3db.ca/toxins/T3D1329,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0005047,P13637,Sodium/potassium-transporting ATPase subunit alpha-3,478.0,ATP1A3,9606.0,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
615,1525915,123278,Toxin and Toxin Target Database (T3DB),Plumbane,T3D1329,Plumbane,http://www.t3db.ca/toxins/T3D1329,BE0005031,Sodium/potassium-transporting ATPase subunit alpha-4,http://www.t3db.ca/biodb/bio_entities/BE0005031,Q13733,Sodium/potassium-transporting ATPase subunit alpha-4,480.0,ATP1A4,9606.0,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
616,1525916,123278,Toxin and Toxin Target Database (T3DB),Plumbane,T3D1329,Plumbane,http://www.t3db.ca/toxins/T3D1329,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0004994,P05026,Sodium/potassium-transporting ATPase subunit beta-1,481.0,ATP1B1,9606.0,Homo sapiens (human),Lead binds to sodium/potassium-transporting atpases. (A24),,,PMID:1664209,https://www.ncbi.nlm.nih.gov/pubmed/1664209,1664209,,
617,1526115,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,140625,ACTRT2,https://ctdbase.org/detail.go?type=gene&acc=140625,,,140625.0,ACTRT2,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of ACTRT2 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
618,1526116,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,95,ACY1,https://ctdbase.org/detail.go?type=gene&acc=95,,,95.0,ACY1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ACY1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
619,1526524,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,146,ADRA1D,https://ctdbase.org/detail.go?type=gene&acc=146,,,146.0,ADRA1D,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of ADRA1D mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
620,1526525,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of ADRA2A mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
621,1526526,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,151,ADRA2B,https://ctdbase.org/detail.go?type=gene&acc=151,,,151.0,ADRA2B,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of ADRA2B mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
622,1526527,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,152,ADRA2C,https://ctdbase.org/detail.go?type=gene&acc=152,,,152.0,ADRA2C,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of ADRA2C mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
623,1526528,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,153,ADRB1,https://ctdbase.org/detail.go?type=gene&acc=153,,,153.0,ADRB1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of ADRB1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
624,1526529,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,165,AEBP1,https://ctdbase.org/detail.go?type=gene&acc=165,,,165.0,AEBP1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AEBP1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
625,1526530,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,27125,AFF4,https://ctdbase.org/detail.go?type=gene&acc=27125,,,27125.0,AFF4,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of AFF4 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
626,1526531,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,116987,AGAP1,https://ctdbase.org/detail.go?type=gene&acc=116987,,,116987.0,AGAP1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AGAP1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
627,1526532,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,116988,AGAP3,https://ctdbase.org/detail.go?type=gene&acc=116988,,,116988.0,AGAP3,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of AGAP3 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
628,1529870,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,994,CDC25B,https://ctdbase.org/detail.go?type=gene&acc=994,,,994.0,CDC25B,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of CDC25B mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
629,1529871,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,9578,CDC42BPB,https://ctdbase.org/detail.go?type=gene&acc=9578,,,9578.0,CDC42BPB,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of CDC42BPB mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
630,1529872,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,55561,CDC42BPG,https://ctdbase.org/detail.go?type=gene&acc=55561,,,55561.0,CDC42BPG,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of CDC42BPG mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
631,1529873,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,56882,CDC42SE1,https://ctdbase.org/detail.go?type=gene&acc=56882,,,56882.0,CDC42SE1,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of CDC42SE1 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
632,1529874,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,1014,CDH16,https://ctdbase.org/detail.go?type=gene&acc=1014,,,1014.0,CDH16,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in decreased expression of CDH16 mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
633,1529875,123591,Comparative Toxicogenomics Database (CTD),Buckminsterfullerene,C069837,fullerene C60,https://ctdbase.org/detail.go?type=chem&acc=C069837,984,CDK11B,https://ctdbase.org/detail.go?type=gene&acc=984,,,984.0,CDK11B,10116.0,Rattus norvegicus (Norway rat),Fullerene C60 results in increased expression of CDK11B mRNA,,,PMID:19167457,https://www.ncbi.nlm.nih.gov/pubmed/19167457,19167457,,
634,1525908,123724,Comparative Toxicogenomics Database (CTD),Perhydroazepin-1-yl leucyl-tryptophyl-tryptophan,C083116,BQ 485,https://ctdbase.org/detail.go?type=chem&acc=C083116,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,10116.0,Rattus norvegicus (Norway rat),[BQ 485 binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein|[bq 485 binds to and results in decreased activity of EDNRA protein] inhibits the reaction [EDN1 protein results in decreased susceptibility to doxorubicin],,,PMID:14736733,https://www.ncbi.nlm.nih.gov/pubmed/14736733,14736733,,
635,1525909,123724,Comparative Toxicogenomics Database (CTD),Perhydroazepin-1-yl leucyl-tryptophyl-tryptophan,C083116,BQ 485,https://ctdbase.org/detail.go?type=chem&acc=C083116,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,9606.0,Homo sapiens (human),BQ 485 binds to and results in decreased activity of EDNRA protein,,,PMID:14736733|PMID:15093706|PMID:15357834|PMID:16391241,https://www.ncbi.nlm.nih.gov/pubmed/14736733|https://www.ncbi.nlm.nih.gov/pubmed/15093706|https://www.ncbi.nlm.nih.gov/pubmed/15357834|https://www.ncbi.nlm.nih.gov/pubmed/16391241,14736733|15093706|15357834|16391241,,
636,1525910,123726,IUPHAR/BPS Guide to PHARMACOLOGY,Mergepta,8675,compound 3 [PMID: 14640538],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8675,1593,Carboxypeptidase B1 (tissue),https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1593,P15086,Carboxypeptidase B,1360.0,CPB1,9606.0,Homo sapiens (human),Inhibition,pIC50,8.09,PMID:14640538,https://www.ncbi.nlm.nih.gov/pubmed/14640538,14640538,,
637,1525911,123726,IUPHAR/BPS Guide to PHARMACOLOGY,Mergepta,8675,compound 3 [PMID: 14640538],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8675,1594,Carboxypeptidase B2 (plasma),https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1594,Q96IY4,Carboxypeptidase B2,1361.0,CPB2,9606.0,Homo sapiens (human),Inhibition,pIC50,6.7,PMID:14640538,https://www.ncbi.nlm.nih.gov/pubmed/14640538,14640538,,
638,1518786,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),[CYP2D6 protein results in increased metabolism of chelidonine] which results in increased abundance of glutathione analog,,,PMID:31102647,https://www.ncbi.nlm.nih.gov/pubmed/31102647,31102647,,
639,1518787,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),[CYP2D6 protein results in increased metabolism of notopterol] promotes the reaction [glutathione binds to notopterol]|glutathione inhibits the reaction [notopterol results in decreased activity of CYP2D6 protein],,,PMID:32198085,https://www.ncbi.nlm.nih.gov/pubmed/32198085,32198085,,
640,1518788,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),[CYP2E1 protein co-treated with GSTP1 protein co-treated with glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac,,,PMID:24246759,https://www.ncbi.nlm.nih.gov/pubmed/24246759,24246759,,
641,1518789,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),[CYP2E1 protein results in increased metabolism of ethanol] which results in decreased abundance of glutathione,,,PMID:10573527,https://www.ncbi.nlm.nih.gov/pubmed/10573527,10573527,,
642,1518790,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),[CYP2E1 protein results in increased metabolism of notopterol] promotes the reaction [glutathione binds to notopterol],,,PMID:32198085,https://www.ncbi.nlm.nih.gov/pubmed/32198085,32198085,,
643,1519614,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,10116.0,Rattus norvegicus (Norway rat),Glutathione inhibits the reaction [cadmium results in increased expression of DUSP1 protein]|glutathione inhibits the reaction [cadmium results in increased expression of DUSP1 mrna],,,PMID:18573614,https://www.ncbi.nlm.nih.gov/pubmed/18573614,18573614,,
644,1519615,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,10116.0,Rattus norvegicus (Norway rat),EGF protein affects the abundance of glutathione,,,PMID:10544272,https://www.ncbi.nlm.nih.gov/pubmed/10544272,10544272,,
645,1519616,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [2'-benzoyloxycinnamaldehyde results in increased phosphorylation of EGFR protein],,,PMID:14660655,https://www.ncbi.nlm.nih.gov/pubmed/14660655,14660655,,
646,1519617,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,37111,GSTE6,https://ctdbase.org/detail.go?type=gene&acc=37111,,,37111.0,GstE6,7107.0,Spodoptera exigua (beet armyworm),GSTE6 protein binds to glutathione,,,PMID:30857628,https://www.ncbi.nlm.nih.gov/pubmed/30857628,30857628,,
647,1519618,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090.0,Mus musculus (house mouse),[acetaminophen results in decreased abundance of glutathione] which results in increased phosphorylation of and results in increased activity of EGFR protein|[phorone results in decreased abundance of glutathione] which results in increased phosphorylation of and results in increased activity of EGFR protein,,,PMID:28123000,https://www.ncbi.nlm.nih.gov/pubmed/28123000,28123000,,
648,1520044,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,10090.0,Mus musculus (house mouse),Glutathione inhibits the reaction [alcohols results in increased expression of FASN protein],,,PMID:28803762,https://www.ncbi.nlm.nih.gov/pubmed/28803762,28803762,,
649,1520045,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2246,FGF1,https://ctdbase.org/detail.go?type=gene&acc=2246,,,2246.0,FGF1,10116.0,Rattus norvegicus (Norway rat),2-tert-butylhydroquinone promotes the reaction [FGF1 protein results in increased abundance of and results in increased secretion of glutathione]|fgf1 protein results in increased abundance of and results in increased secretion of glutathione,,,PMID:16524372,https://www.ncbi.nlm.nih.gov/pubmed/16524372,16524372,,
650,1520046,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,693030,FIBH,https://ctdbase.org/detail.go?type=gene&acc=693030,,,693030.0,FIBH,9606.0,Homo sapiens (human),[FIBH protein binds to FIB-L protein] which results in decreased abundance of glutathione,,,PMID:29719092,https://www.ncbi.nlm.nih.gov/pubmed/29719092,29719092,,
651,1521576,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,10116.0,Rattus norvegicus (Norway rat),Glutathione deficiency results in increased expression of GCLM mRNA,,,PMID:15345336|PMID:20621112,https://www.ncbi.nlm.nih.gov/pubmed/15345336|https://www.ncbi.nlm.nih.gov/pubmed/20621112,15345336|20621112,,
652,1521577,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9823.0,Sus scrofa (pig),[glutathione co-treated with paraquat] results in increased expression of GCLM mRNA,,,PMID:36615853,https://www.ncbi.nlm.nih.gov/pubmed/36615853,36615853,,
653,1521578,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2653,GCSH,https://ctdbase.org/detail.go?type=gene&acc=2653,,,2653.0,GCSH,9606.0,Homo sapiens (human),[GCSH mRNA co-treated with CYP3A4 protein] affects the abundance of glutathione,,,PMID:19958826,https://www.ncbi.nlm.nih.gov/pubmed/19958826,19958826,,
654,1521579,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,9913.0,Bos taurus (cattle),[GGT1 protein results in increased metabolism of [acetaminophen cysteine co-treated with glutathione]] which results in increased abundance of gamma-glutamylcysteinylacetominophen|ggt1 protein affects the reaction [acetaminophen cysteine results in decreased abundance of glutathione],,,PMID:15629191,https://www.ncbi.nlm.nih.gov/pubmed/15629191,15629191,,
655,1521580,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10090.0,Mus musculus (house mouse),[hexylglutathione results in decreased activity of GGT1 protein] which results in decreased susceptibility to glutathione|[acivicin results in decreased activity of GGT1 protein] which results in decreased susceptibility to glutathione|ggt1 results in increased metabolism of glutathione,,,PMID:19419996,https://www.ncbi.nlm.nih.gov/pubmed/19419996,19419996,,
656,1521581,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2745,GLRX,https://ctdbase.org/detail.go?type=gene&acc=2745,,,2745.0,GLRX,9606.0,Homo sapiens (human),[CDC25B protein co-treated with GLRX protein co-treated with GSR protein co-treated with glutathione] results in increased reduction of sodium arsenate|[cdc25c protein co-treated with GLRX protein co-treated with GSR protein co-treated with glutathione] results in increased reduction of sodium arsenate,,,PMID:20025242,https://www.ncbi.nlm.nih.gov/pubmed/20025242,20025242,,
657,1523551,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10114.0,Rattus,GSTM2 protein affects the metabolism of [dinitrochlorobenzene co-treated with glutathione]|gstm2 protein affects the metabolism of [dinitrochlorobenzene co-treated with glutathione analog],,,PMID:2375757,https://www.ncbi.nlm.nih.gov/pubmed/2375757,2375757,,
658,1523552,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),Dinitrochlorobenzene promotes the reaction [GSTM2 protein affects the metabolism of glutathione],,,PMID:9794801,https://www.ncbi.nlm.nih.gov/pubmed/9794801,9794801,,
659,1523553,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),GSTM2 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with glutathione],,,PMID:8973562,https://www.ncbi.nlm.nih.gov/pubmed/8973562,8973562,,
660,1523554,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),GSTM2 protein affects the metabolism of glutathione,,,PMID:8924604,https://www.ncbi.nlm.nih.gov/pubmed/8924604,8924604,,
661,1523555,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),GSTM2 protein affects the metabolism of [styrene oxide co-treated with glutathione],,,PMID:2604743,https://www.ncbi.nlm.nih.gov/pubmed/2604743,2604743,,
662,1523556,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947.0,GSTM3,9606.0,Homo sapiens (human),GSTM3 protein affects the metabolism of glutathione,,,PMID:9545290,https://www.ncbi.nlm.nih.gov/pubmed/9545290,9545290,,
663,1523557,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2948,GSTM4,https://ctdbase.org/detail.go?type=gene&acc=2948,,,2948.0,GSTM4,9606.0,Homo sapiens (human),GSTM4 protein affects the metabolism of [dinitrochlorobenzene co-treated with glutathione],,,PMID:8203914,https://www.ncbi.nlm.nih.gov/pubmed/8203914,8203914,,
664,1523558,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2948,GSTM4,https://ctdbase.org/detail.go?type=gene&acc=2948,,,2948.0,GSTM4,9606.0,Homo sapiens (human),[GSTM4 protein co-treated with glutathione] results in increased metabolism of amodiaquine quinoneimine|[gstm4 protein co-treated with glutathione] results in increased metabolism of desethylamodiaquine,,,PMID:28478157,https://www.ncbi.nlm.nih.gov/pubmed/28478157,28478157,,
665,1523559,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,2949,GSTM5,https://ctdbase.org/detail.go?type=gene&acc=2949,,,2949.0,GSTM5,10090.0,Mus musculus (house mouse),GSTM5 protein affects the metabolism of glutathione,,,PMID:9545290,https://www.ncbi.nlm.nih.gov/pubmed/9545290,9545290,,
666,1524853,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),TNF protein inhibits the reaction [[buthionine sulfoximine results in decreased abundance of glutathione] which results in increased expression of HMOX1 mrna]|[buthionine sulfoximine results in decreased abundance of glutathione] which results in increased expression of HMOX1 mrna|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[buthionine sulfoximine results in decreased abundance of glutathione] which results in increased expression of HMOX1 mrna],,,PMID:21971136,https://www.ncbi.nlm.nih.gov/pubmed/21971136,21971136,,
667,1524854,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),[acetylcysteine results in increased abundance of glutathione] inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mrna],,,PMID:20020861,https://www.ncbi.nlm.nih.gov/pubmed/20020861,20020861,,
668,1524855,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] inhibits the reaction [ethanol results in decreased abundance of glutathione]|zinc protoporphyrin inhibits the reaction [[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] inhibits the reaction [ethanol results in decreased abundance of glutathione]],,,PMID:15602829,https://www.ncbi.nlm.nih.gov/pubmed/15602829,15602829,,
669,1524856,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [dimethyl fumarate results in increased expression of HMOX1 protein]|[dimethyl fumarate results in decreased abundance of glutathione] which results in increased expression of HMOX1 protein,,,PMID:20961405,https://www.ncbi.nlm.nih.gov/pubmed/20961405,20961405,,
670,1524857,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Glutathione affects the expression of HMOX1 mRNA,,,PMID:8743975,https://www.ncbi.nlm.nih.gov/pubmed/8743975,8743975,,
671,1524858,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of HMOX1 mrna],,,PMID:16631525,https://www.ncbi.nlm.nih.gov/pubmed/16631525,16631525,,
672,1527531,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606.0,Homo sapiens (human),"Desmethylnaproxen promotes the reaction [[hydrogen peroxide co-treated with MPO protein co-treated with glutathione] results in increased glutathionylation of 5,5-dimethyl-1-pyrroline-1-oxide]|[[hydrogen peroxide results in increased activity of MPO protein] which results in increased oxidation of glutathione] which results in increased glutathionylation of 5,5-dimethyl-1-pyrroline-1-oxide|[hydrogen peroxide co-treated with MPO protein co-treated with glutathione] results in increased glutathionylation of 5,5-dimethyl-1-pyrroline-1-oxide|4'-hydroxydiclofenac promotes the reaction [[hydrogen peroxide co-treated with MPO protein co-treated with glutathione] results in increased glutathionylation of 5,5-dimethyl-1-pyrroline-1-oxide]|[hydrogen peroxide results in increased activity of MPO protein] which results in increased oxidation of glutathione",,,PMID:28754375,https://www.ncbi.nlm.nih.gov/pubmed/28754375,28754375,,
673,1527532,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [[MPO protein co-treated with hydrogen peroxide] results in increased oxidation of albuterol]|glutathione inhibits the reaction [[MPO protein co-treated with hydrogen peroxide] results in increased oxidation of fenoterol],,,PMID:19462961,https://www.ncbi.nlm.nih.gov/pubmed/19462961,19462961,,
674,1529742,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,10116.0,Rattus norvegicus (Norway rat),Glutathione deficiency results in increased expression of PRDX6 mRNA,,,PMID:15345336,https://www.ncbi.nlm.nih.gov/pubmed/15345336,15345336,,
675,1529743,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,9588,PRDX6,https://ctdbase.org/detail.go?type=gene&acc=9588,,,9588.0,PRDX6,9606.0,Homo sapiens (human),[PRDX6 protein binds to PRDX6 protein] which binds to glutathione,,,PMID:16401067,https://www.ncbi.nlm.nih.gov/pubmed/16401067,16401067,,
676,1529744,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5558,PRIM2,https://ctdbase.org/detail.go?type=gene&acc=5558,,,5558.0,PRIM2,10116.0,Rattus norvegicus (Norway rat),Glutathione deficiency results in increased expression of PRIM2 mRNA,,,PMID:20621112,https://www.ncbi.nlm.nih.gov/pubmed/20621112,20621112,,
677,1529745,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of PRKCD protein],,,PMID:15707588,https://www.ncbi.nlm.nih.gov/pubmed/15707588,15707588,,
678,1529746,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Glutathione inhibits the reaction [curcumin results in increased phosphorylation of PRKCD protein],,,PMID:17171638,https://www.ncbi.nlm.nih.gov/pubmed/17171638,17171638,,
679,1529747,124886,Comparative Toxicogenomics Database (CTD),Glutathione,D005978,Glutathione,https://ctdbase.org/detail.go?type=chem&acc=D005978,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),PRKCD protein affects the abundance of glutathione,,,PMID:15131007,https://www.ncbi.nlm.nih.gov/pubmed/15131007,15131007,,
680,1527298,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCL8,,,PMID:19732956,https://www.ncbi.nlm.nih.gov/pubmed/19732956,19732956,,
681,1527299,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCL8 mRNA,,,PMID:15476228|PMID:17400583|PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/15476228|https://www.ncbi.nlm.nih.gov/pubmed/17400583|https://www.ncbi.nlm.nih.gov/pubmed/19192274,15476228|17400583|19192274,,
682,1527300,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCL8 protein,,,PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/19192274,19192274,,
683,1527301,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Methotrexate results in increased expression of CXCL8 mRNA,,,PMID:17379860|PMID:24657277,https://www.ncbi.nlm.nih.gov/pubmed/17379860|https://www.ncbi.nlm.nih.gov/pubmed/24657277,17379860|24657277,,
684,1527302,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Methotrexate results in increased secretion of CXCL8 protein,,,PMID:19100307|PMID:27605418,https://www.ncbi.nlm.nih.gov/pubmed/19100307|https://www.ncbi.nlm.nih.gov/pubmed/27605418,19100307|27605418,,
685,1527303,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),SB 203580 inhibits the reaction [methotrexate results in increased secretion of CXCL8 protein],,,PMID:19100307,https://www.ncbi.nlm.nih.gov/pubmed/19100307,19100307,,
686,1527304,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,3579,CXCR2,https://ctdbase.org/detail.go?type=gene&acc=3579,,,3579.0,CXCR2,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCR2 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
687,1527305,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,7852,CXCR4,https://ctdbase.org/detail.go?type=gene&acc=7852,,,7852.0,CXCR4,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCR4 mRNA,,,PMID:19192274,https://www.ncbi.nlm.nih.gov/pubmed/19192274,19192274,,
688,1527306,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,10663,CXCR6,https://ctdbase.org/detail.go?type=gene&acc=10663,,,10663.0,CXCR6,9606.0,Homo sapiens (human),Methotrexate results in decreased expression of CXCR6 mRNA,,,PMID:24449571,https://www.ncbi.nlm.nih.gov/pubmed/24449571,24449571,,
689,1528101,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of DAB2 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
690,1528102,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1613,DAPK3,https://ctdbase.org/detail.go?type=gene&acc=1613,,,1613.0,DAPK3,9606.0,Homo sapiens (human),DAPK3 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
691,1528103,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1622,DBI,https://ctdbase.org/detail.go?type=gene&acc=1622,,,1622.0,DBI,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of DBI mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
692,1528104,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1627,DBN1,https://ctdbase.org/detail.go?type=gene&acc=1627,,,1627.0,DBN1,9606.0,Homo sapiens (human),DBN1 protein affects the susceptibility to methotrexate,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
693,1530006,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,25975,EGFL6,https://ctdbase.org/detail.go?type=gene&acc=25975,,,25975.0,EGFL6,9606.0,Homo sapiens (human),EGFL6 mRNA results in decreased susceptibility to methotrexate,,,PMID:25199881,https://www.ncbi.nlm.nih.gov/pubmed/25199881,25199881,,
694,1530007,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,25975,EGFL6,https://ctdbase.org/detail.go?type=gene&acc=25975,,,25975.0,EGFL6,10090.0,Mus musculus (house mouse),Methotrexate affects the expression of EGFL6 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
695,1530008,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090.0,Mus musculus (house mouse),EGFR mRNA results in decreased susceptibility to methotrexate,,,PMID:16918715,https://www.ncbi.nlm.nih.gov/pubmed/16918715,16918715,,
696,1530009,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116.0,Rattus norvegicus (Norway rat),Methotrexate results in increased expression of EGFR mRNA,,,PMID:18803016,https://www.ncbi.nlm.nih.gov/pubmed/18803016,18803016,,
697,1411361,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,9031.0,Gallus gallus (chicken),Nitric oxide inhibits the reaction [cadmium results in decreased expression of FOXO1 mrna],,,PMID:25490952,https://www.ncbi.nlm.nih.gov/pubmed/25490952,25490952,,
698,1411362,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9031.0,Gallus gallus (chicken),Nitric oxide inhibits the reaction [cadmium results in increased expression of FOXO3 mrna],,,PMID:25490952,https://www.ncbi.nlm.nih.gov/pubmed/25490952,25490952,,
699,1412121,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,8692,HYAL2,https://ctdbase.org/detail.go?type=gene&acc=8692,,,8692.0,HYAL2,10090.0,Mus musculus (house mouse),Nitric oxide deficiency results in decreased expression of HYAL2 mRNA,,,PMID:15878706,https://www.ncbi.nlm.nih.gov/pubmed/15878706,15878706,,
700,1412274,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,115677,NOSTRIN,https://ctdbase.org/detail.go?type=gene&acc=115677,,,115677.0,NOSTRIN,9606.0,Homo sapiens (human),[NOSTRIN protein results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of nitric oxide,,,PMID:28235804,https://www.ncbi.nlm.nih.gov/pubmed/28235804,28235804,,
701,1412275,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,79400,NOX5,https://ctdbase.org/detail.go?type=gene&acc=79400,,,79400.0,NOX5,9913.0,Bos taurus (cattle),NOX5 protein promotes the reaction [NOS3 protein results in increased chemical synthesis of nitric oxide],,,PMID:18556569,https://www.ncbi.nlm.nih.gov/pubmed/18556569,18556569,,
702,1412276,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4864,NPC1,https://ctdbase.org/detail.go?type=gene&acc=4864,,,4864.0,NPC1,10090.0,Mus musculus (house mouse),Nitric oxide deficiency results in decreased expression of NPC1 mRNA,,,PMID:15878706,https://www.ncbi.nlm.nih.gov/pubmed/15878706,15878706,,
703,1412277,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116.0,Rattus norvegicus (Norway rat),Losartan inhibits the reaction [nitric oxide deficiency results in increased expression of NPPA mrna],,,PMID:12198334,https://www.ncbi.nlm.nih.gov/pubmed/12198334,12198334,,
704,1412278,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116.0,Rattus norvegicus (Norway rat),Nitric oxide deficiency results in increased expression of NPPA mRNA,,,PMID:10397678|PMID:12198334|PMID:15177930,https://www.ncbi.nlm.nih.gov/pubmed/10397678|https://www.ncbi.nlm.nih.gov/pubmed/12198334|https://www.ncbi.nlm.nih.gov/pubmed/15177930,10397678|12198334|15177930,,
705,1412279,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116.0,Rattus norvegicus (Norway rat),Nitric oxide deficiency results in increased expression of NPPA protein,,,PMID:14700747|PMID:15177930,https://www.ncbi.nlm.nih.gov/pubmed/14700747|https://www.ncbi.nlm.nih.gov/pubmed/15177930,14700747|15177930,,
706,1412280,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4879,NPPB,https://ctdbase.org/detail.go?type=gene&acc=4879,,,4879.0,NPPB,10116.0,Rattus norvegicus (Norway rat),Hydralazine inhibits the reaction [nitric oxide deficiency results in increased expression of NPPB mrna]|hydrochlorothiazide inhibits the reaction [nitric oxide deficiency results in increased expression of NPPB mrna],,,PMID:16326922,https://www.ncbi.nlm.nih.gov/pubmed/16326922,16326922,,
707,1412281,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4879,NPPB,https://ctdbase.org/detail.go?type=gene&acc=4879,,,4879.0,NPPB,10116.0,Rattus norvegicus (Norway rat),Losartan inhibits the reaction [nitric oxide deficiency results in increased expression of NPPB mrna]|nitric oxide deficiency results in increased expression of NPPB protein,,,PMID:12198334,https://www.ncbi.nlm.nih.gov/pubmed/12198334,12198334,,
708,1412282,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4879,NPPB,https://ctdbase.org/detail.go?type=gene&acc=4879,,,4879.0,NPPB,10116.0,Rattus norvegicus (Norway rat),Nitric oxide deficiency results in increased expression of NPPB mRNA,,,PMID:12198334|PMID:16326922,https://www.ncbi.nlm.nih.gov/pubmed/12198334|https://www.ncbi.nlm.nih.gov/pubmed/16326922,12198334|16326922,,
709,1412597,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),Pimagedine inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of nitric oxide]|[lipopolysaccharides co-treated with TNF protein co-treated with IFNG protein] results in increased chemical synthesis of nitric oxide|[[tnf protein co-treated with IFNG protein] affects the expression of NOS2 protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of nitric oxide]|dexamethasone inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of nitric oxide]|il4 protein inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of nitric oxide]|[[tnf protein co-treated with IFNG protein] affects the expression of NOS2 mrna] promotes the reaction [NOS2 protein results in increased chemical synthesis of nitric oxide],,,PMID:12612912,https://www.ncbi.nlm.nih.gov/pubmed/12612912,12612912,,
710,1412598,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),[lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of nitric oxide|diquat promotes the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of nitric oxide]|pimagedine inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of nitric oxide]|ditiocarb inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of nitric oxide]|gpx1 protein affects the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of nitric oxide],,,PMID:11498278,https://www.ncbi.nlm.nih.gov/pubmed/11498278,11498278,,
711,1412599,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),[lipopolysaccharides co-treated with IFNG] results in increased abundance of nitric oxide|dronabinol inhibits the reaction [[lipopolysaccharides co-treated with IFNG] results in increased abundance of nitric oxide],,,PMID:8765472,https://www.ncbi.nlm.nih.gov/pubmed/8765472,8765472,,
712,1412600,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),Estriol inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of nitric oxide]|progesterone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased abundance of nitric oxide]|[ifng protein co-treated with TNF protein] results in increased abundance of nitric oxide,,,PMID:11063824,https://www.ncbi.nlm.nih.gov/pubmed/11063824,11063824,,
713,1413328,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Selenomethylselenocysteine results in increased activity of CASP3 protein,,,PMID:15318939,https://www.ncbi.nlm.nih.gov/pubmed/15318939,15318939,,
714,1413329,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,839,CASP6,https://ctdbase.org/detail.go?type=gene&acc=839,,,839.0,CASP6,9606.0,Homo sapiens (human),Selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form|bmf protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form],,,PMID:25321483,https://www.ncbi.nlm.nih.gov/pubmed/25321483,25321483,,
715,1413330,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Selenomethylselenocysteine metabolite results in increased expression of CASP8 protein modified form,,,PMID:25321483,https://www.ncbi.nlm.nih.gov/pubmed/25321483,25321483,,
716,1413331,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form|bmf protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form],,,PMID:25321483,https://www.ncbi.nlm.nih.gov/pubmed/25321483,25321483,,
717,1413332,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,10116.0,Rattus norvegicus (Norway rat),Selenomethylselenocysteine results in decreased expression of CCNA2 protein,,,PMID:11396176,https://www.ncbi.nlm.nih.gov/pubmed/11396176,11396176,,
718,1413333,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),[selenomethylselenocysteine co-treated with tamoxifen] results in decreased expression of CCND1 protein|selenomethylselenocysteine results in decreased expression of CCND1 protein,,,PMID:18855134,https://www.ncbi.nlm.nih.gov/pubmed/18855134,18855134,,
719,1413334,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),Selenomethylselenocysteine results in decreased expression of CCND1 mRNA,,,PMID:19276161,https://www.ncbi.nlm.nih.gov/pubmed/19276161,19276161,,
720,1413335,147004,Comparative Toxicogenomics Database (CTD),Se-methylselenocysteine,C002979,selenomethylselenocysteine,https://ctdbase.org/detail.go?type=chem&acc=C002979,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116.0,Rattus norvegicus (Norway rat),Selenomethylselenocysteine results in decreased expression of CCND1 protein,,,PMID:11396176|PMID:19276161,https://www.ncbi.nlm.nih.gov/pubmed/11396176|https://www.ncbi.nlm.nih.gov/pubmed/19276161,11396176|19276161,,
721,1413923,156422,Drug Gene Interaction database (DGIdb),Doramapimod,,DORAMAPIMOD,https://www.dgidb.org/drugs/ncit:C76770,,HCK,https://www.dgidb.org/genes/hgnc:4840,,,3055.0,HCK,9606.0,Homo sapiens (human),,,,,,,,
722,1413924,157143,BindingDB,Mulberrofuran C,50179010,CHEMBL378806,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50179010,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049.0,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),99500,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
723,1413925,157313,ChEMBL,Epinastine Hydrochloride,CHEMBL1200491,EPINASTINE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200491/,CHEMBL231,Histamine H1 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL231/,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Histamine H1 receptor antagonist,,,,,,,
724,1414060,159252,DrugBank,Butanedioic acid;iron(2+),DB14489,Ferrous succinate,https://www.drugbank.ca/drugs/DB14489,BE0002217,Egl nine homolog 1,https://www.drugbank.ca/bio_entities/BE0002217,Q9GZT9,Egl nine homolog 1,54583.0,EGLN1,9606.0,Homo sapiens (human),,,,PMID:16649251,https://www.ncbi.nlm.nih.gov/pubmed/16649251,16649251,,
725,1414061,159252,DrugBank,Butanedioic acid;iron(2+),DB14489,Ferrous succinate,https://www.drugbank.ca/drugs/DB14489,BE0001608,Histone deacetylase 8,https://www.drugbank.ca/bio_entities/BE0001608,Q9BY41,Histone deacetylase 8,55869.0,HDAC8,9606.0,Homo sapiens (human),,,,PMID:16681389,https://www.ncbi.nlm.nih.gov/pubmed/16681389,16681389,,
726,1414062,159252,DrugBank,Butanedioic acid;iron(2+),DB14489,Ferrous succinate,https://www.drugbank.ca/drugs/DB14489,BE0008990,Alpha-hemoglobin-stabilizing protein,https://www.drugbank.ca/bio_entities/BE0008990,Q9NZD4,Alpha-hemoglobin-stabilizing protein,51327.0,AHSP,9606.0,Homo sapiens (human),,,,PMID:16901899,https://www.ncbi.nlm.nih.gov/pubmed/16901899,16901899,,
727,1411214,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4124,MAN2A1,https://ctdbase.org/detail.go?type=gene&acc=4124,,,4124.0,MAN2A1,9606.0,Homo sapiens (human),Abrine results in decreased expression of MAN2A1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
728,1411215,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23324,MAN2B2,https://ctdbase.org/detail.go?type=gene&acc=23324,,,23324.0,MAN2B2,9606.0,Homo sapiens (human),Abrine results in decreased expression of MAN2B2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
729,1411216,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79694,MANEA,https://ctdbase.org/detail.go?type=gene&acc=79694,,,79694.0,MANEA,9606.0,Homo sapiens (human),Abrine results in decreased expression of MANEA mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
730,1411217,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,149175,MANEAL,https://ctdbase.org/detail.go?type=gene&acc=149175,,,149175.0,MANEAL,9606.0,Homo sapiens (human),Abrine results in decreased expression of MANEAL mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
731,1411218,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,54682,MANSC1,https://ctdbase.org/detail.go?type=gene&acc=54682,,,54682.0,MANSC1,9606.0,Homo sapiens (human),Abrine results in decreased expression of MANSC1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
732,1411219,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128.0,MAOA,9606.0,Homo sapiens (human),Abrine results in decreased expression of MAOA mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
733,1411975,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23366,MATCAP2,https://ctdbase.org/detail.go?type=gene&acc=23366,,,23366.0,MATCAP2,9606.0,Homo sapiens (human),Abrine results in increased expression of MATCAP2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
734,1411976,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4145,MATK,https://ctdbase.org/detail.go?type=gene&acc=4145,,,4145.0,MATK,9606.0,Homo sapiens (human),Abrine results in increased expression of MATK mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
735,1411977,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4147,MATN2,https://ctdbase.org/detail.go?type=gene&acc=4147,,,4147.0,MATN2,9606.0,Homo sapiens (human),Abrine results in decreased expression of MATN2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
736,1413610,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,22877,MLXIP,https://ctdbase.org/detail.go?type=gene&acc=22877,,,22877.0,MLXIP,9606.0,Homo sapiens (human),Abrine results in decreased expression of MLXIP mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
737,1413611,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,9606.0,Homo sapiens (human),Abrine results in decreased expression of MLXIPL mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
738,1413612,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,166785,MMAA,https://ctdbase.org/detail.go?type=gene&acc=166785,,,166785.0,MMAA,9606.0,Homo sapiens (human),Abrine results in decreased expression of MMAA mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
739,1413613,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,25974,MMACHC,https://ctdbase.org/detail.go?type=gene&acc=25974,,,25974.0,MMACHC,9606.0,Homo sapiens (human),Abrine results in decreased expression of MMACHC mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
740,1413614,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27249,MMADHC,https://ctdbase.org/detail.go?type=gene&acc=27249,,,27249.0,MMADHC,9606.0,Homo sapiens (human),Abrine results in increased expression of MMADHC mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
741,1413615,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,93380,MMGT1,https://ctdbase.org/detail.go?type=gene&acc=93380,,,93380.0,MMGT1,9606.0,Homo sapiens (human),Abrine results in decreased expression of MMGT1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
742,1413616,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4319,MMP10,https://ctdbase.org/detail.go?type=gene&acc=4319,,,4319.0,MMP10,9606.0,Homo sapiens (human),Abrine results in increased expression of MMP10 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
743,1413617,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4321,MMP12,https://ctdbase.org/detail.go?type=gene&acc=4321,,,4321.0,MMP12,9606.0,Homo sapiens (human),Abrine results in increased expression of MMP12 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
744,1413618,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10090.0,Mus musculus (house mouse),Abrine results in decreased expression of MMP13 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
745,1414566,161408,BindingDB,,21868,"2-amino-9-(4-hydroxybutyl)-6,9-dihydro-3H-purin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21868,2215,Thymidine kinase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2215,P04407,Thymidine kinase,,,10313.0,Human herpesvirus 2 strain 333,,IC50 (nM),160000,PMID:15916444|DOI:10.1021/jm049059x,https://www.ncbi.nlm.nih.gov/pubmed/15916444|https://doi.org/10.1021/jm049059x,15916444,10.1021/jm049059x,
746,1414567,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606.0,Homo sapiens (human),AR protein inhibits the reaction [methylselenic acid results in decreased expression of ABCC4 mrna],,,PMID:16020662,https://www.ncbi.nlm.nih.gov/pubmed/16020662,16020662,,
747,1414687,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,2181,ACSL3,https://ctdbase.org/detail.go?type=gene&acc=2181,,,2181.0,ACSL3,9606.0,Homo sapiens (human),Methylselenic acid results in decreased expression of ACSL3 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
748,1414688,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of ACTA2 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
749,1414689,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,72,ACTG2,https://ctdbase.org/detail.go?type=gene&acc=72,,,72.0,ACTG2,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of ACTG2 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
750,1414690,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,53616,ADAM22,https://ctdbase.org/detail.go?type=gene&acc=53616,,,53616.0,ADAM22,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of ADAM22 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
751,1414691,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,120,ADD3,https://ctdbase.org/detail.go?type=gene&acc=120,,,120.0,ADD3,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of ADD3 mRNA,,,PMID:12517777,https://www.ncbi.nlm.nih.gov/pubmed/12517777,12517777,,
752,1414692,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,23284,ADGRL3,https://ctdbase.org/detail.go?type=gene&acc=23284,,,23284.0,ADGRL3,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of ADGRL3 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
753,1415548,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606.0,Homo sapiens (human),Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of CASP7 protein],,,PMID:18790785,https://www.ncbi.nlm.nih.gov/pubmed/18790785,18790785,,
754,1415549,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),"[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP8 protein",,,PMID:18444175,https://www.ncbi.nlm.nih.gov/pubmed/18444175,18444175,,
755,1415550,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),[methylselenic acid co-treated with tamoxifen] results in increased cleavage of CASP8 protein|[methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein|[[methylselenic acid co-treated with tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein|methylselenic acid results in increased cleavage of CASP8 protein,,,PMID:18790785,https://www.ncbi.nlm.nih.gov/pubmed/18790785,18790785,,
756,1415551,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),"[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein",,,PMID:18444175,https://www.ncbi.nlm.nih.gov/pubmed/18444175,18444175,,
757,1415552,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),BCL2L11 protein promotes the reaction [[doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein]|[doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein,,,PMID:17339365,https://www.ncbi.nlm.nih.gov/pubmed/17339365,17339365,,
758,1415553,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),[methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein|[[methylselenic acid co-treated with tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein|[methylselenic acid co-treated with tamoxifen] results in increased cleavage of CASP9 protein,,,PMID:18790785,https://www.ncbi.nlm.nih.gov/pubmed/18790785,18790785,,
759,1415554,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Methylselenic acid results in increased cleavage of and results in increased activity of CASP9 protein,,,PMID:28161410,https://www.ncbi.nlm.nih.gov/pubmed/28161410,28161410,,
760,1415665,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Methylselenic acid results in increased cleavage of CASP9 protein,,,PMID:18444175|PMID:18790785,https://www.ncbi.nlm.nih.gov/pubmed/18444175|https://www.ncbi.nlm.nih.gov/pubmed/18790785,18444175|18790785,,
761,1415666,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of CASP9 mRNA,,,PMID:12517777,https://www.ncbi.nlm.nih.gov/pubmed/12517777,12517777,,
762,1415667,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,831,CAST,https://ctdbase.org/detail.go?type=gene&acc=831,,,831.0,CAST,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of CAST mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
763,1415668,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,23492,CBX7,https://ctdbase.org/detail.go?type=gene&acc=23492,,,23492.0,CBX7,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of CBX7 mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
764,1415669,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,885,CCK,https://ctdbase.org/detail.go?type=gene&acc=885,,,885.0,CCK,9606.0,Homo sapiens (human),Methylselenic acid results in increased expression of CCK mRNA,,,PMID:18548127,https://www.ncbi.nlm.nih.gov/pubmed/18548127,18548127,,
765,1415670,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),Methylselenic acid results in decreased expression of CCNA2 mRNA,,,PMID:12517777,https://www.ncbi.nlm.nih.gov/pubmed/12517777,12517777,,
766,1415794,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,993,CDC25A,https://ctdbase.org/detail.go?type=gene&acc=993,,,993.0,CDC25A,9606.0,Homo sapiens (human),Methylselenic acid results in decreased expression of CDC25A protein|methylselenic acid results in decreased expression of CDC25A mRNA,,,PMID:11830524,https://www.ncbi.nlm.nih.gov/pubmed/11830524,11830524,,
767,1415917,161597,Comparative Toxicogenomics Database (CTD),Methylselenic acid,C008493,methylselenic acid,https://ctdbase.org/detail.go?type=chem&acc=C008493,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Methylselenic acid results in decreased expression of CDK1 protein,,,PMID:11830524|PMID:16205645,https://www.ncbi.nlm.nih.gov/pubmed/11830524|https://www.ncbi.nlm.nih.gov/pubmed/16205645,11830524|16205645,,
768,1410801,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,245910,DEFB107A,https://ctdbase.org/detail.go?type=gene&acc=245910,,,245910.0,DEFB107A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of DEFB107A gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
769,1410802,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,503614,DEFB107B,https://ctdbase.org/detail.go?type=gene&acc=503614,,,503614.0,DEFB107B,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of DEFB107B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
770,1410803,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,245927,DEFB113,https://ctdbase.org/detail.go?type=gene&acc=245927,,,245927.0,DEFB113,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of DEFB113 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
771,1410804,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,245928,DEFB114,https://ctdbase.org/detail.go?type=gene&acc=245928,,,245928.0,DEFB114,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of DEFB114 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
772,1410805,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,245929,DEFB115,https://ctdbase.org/detail.go?type=gene&acc=245929,,,245929.0,DEFB115,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of DEFB115 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
773,1410806,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,245930,DEFB116,https://ctdbase.org/detail.go?type=gene&acc=245930,,,245930.0,DEFB116,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of DEFB116 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
774,1411679,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9162,DGKI,https://ctdbase.org/detail.go?type=gene&acc=9162,,,9162.0,DGKI,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of DGKI intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
775,1412758,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,122953,JDP2,https://ctdbase.org/detail.go?type=gene&acc=122953,,,122953.0,JDP2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of JDP2 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
776,1412759,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79864,JHY,https://ctdbase.org/detail.go?type=gene&acc=79864,,,79864.0,JHY,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of JHY intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
777,1412760,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51528,JKAMP,https://ctdbase.org/detail.go?type=gene&acc=51528,,,51528.0,JKAMP,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of JKAMP gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
778,1412761,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,221037,JMJD1C,https://ctdbase.org/detail.go?type=gene&acc=221037,,,221037.0,JMJD1C,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of JMJD1C gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
779,1412762,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,221037,JMJD1C,https://ctdbase.org/detail.go?type=gene&acc=221037,,,221037.0,JMJD1C,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of JMJD1C mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
780,1412763,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23210,JMJD6,https://ctdbase.org/detail.go?type=gene&acc=23210,,,23210.0,JMJD6,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of JMJD6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
781,1412764,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8681,JMJD7-PLA2G4B,https://ctdbase.org/detail.go?type=gene&acc=8681,,,8681.0,JMJD7-PLA2G4B,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of JMJD7-PLA2G4B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
782,1412765,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8681,JMJD7-PLA2G4B,https://ctdbase.org/detail.go?type=gene&acc=8681,,,8681.0,JMJD7-PLA2G4B,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of JMJD7-PLA2G4B intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
783,1412766,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,133746,JMY,https://ctdbase.org/detail.go?type=gene&acc=133746,,,133746.0,JMY,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of JMY protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
784,1412880,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57338,JPH3,https://ctdbase.org/detail.go?type=gene&acc=57338,,,57338.0,JPH3,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of JPH3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
785,1412881,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51155,JPT1,https://ctdbase.org/detail.go?type=gene&acc=51155,,,51155.0,JPT1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of JPT1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
786,1412882,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,90861,JPT2,https://ctdbase.org/detail.go?type=gene&acc=90861,,,90861.0,JPT2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of JPT2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
787,1412883,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,554203,JPX,https://ctdbase.org/detail.go?type=gene&acc=554203,,,554203.0,JPX,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of JPX intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
788,1412884,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of JUN protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
789,1412885,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of JUN mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
790,1412886,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of JUN mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
791,1412887,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of JUN mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
792,1412888,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3726,JUNB,https://ctdbase.org/detail.go?type=gene&acc=3726,,,3726.0,JUNB,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of JUNB protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
793,1413177,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9228,DLGAP2,https://ctdbase.org/detail.go?type=gene&acc=9228,,,9228.0,DLGAP2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of DLGAP2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
794,1413178,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,58512,DLGAP3,https://ctdbase.org/detail.go?type=gene&acc=58512,,,58512.0,DLGAP3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of DLGAP3 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
795,1413179,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,58512,DLGAP3,https://ctdbase.org/detail.go?type=gene&acc=58512,,,58512.0,DLGAP3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of DLGAP3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
796,1413180,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22839,DLGAP4,https://ctdbase.org/detail.go?type=gene&acc=22839,,,22839.0,DLGAP4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of DLGAP4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
797,1413181,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22839,DLGAP4,https://ctdbase.org/detail.go?type=gene&acc=22839,,,22839.0,DLGAP4,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of DLGAP4 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
798,1413182,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9787,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787.0,DLGAP5,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of DLGAP5 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
799,1413183,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9787,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787.0,DLGAP5,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of DLGAP5 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
800,1413184,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9787,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787.0,DLGAP5,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of DLGAP5 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
801,1414211,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10049,DNAJB6,https://ctdbase.org/detail.go?type=gene&acc=10049,,,10049.0,DNAJB6,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of DNAJB6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
802,1414212,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4189,DNAJB9,https://ctdbase.org/detail.go?type=gene&acc=4189,,,4189.0,DNAJB9,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of DNAJB9 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
803,1415028,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,202559,KHDRBS2,https://ctdbase.org/detail.go?type=gene&acc=202559,,,202559.0,KHDRBS2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of KHDRBS2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
804,1514220,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54762,GRAMD1C,https://ctdbase.org/detail.go?type=gene&acc=54762,,,54762.0,GRAMD1C,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of GRAMD1C mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
805,1514495,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91947,ARRDC4,https://ctdbase.org/detail.go?type=gene&acc=91947,,,91947.0,ARRDC4,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ARRDC4 gene|aflatoxin B1 results in decreased expression of ARRDC4 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
806,1514496,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91947,ARRDC4,https://ctdbase.org/detail.go?type=gene&acc=91947,,,91947.0,ARRDC4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ARRDC4 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
807,1514497,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,645432,ARRDC5,https://ctdbase.org/detail.go?type=gene&acc=645432,,,645432.0,ARRDC5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ARRDC5 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
808,1514498,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ARSB gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
809,1514499,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ARSB intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
810,1514500,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ARSB mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
811,1514980,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2905,GRIN2C,https://ctdbase.org/detail.go?type=gene&acc=2905,,,2905.0,GRIN2C,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of GRIN2C mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
812,1514981,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GRIN2D gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
813,1514982,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GRIN2D intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
814,1514983,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,116444,GRIN3B,https://ctdbase.org/detail.go?type=gene&acc=116444,,,116444.0,GRIN3B,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GRIN3B intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
815,1514984,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2907,GRINA,https://ctdbase.org/detail.go?type=gene&acc=2907,,,2907.0,GRINA,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of GRINA protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
816,1515168,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64754,SMYD3,https://ctdbase.org/detail.go?type=gene&acc=64754,,,64754.0,SMYD3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SMYD3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
817,1515169,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64754,SMYD3,https://ctdbase.org/detail.go?type=gene&acc=64754,,,64754.0,SMYD3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of SMYD3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
818,1515315,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,134266,GRPEL2,https://ctdbase.org/detail.go?type=gene&acc=134266,,,134266.0,GRPEL2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GRPEL2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
819,1515316,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,134266,GRPEL2,https://ctdbase.org/detail.go?type=gene&acc=134266,,,134266.0,GRPEL2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of GRPEL2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
820,1515317,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2925,GRPR,https://ctdbase.org/detail.go?type=gene&acc=2925,,,2925.0,GRPR,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GRPR gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
821,1515318,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2926,GRSF1,https://ctdbase.org/detail.go?type=gene&acc=2926,,,2926.0,GRSF1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GRSF1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
822,1515909,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ASNS mRNA,,,PMID:21632981|PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22100608,21632981|22100608,,
823,1515910,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ASNS mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
824,1515911,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of ASNS mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
825,1515912,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54529,ASNSD1,https://ctdbase.org/detail.go?type=gene&acc=54529,,,54529.0,ASNSD1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASNSD1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
826,1515913,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,443,ASPA,https://ctdbase.org/detail.go?type=gene&acc=443,,,443.0,ASPA,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ASPA protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
827,1515914,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,443,ASPA,https://ctdbase.org/detail.go?type=gene&acc=443,,,443.0,ASPA,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASPA gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
828,1515915,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,443,ASPA,https://ctdbase.org/detail.go?type=gene&acc=443,,,443.0,ASPA,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ASPA mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
829,1515916,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,443,ASPA,https://ctdbase.org/detail.go?type=gene&acc=443,,,443.0,ASPA,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ASPA intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
830,1515917,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,554235,ASPDH,https://ctdbase.org/detail.go?type=gene&acc=554235,,,554235.0,ASPDH,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASPDH promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
831,1516214,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100033453,SNORD115-15,https://ctdbase.org/detail.go?type=gene&acc=100033453,,,100033453.0,SNORD115-15,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD115-15 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
832,1516362,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ASS1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
833,1516363,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,28990,ASTE1,https://ctdbase.org/detail.go?type=gene&acc=28990,,,28990.0,ASTE1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASTE1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
834,1516364,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,460,ASTN1,https://ctdbase.org/detail.go?type=gene&acc=460,,,460.0,ASTN1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASTN1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
835,1516365,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23245,ASTN2,https://ctdbase.org/detail.go?type=gene&acc=23245,,,23245.0,ASTN2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of ASTN2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
836,1516366,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23245,ASTN2,https://ctdbase.org/detail.go?type=gene&acc=23245,,,23245.0,ASTN2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASTN2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
837,1516367,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23245,ASTN2,https://ctdbase.org/detail.go?type=gene&acc=23245,,,23245.0,ASTN2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ASTN2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
838,1516368,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23245,ASTN2,https://ctdbase.org/detail.go?type=gene&acc=23245,,,23245.0,ASTN2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ASTN2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
839,1516369,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ASXL1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
840,1516370,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100033446,SNORD115-9,https://ctdbase.org/detail.go?type=gene&acc=100033446,,,100033446.0,SNORD115-9,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of SNORD115-9 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
841,1517002,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2959,GTF2B,https://ctdbase.org/detail.go?type=gene&acc=2959,,,2959.0,GTF2B,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of GTF2B mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
842,1517003,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2961,GTF2E2,https://ctdbase.org/detail.go?type=gene&acc=2961,,,2961.0,GTF2E2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of GTF2E2 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
843,1517004,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2965,GTF2H1,https://ctdbase.org/detail.go?type=gene&acc=2965,,,2965.0,GTF2H1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GTF2H1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
844,1517005,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2966,GTF2H2,https://ctdbase.org/detail.go?type=gene&acc=2966,,,2966.0,GTF2H2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GTF2H2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
845,1517006,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,653238,GTF2H2B,https://ctdbase.org/detail.go?type=gene&acc=653238,,,653238.0,GTF2H2B,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GTF2H2B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
846,1517007,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,728340,GTF2H2C,https://ctdbase.org/detail.go?type=gene&acc=728340,,,728340.0,GTF2H2C,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GTF2H2C gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
847,1517008,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,730394,GTF2H2C_2,https://ctdbase.org/detail.go?type=gene&acc=730394,,,730394.0,GTF2H2C_2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of GTF2H2C_2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
848,1517009,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,2967,GTF2H3,https://ctdbase.org/detail.go?type=gene&acc=2967,,,2967.0,GTF2H3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GTF2H3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
849,1517010,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,404672,GTF2H5,https://ctdbase.org/detail.go?type=gene&acc=404672,,,404672.0,GTF2H5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GTF2H5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
850,1517011,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,729156,GTF2IRD1P1,https://ctdbase.org/detail.go?type=gene&acc=729156,,,729156.0,GTF2IRD1P1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of GTF2IRD1P1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
851,1518070,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8329,H2AC13,https://ctdbase.org/detail.go?type=gene&acc=8329,,,8329.0,H2AC13,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H2AC13 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
852,1518071,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8331,H2AC14,https://ctdbase.org/detail.go?type=gene&acc=8331,,,8331.0,H2AC14,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H2AC14 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
853,1518072,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8330,H2AC15,https://ctdbase.org/detail.go?type=gene&acc=8330,,,8330.0,H2AC15,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of H2AC15 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
854,1518073,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,723790,H2AC19,https://ctdbase.org/detail.go?type=gene&acc=723790,,,723790.0,H2AC19,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of H2AC19 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
855,1518423,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,490,ATP2B1,https://ctdbase.org/detail.go?type=gene&acc=490,,,490.0,ATP2B1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ATP2B1 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
856,1518424,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,491,ATP2B2,https://ctdbase.org/detail.go?type=gene&acc=491,,,491.0,ATP2B2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ATP2B2 mrna|aflatoxin B1 results in increased methylation of ATP2B2 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
857,1518425,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,491,ATP2B2,https://ctdbase.org/detail.go?type=gene&acc=491,,,491.0,ATP2B2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ATP2B2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
858,1518426,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100874325,ATP2B2-IT2,https://ctdbase.org/detail.go?type=gene&acc=100874325,,,100874325.0,ATP2B2-IT2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ATP2B2-IT2 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
859,1518427,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,492,ATP2B3,https://ctdbase.org/detail.go?type=gene&acc=492,,,492.0,ATP2B3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ATP2B3 exon|aflatoxin B1 results in increased methylation of ATP2B3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
860,1518428,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,493,ATP2B4,https://ctdbase.org/detail.go?type=gene&acc=493,,,493.0,ATP2B4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of ATP2B4 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
861,1518429,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,493,ATP2B4,https://ctdbase.org/detail.go?type=gene&acc=493,,,493.0,ATP2B4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ATP2B4 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
862,1520686,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,416651,HBAD,https://ctdbase.org/detail.go?type=gene&acc=416651,,,416651.0,HBAD,9031.0,Gallus gallus (chicken),Aflatoxin B1 results in decreased expression of HBAD protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
863,1520687,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HBB gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
864,1520688,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3045,HBD,https://ctdbase.org/detail.go?type=gene&acc=3045,,,3045.0,HBD,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HBD gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
865,1520689,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3046,HBE1,https://ctdbase.org/detail.go?type=gene&acc=3046,,,3046.0,HBE1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HBE1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
866,1520858,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79369,B3GNT4,https://ctdbase.org/detail.go?type=gene&acc=79369,,,79369.0,B3GNT4,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of B3GNT4 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
867,1520859,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84002,B3GNT5,https://ctdbase.org/detail.go?type=gene&acc=84002,,,84002.0,B3GNT5,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of B3GNT5 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
868,1520860,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,93010,B3GNT7,https://ctdbase.org/detail.go?type=gene&acc=93010,,,93010.0,B3GNT7,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of B3GNT7 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
869,1520861,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,146712,B3GNTL1,https://ctdbase.org/detail.go?type=gene&acc=146712,,,146712.0,B3GNTL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of B3GNTL1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
870,1520862,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,146712,B3GNTL1,https://ctdbase.org/detail.go?type=gene&acc=146712,,,146712.0,B3GNTL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of B3GNTL1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
871,1520863,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,283358,B4GALNT3,https://ctdbase.org/detail.go?type=gene&acc=283358,,,283358.0,B4GALNT3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of B4GALNT3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
872,1521717,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,440465,BAIAP2-DT,https://ctdbase.org/detail.go?type=gene&acc=440465,,,440465.0,BAIAP2-DT,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of BAIAP2-DT mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
873,1521718,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,440465,BAIAP2-DT,https://ctdbase.org/detail.go?type=gene&acc=440465,,,440465.0,BAIAP2-DT,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of BAIAP2-DT intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
874,1521719,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80115,BAIAP2L2,https://ctdbase.org/detail.go?type=gene&acc=80115,,,80115.0,BAIAP2L2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of BAIAP2L2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
875,1521720,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8938,BAIAP3,https://ctdbase.org/detail.go?type=gene&acc=8938,,,8938.0,BAIAP3,9606.0,Homo sapiens (human),Aflatoxin B1 affects the methylation of BAIAP3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
876,1521721,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of BAK1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
877,1521722,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25805,BAMBI,https://ctdbase.org/detail.go?type=gene&acc=25805,,,25805.0,BAMBI,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of BAMBI protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
878,1521723,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25805,BAMBI,https://ctdbase.org/detail.go?type=gene&acc=25805,,,25805.0,BAMBI,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of BAMBI gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
879,1521724,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,25805,BAMBI,https://ctdbase.org/detail.go?type=gene&acc=25805,,,25805.0,BAMBI,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of BAMBI mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
880,1522986,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116.0,Rattus norvegicus (Norway rat),Tadalafil inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of HIF1A protein]|sildenafil citrate inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of HIF1A protein]|[aflatoxin B1 co-treated with ethanol] results in increased expression of HIF1A protein,,,PMID:35608386,https://www.ncbi.nlm.nih.gov/pubmed/35608386,35608386,,
881,1522987,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55662,HIF1AN,https://ctdbase.org/detail.go?type=gene&acc=55662,,,55662.0,HIF1AN,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HIF1AN intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
882,1523276,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of BCAS3 mRNA,,,PMID:21641981|PMID:22100608|PMID:27153756|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21641981|22100608|27153756|32234424,,
883,1523277,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of BCAS3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
884,1523278,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of BCAS3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
885,1524191,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of HMGA2 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
886,1524192,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of HMGA2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
887,1524193,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HMGB1 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
888,1524194,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of HMGB2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
889,1524195,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HMGB2 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
890,1524196,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of HMGB2 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
891,1524197,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54511,HMGCLL1,https://ctdbase.org/detail.go?type=gene&acc=54511,,,54511.0,HMGCLL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HMGCLL1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
892,1524198,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HMGCR mRNA,,,PMID:21641981|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/27153756,21641981|27153756,,
893,1524666,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56898,BDH2,https://ctdbase.org/detail.go?type=gene&acc=56898,,,56898.0,BDH2,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of BDH2 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
894,1524667,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,624,BDKRB2,https://ctdbase.org/detail.go?type=gene&acc=624,,,624.0,BDKRB2,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of BDKRB2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
895,1524668,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BDNF gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
896,1524669,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of BDNF mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
897,1524670,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of BDNF mRNA,,,PMID:26260870,https://www.ncbi.nlm.nih.gov/pubmed/26260870,26260870,,
898,1524671,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,497258,BDNF-AS,https://ctdbase.org/detail.go?type=gene&acc=497258,,,497258.0,BDNF-AS,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of BDNF-AS gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
899,1524672,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55814,BDP1,https://ctdbase.org/detail.go?type=gene&acc=55814,,,55814.0,BDP1,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of BDP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
900,1524673,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55814,BDP1,https://ctdbase.org/detail.go?type=gene&acc=55814,,,55814.0,BDP1,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased mutagenesis of BDP1 gene,,,PMID:36908029,https://www.ncbi.nlm.nih.gov/pubmed/36908029,36908029,,
901,1526655,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,27306,HPGDS,https://ctdbase.org/detail.go?type=gene&acc=27306,,,27306.0,HPGDS,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of HPGDS mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
902,1527059,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3273,HRG,https://ctdbase.org/detail.go?type=gene&acc=3273,,,3273.0,HRG,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of HRG protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
903,1527838,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3284,HSD3B2,https://ctdbase.org/detail.go?type=gene&acc=3284,,,3284.0,HSD3B2,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased mutagenesis of HSD3B2 gene,,,PMID:36908029,https://www.ncbi.nlm.nih.gov/pubmed/36908029,36908029,,
904,1527839,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,15494,HSD3B3,https://ctdbase.org/detail.go?type=gene&acc=15494,,,15494.0,Hsd3b3,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of HSD3B3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
905,1527840,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,15497,HSD3B6,https://ctdbase.org/detail.go?type=gene&acc=15497,,,15497.0,Hsd3b6,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of HSD3B6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
906,1527841,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80270,HSD3B7,https://ctdbase.org/detail.go?type=gene&acc=80270,,,80270.0,HSD3B7,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of HSD3B7 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
907,1527842,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,391081,HSD3BP5,https://ctdbase.org/detail.go?type=gene&acc=391081,,,391081.0,HSD3BP5,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of HSD3BP5 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
908,1527843,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,83693,HSDL1,https://ctdbase.org/detail.go?type=gene&acc=83693,,,83693.0,HSDL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of HSDL1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
909,1527844,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,83693,HSDL1,https://ctdbase.org/detail.go?type=gene&acc=83693,,,83693.0,HSDL1,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of HSDL1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
910,1528227,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6782,HSPA13,https://ctdbase.org/detail.go?type=gene&acc=6782,,,6782.0,HSPA13,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of HSPA13 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
911,1528228,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of HSPA1A protein,,,PMID:34089297,https://www.ncbi.nlm.nih.gov/pubmed/34089297,34089297,,
912,1528229,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3304,HSPA1B,https://ctdbase.org/detail.go?type=gene&acc=3304,,,3304.0,HSPA1B,10090.0,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of HSPA1B mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
913,1528230,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3305,HSPA1L,https://ctdbase.org/detail.go?type=gene&acc=3305,,,3305.0,HSPA1L,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased methylation of HSPA1L gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
914,1529739,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3416,IDE,https://ctdbase.org/detail.go?type=gene&acc=3416,,,3416.0,IDE,10116.0,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of IDE mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
915,1529740,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3417,IDH1,https://ctdbase.org/detail.go?type=gene&acc=3417,,,3417.0,IDH1,9031.0,Gallus gallus (chicken),[aflatoxin B1 co-treated with selenium deficiency] results in decreased expression of IDH1 protein|aflatoxin B1 results in decreased expression of IDH1 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
916,1529741,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,3417,IDH1,https://ctdbase.org/detail.go?type=gene&acc=3417,,,3417.0,IDH1,9606.0,Homo sapiens (human),Aflatoxin B1 results in decreased expression of IDH1 mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
917,1527835,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,875,CBS,https://ctdbase.org/detail.go?type=gene&acc=875,,,875.0,CBS,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of CBS mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
918,1527836,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CCL2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
919,1527837,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364.0,CCL20,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of CCL20 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
920,1529411,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1672,DEFB1,https://ctdbase.org/detail.go?type=gene&acc=1672,,,1672.0,DEFB1,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DEFB1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
921,1529412,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1723,DHODH,https://ctdbase.org/detail.go?type=gene&acc=1723,,,1723.0,DHODH,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DHODH mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
922,1529413,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,9249,DHRS3,https://ctdbase.org/detail.go?type=gene&acc=9249,,,9249.0,DHRS3,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DHRS3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
923,1529414,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,10901,DHRS4,https://ctdbase.org/detail.go?type=gene&acc=10901,,,10901.0,DHRS4,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of DHRS4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
924,1529876,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of EHHADH mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
925,1529877,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of ELOVL6 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
926,1529878,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in increased expression of EPHX2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
927,1529879,206044,Comparative Toxicogenomics Database (CTD),Muraglitazar,C500085,muraglitazar,https://ctdbase.org/detail.go?type=chem&acc=C500085,131831,ERICH6,https://ctdbase.org/detail.go?type=gene&acc=131831,,,131831.0,ERICH6,10116.0,Rattus norvegicus (Norway rat),Muraglitazar results in decreased expression of ERICH6 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
928,1513245,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,48,ACO1,https://ctdbase.org/detail.go?type=gene&acc=48,,,48.0,ACO1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ACO1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
929,1513246,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,641371,ACOT1,https://ctdbase.org/detail.go?type=gene&acc=641371,,,641371.0,ACOT1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ACOT1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
930,1513247,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,134526,ACOT12,https://ctdbase.org/detail.go?type=gene&acc=134526,,,134526.0,ACOT12,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ACOT12 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
931,1513248,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,10965,ACOT2,https://ctdbase.org/detail.go?type=gene&acc=10965,,,10965.0,ACOT2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ACOT2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
932,1513249,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,11332,ACOT7,https://ctdbase.org/detail.go?type=gene&acc=11332,,,11332.0,ACOT7,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ACOT7 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
933,1513250,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,10005,ACOT8,https://ctdbase.org/detail.go?type=gene&acc=10005,,,10005.0,ACOT8,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ACOT8 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
934,1513727,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of ALCAM mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
935,1513728,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ALDH1A1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
936,1513729,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,224,ALDH3A2,https://ctdbase.org/detail.go?type=gene&acc=224,,,224.0,ALDH3A2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ALDH3A2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
937,1513730,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,221,ALDH3B1,https://ctdbase.org/detail.go?type=gene&acc=221,,,221.0,ALDH3B1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of ALDH3B1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
938,1513731,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,7915,ALDH5A1,https://ctdbase.org/detail.go?type=gene&acc=7915,,,7915.0,ALDH5A1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ALDH5A1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
939,1513732,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of ALPI mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
940,1516533,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,10901,DHRS4,https://ctdbase.org/detail.go?type=gene&acc=10901,,,10901.0,DHRS4,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of DHRS4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
941,1516534,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,205428,DIPK2A,https://ctdbase.org/detail.go?type=gene&acc=205428,,,205428.0,DIPK2A,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of DIPK2A mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
942,1516827,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2022,ENG,https://ctdbase.org/detail.go?type=gene&acc=2022,,,2022.0,ENG,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of ENG mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
943,1516828,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of EPHX2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
944,1516829,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,55040,EPN3,https://ctdbase.org/detail.go?type=gene&acc=55040,,,55040.0,EPN3,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of EPN3 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
945,1516830,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,131831,ERICH6,https://ctdbase.org/detail.go?type=gene&acc=131831,,,131831.0,ERICH6,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of ERICH6 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
946,1518420,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,3400,ID4,https://ctdbase.org/detail.go?type=gene&acc=3400,,,3400.0,ID4,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of ID4 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
947,1518421,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,389792,IER5L,https://ctdbase.org/detail.go?type=gene&acc=389792,,,389792.0,IER5L,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of IER5L mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
948,1518422,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in decreased expression of IL1B mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
949,1521716,208901,Comparative Toxicogenomics Database (CTD),Tesaglitazar,C501413,tesaglitazar,https://ctdbase.org/detail.go?type=chem&acc=C501413,414787,RT1-M10-1,https://ctdbase.org/detail.go?type=gene&acc=414787,,,414787.0,RT1-M10-1,10116.0,Rattus norvegicus (Norway rat),Tesaglitazar results in increased expression of RT1-M10-1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
950,1525437,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Acetamiprid results in decreased activity of CAT protein,,,PMID:31935421,https://www.ncbi.nlm.nih.gov/pubmed/31935421,31935421,,
951,1525438,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in decreased activity of CAT protein|berberine inhibits the reaction [acetamiprid results in decreased activity of CAT protein],,,PMID:37350525,https://www.ncbi.nlm.nih.gov/pubmed/37350525,37350525,,
952,1526259,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,7955.0,Danio rerio (zebrafish),Acetamiprid affects the expression of FSHB mRNA,,,PMID:36006007,https://www.ncbi.nlm.nih.gov/pubmed/36006007,36006007,,
953,1526260,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,7955.0,Danio rerio (zebrafish),Acetamiprid affects the expression of FSHR mRNA,,,PMID:36006007,https://www.ncbi.nlm.nih.gov/pubmed/36006007,36006007,,
954,1526261,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,2797,GNRH2,https://ctdbase.org/detail.go?type=gene&acc=2797,,,2797.0,GNRH2,7955.0,Danio rerio (zebrafish),Acetamiprid affects the expression of GNRH2 mRNA,,,PMID:36006007,https://www.ncbi.nlm.nih.gov/pubmed/36006007,36006007,,
955,1526262,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,360141,GNRH3,https://ctdbase.org/detail.go?type=gene&acc=360141,,,360141.0,gnrh3,7955.0,Danio rerio (zebrafish),Acetamiprid affects the expression of GNRH3 mRNA,,,PMID:36006007,https://www.ncbi.nlm.nih.gov/pubmed/36006007,36006007,,
956,1526263,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Folic acid inhibits the reaction [acetamiprid results in increased activity of GPT protein]|acetamiprid results in increased activity of GPT protein,,,PMID:35124148,https://www.ncbi.nlm.nih.gov/pubmed/35124148,35124148,,
957,1526264,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,41503,GSTD1,https://ctdbase.org/detail.go?type=gene&acc=41503,,,41503.0,GstD1,7091.0,Bombyx mori (domestic silkworm),Acetamiprid affects the expression of GSTD1 mRNA,,,PMID:32169693,https://www.ncbi.nlm.nih.gov/pubmed/32169693,32169693,,
958,1526265,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,41503,GSTD1,https://ctdbase.org/detail.go?type=gene&acc=41503,,,41503.0,GstD1,192188.0,Grapholita molesta (oriental fruit moth),Acetamiprid results in decreased activity of GSTD1 protein,,,PMID:30387866,https://www.ncbi.nlm.nih.gov/pubmed/30387866,30387866,,
959,1526266,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,37107,GSTE2,https://ctdbase.org/detail.go?type=gene&acc=37107,,,37107.0,GstE2,7091.0,Bombyx mori (domestic silkworm),Acetamiprid affects the expression of GSTE2 mRNA,,,PMID:32169693,https://www.ncbi.nlm.nih.gov/pubmed/32169693,32169693,,
960,1526267,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,37108,GSTE3,https://ctdbase.org/detail.go?type=gene&acc=37108,,,37108.0,GstE3,7091.0,Bombyx mori (domestic silkworm),Acetamiprid affects the expression of GSTE3 mRNA,,,PMID:32169693,https://www.ncbi.nlm.nih.gov/pubmed/32169693,32169693,,
961,1526791,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,157777,MCMDC2,https://ctdbase.org/detail.go?type=gene&acc=157777,,,157777.0,MCMDC2,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in increased expression of MCMDC2 mRNA,,,PMID:27782041,https://www.ncbi.nlm.nih.gov/pubmed/27782041,27782041,,
962,1526792,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10090.0,Mus musculus (house mouse),Acetamiprid results in decreased expression of MKI67 mRNA,,,PMID:30103633,https://www.ncbi.nlm.nih.gov/pubmed/30103633,30103633,,
963,1526793,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,4656,MYOG,https://ctdbase.org/detail.go?type=gene&acc=4656,,,4656.0,MYOG,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in decreased expression of MYOG mRNA,,,PMID:27782041,https://www.ncbi.nlm.nih.gov/pubmed/27782041,27782041,,
964,1526794,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,662725,NACHRA1,https://ctdbase.org/detail.go?type=gene&acc=662725,,,662725.0,,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein],,,PMID:16981889|PMID:25459289,https://www.ncbi.nlm.nih.gov/pubmed/16981889|https://www.ncbi.nlm.nih.gov/pubmed/25459289,16981889|25459289,,
965,1526795,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,658018,NACHRA8,https://ctdbase.org/detail.go?type=gene&acc=658018,,,658018.0,,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein],,,PMID:25459289,https://www.ncbi.nlm.nih.gov/pubmed/25459289,25459289,,
966,1526796,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,162417,NAGS,https://ctdbase.org/detail.go?type=gene&acc=162417,,,162417.0,NAGS,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in decreased expression of NAGS mRNA,,,PMID:27782041,https://www.ncbi.nlm.nih.gov/pubmed/27782041,27782041,,
967,1526797,213021,Comparative Toxicogenomics Database (CTD),Acetamiprid,C464485,acetamiprid,https://ctdbase.org/detail.go?type=chem&acc=C464485,63908,NAPB,https://ctdbase.org/detail.go?type=gene&acc=63908,,,63908.0,NAPB,10116.0,Rattus norvegicus (Norway rat),Acetamiprid results in increased expression of NAPB mRNA,,,PMID:27782041,https://www.ncbi.nlm.nih.gov/pubmed/27782041,27782041,,
968,1527960,223368,Toxin and Toxin Target Database (T3DB),Equilin,T3D4693,Equilin,http://www.t3db.ca/toxins/T3D4693,BE0000194,Estradiol 17-beta-dehydrogenase 1,http://www.t3db.ca/biodb/bio_entities/BE0000194,P14061,17-beta-hydroxysteroid dehydrogenase type 1,3292.0,HSD17B1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
969,1527961,223368,Toxin and Toxin Target Database (T3DB),Equilin,T3D4693,Equilin,http://www.t3db.ca/toxins/T3D4693,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
970,1527962,223368,Toxin and Toxin Target Database (T3DB),Equilin,T3D4693,Equilin,http://www.t3db.ca/toxins/T3D4693,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
971,1528706,252608,BindingDB,3-Benzamidocoumarin,95955,MLS000693557,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=95955,2135,Adenosine receptor A3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2135,P0DMS8,Adenosine receptor A3,140.0,ADORA3,9606.0,Homo sapiens (human),,Ki (nM),3.24e+3,PMID:26042529|DOI:10.1016/j.bioorg.2015.05.008,https://www.ncbi.nlm.nih.gov/pubmed/26042529|https://doi.org/10.1016/j.bioorg.2015.05.008,26042529,10.1016/j.bioorg.2015.05.008,
972,1528707,252682,BindingDB,2-Hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid,20283,2-hydroxy-4-(2-{[(4-methylbenzene)sulfonyl]oxy}acetamido)benzoic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20283,2056,Signal transducer and activator of transcription 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2056,P42227,Signal transducer and activator of transcription 3 ,20848.0,Stat3,10090.0,Mus musculus (house mouse),,IC50 (nM),86000,PMID:17463090|DOI:10.1073/pnas.0609757104,https://www.ncbi.nlm.nih.gov/pubmed/17463090|https://doi.org/10.1073/pnas.0609757104,17463090,10.1073/pnas.0609757104,
973,1529102,253613,Comparative Toxicogenomics Database (CTD),"2,3-Diphenylbenzofuran",D001572,Benzofurans,https://ctdbase.org/detail.go?type=chem&acc=D001572,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),Benzofurans results in increased expression of CYP11A1 mRNA,,,PMID:17447562,https://www.ncbi.nlm.nih.gov/pubmed/17447562,17447562,,
974,1529103,253613,Comparative Toxicogenomics Database (CTD),"2,3-Diphenylbenzofuran",D001572,Benzofurans,https://ctdbase.org/detail.go?type=chem&acc=D001572,1585,CYP11B2,https://ctdbase.org/detail.go?type=gene&acc=1585,,,1585.0,CYP11B2,9606.0,Homo sapiens (human),Benzofurans results in increased expression of CYP11B2 mRNA,,,PMID:17447562,https://www.ncbi.nlm.nih.gov/pubmed/17447562,17447562,,
975,1520513,258027,Toxin and Toxin Target Database (T3DB),Tris(4-bromophenyl)amine,T3D1900,Tris(4-bromophenyl)aminium hexachloroantimonate,http://www.t3db.ca/toxins/T3D1900,BE0002290,Microsomal glutathione S-transferase 2,http://www.t3db.ca/biodb/bio_entities/BE0002290,Q99735,Microsomal glutathione S-transferase 2,4258.0,MGST2,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
976,1520514,258027,Toxin and Toxin Target Database (T3DB),Tris(4-bromophenyl)amine,T3D1900,Tris(4-bromophenyl)aminium hexachloroantimonate,http://www.t3db.ca/toxins/T3D1900,BE0002279,Microsomal glutathione S-transferase 3,http://www.t3db.ca/biodb/bio_entities/BE0002279,O14880,Microsomal glutathione S-transferase 3,4259.0,MGST3,9606.0,Homo sapiens (human),"Trivalent antimony inhibits glutathione-S-transferases from human erythrocytes, reducing their detoxification ability. (L137)",,,,,,,
977,1529600,259331,DrugBank,Estramustine,DB01196,Estramustine,https://www.drugbank.ca/drugs/DB01196,BE0001100,Microtubule-associated protein 2,https://www.drugbank.ca/bio_entities/BE0001100,P11137,Microtubule-associated protein 2,4133.0,MAP2,9606.0,Homo sapiens (human),Antagonist,,,PMID:1599956|PMID:1647395|PMID:1908244|PMID:2125244|PMID:2679799|PMID:6364362,https://www.ncbi.nlm.nih.gov/pubmed/1599956|https://www.ncbi.nlm.nih.gov/pubmed/1647395|https://www.ncbi.nlm.nih.gov/pubmed/1908244|https://www.ncbi.nlm.nih.gov/pubmed/2125244|https://www.ncbi.nlm.nih.gov/pubmed/2679799|https://www.ncbi.nlm.nih.gov/pubmed/6364362,1599956|1647395|1908244|2125244|2679799|6364362,,
978,1520680,266054,Drug Gene Interaction database (DGIdb),"1,4-Dimethoxyanthraquinone",,"1,4-DIMETHOXYANTHRAQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL570408,,RAPGEF3,https://www.dgidb.org/genes/hgnc:16629,,,10411.0,RAPGEF3,9606.0,Homo sapiens (human),,,,,,,,
979,1520681,266054,Drug Gene Interaction database (DGIdb),"1,4-Dimethoxyanthraquinone",,"1,4-DIMETHOXYANTHRAQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL570408,,DUSP3,https://www.dgidb.org/genes/hgnc:3069,,,1845.0,DUSP3,9606.0,Homo sapiens (human),,,,,,,,
980,1520682,266054,Drug Gene Interaction database (DGIdb),"1,4-Dimethoxyanthraquinone",,"1,4-DIMETHOXYANTHRAQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL570408,,PLK1,https://www.dgidb.org/genes/hgnc:9077,,,5347.0,PLK1,9606.0,Homo sapiens (human),,,,,,,,
981,1520683,266054,Drug Gene Interaction database (DGIdb),"1,4-Dimethoxyanthraquinone",,"1,4-DIMETHOXYANTHRAQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL570408,,TSG101,https://www.dgidb.org/genes/hgnc:15971,,,7251.0,TSG101,9606.0,Homo sapiens (human),,,,,,,,
982,1520684,266054,Drug Gene Interaction database (DGIdb),"1,4-Dimethoxyanthraquinone",,"1,4-DIMETHOXYANTHRAQUINONE",https://www.dgidb.org/drugs/chembl:CHEMBL570408,,USP1,https://www.dgidb.org/genes/hgnc:12607,,,7398.0,USP1,9606.0,Homo sapiens (human),,,,,,,,
983,1520685,269167,Therapeutic Target Database (TTD),"5,8-Dimethoxy-4-methylquinolin-2(1H)-one",D0S1AY,"5,8-Dimethoxy-4-methylquinolin-2(1H)-one",https://idrblab.net/ttd/data/drug/details/D0S1AY,T75498,Quinone reductase 2 (NQO2),https://idrblab.net/ttd/data/target/details/T75498,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],4835.0,NQO2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
984,1518957,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),Boc-D-FMK inhibits the reaction [[bortezomib co-treated with vorinostat] results in decreased expression of CCND1 protein]|[[bortezomib co-treated with butyrates] results in increased abundance of reactive oxygen species] which results in decreased expression of CCND1 protein|acetylcysteine inhibits the reaction [[bortezomib co-treated with butyrates] results in decreased expression of CCND1 protein]|boc-D-FMK inhibits the reaction [[bortezomib co-treated with butyrates] results in decreased expression of CCND1 protein]|[[bortezomib co-treated with vorinostat] results in increased abundance of reactive oxygen species] which results in decreased expression of CCND1 protein,,,PMID:15173093,https://www.ncbi.nlm.nih.gov/pubmed/15173093,15173093,,
985,1520367,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,9606.0,Homo sapiens (human),Bortezomib inhibits the reaction [arsenic trioxide results in decreased expression of CEBPB mrna]|bortezomib results in decreased expression of CEBPB mRNA,,,PMID:20471514,https://www.ncbi.nlm.nih.gov/pubmed/20471514,20471514,,
986,1520368,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10116.0,Rattus norvegicus (Norway rat),Bortezomib results in increased expression of CEBPB protein,,,PMID:20830808,https://www.ncbi.nlm.nih.gov/pubmed/20830808,20830808,,
987,1520369,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1060,CENPC,https://ctdbase.org/detail.go?type=gene&acc=1060,,,1060.0,CENPC,9606.0,Homo sapiens (human),Bortezomib results in increased expression of CENPC mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
988,1520370,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,80184,CEP290,https://ctdbase.org/detail.go?type=gene&acc=80184,,,80184.0,CEP290,9606.0,Homo sapiens (human),Bortezomib results in increased expression of CEP290 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
989,1521877,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Bortezomib inhibits the reaction [tunicamycin results in increased expression of DDIT3 protein],,,PMID:16357177,https://www.ncbi.nlm.nih.gov/pubmed/16357177,16357177,,
990,1521878,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Bortezomib promotes the reaction [gambogic acid results in increased expression of DDIT3 protein]|gambogic acid promotes the reaction [bortezomib results in increased expression of DDIT3 protein],,,PMID:24291039,https://www.ncbi.nlm.nih.gov/pubmed/24291039,24291039,,
991,1521879,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Bortezomib results in increased expression of DDIT3 mRNA,,,PMID:17659339|PMID:17898295,https://www.ncbi.nlm.nih.gov/pubmed/17659339|https://www.ncbi.nlm.nih.gov/pubmed/17898295,17659339|17898295,,
992,1525439,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,54801,HAUS6,https://ctdbase.org/detail.go?type=gene&acc=54801,,,54801.0,HAUS6,9606.0,Homo sapiens (human),Bortezomib results in increased expression of HAUS6 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
993,1525440,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,83933,HDAC10,https://ctdbase.org/detail.go?type=gene&acc=83933,,,83933.0,HDAC10,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of HDAC10 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
994,1525441,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of HDAC4 mRNA,,,PMID:17659339,https://www.ncbi.nlm.nih.gov/pubmed/17659339,17659339,,
995,1525442,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10013,HDAC6,https://ctdbase.org/detail.go?type=gene&acc=10013,,,10013.0,HDAC6,9606.0,Homo sapiens (human),HDAC6 results in decreased susceptibility to bortezomib,,,PMID:16585204,https://www.ncbi.nlm.nih.gov/pubmed/16585204,16585204,,
996,1525443,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,143279,HECTD2,https://ctdbase.org/detail.go?type=gene&acc=143279,,,143279.0,HECTD2,9606.0,Homo sapiens (human),Bortezomib results in increased expression of HECTD2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
997,1525444,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,23072,HECW1,https://ctdbase.org/detail.go?type=gene&acc=23072,,,23072.0,HECW1,9606.0,Homo sapiens (human),[BRCA1 mutant form results in increased susceptibility to bortezomib] which results in increased expression of HECW1 mRNA,,,PMID:25522274,https://www.ncbi.nlm.nih.gov/pubmed/25522274,25522274,,
998,1525445,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,284004,HEXD,https://ctdbase.org/detail.go?type=gene&acc=284004,,,284004.0,HEXD,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of HEXD mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
999,1525657,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),[arsenic trioxide co-treated with bortezomib] results in decreased expression of HMOX1 mRNA,,,PMID:25913414,https://www.ncbi.nlm.nih.gov/pubmed/25913414,25913414,,
1000,1525658,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of HMOX1 mRNA,,,PMID:15509775|PMID:17895889|PMID:20471514,https://www.ncbi.nlm.nih.gov/pubmed/15509775|https://www.ncbi.nlm.nih.gov/pubmed/17895889|https://www.ncbi.nlm.nih.gov/pubmed/20471514,15509775|17895889|20471514,,
1001,1525659,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),HMOX1 protein results in increased susceptibility to bortezomib|[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in increased susceptibility to bortezomib|bortezomib results in increased expression of HMOX1 protein,,,PMID:17895889,https://www.ncbi.nlm.nih.gov/pubmed/17895889,17895889,,
1002,1525660,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Bortezomib results in increased expression of HMOX1 mrna|berberine inhibits the reaction [bortezomib results in increased expression of HMOX1 mrna],,,PMID:35121005,https://www.ncbi.nlm.nih.gov/pubmed/35121005,35121005,,
1003,1525661,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3163,HMOX2,https://ctdbase.org/detail.go?type=gene&acc=3163,,,3163.0,HMOX2,9606.0,Homo sapiens (human),Abexinostat promotes the reaction [bortezomib results in decreased expression of HMOX2 mrna],,,PMID:19417023,https://www.ncbi.nlm.nih.gov/pubmed/19417023,19417023,,
1004,1526798,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10561,IFI44,https://ctdbase.org/detail.go?type=gene&acc=10561,,,10561.0,IFI44,9606.0,Homo sapiens (human),Bortezomib results in increased expression of IFI44 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1005,1526799,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,8519,IFITM1,https://ctdbase.org/detail.go?type=gene&acc=8519,,,8519.0,IFITM1,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of IFITM1 mRNA,,,PMID:17659339,https://www.ncbi.nlm.nih.gov/pubmed/17659339,17659339,,
1006,1527423,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3667,IRS1,https://ctdbase.org/detail.go?type=gene&acc=3667,,,3667.0,IRS1,9606.0,Homo sapiens (human),Bortezomib results in decreased degradation of IRS1 protein,,,PMID:16227402,https://www.ncbi.nlm.nih.gov/pubmed/16227402,16227402,,
1007,1527424,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,81689,ISCA1,https://ctdbase.org/detail.go?type=gene&acc=81689,,,81689.0,ISCA1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ISCA1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1008,1527425,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3655,ITGA6,https://ctdbase.org/detail.go?type=gene&acc=3655,,,3655.0,ITGA6,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of ITGA6 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1009,1527426,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3683,ITGAL,https://ctdbase.org/detail.go?type=gene&acc=3683,,,3683.0,ITGAL,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of ITGAL mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1010,1527427,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3685,ITGAV,https://ctdbase.org/detail.go?type=gene&acc=3685,,,3685.0,ITGAV,9606.0,Homo sapiens (human),[arsenic trioxide co-treated with bortezomib] results in decreased expression of ITGAV mRNA,,,PMID:25913414,https://www.ncbi.nlm.nih.gov/pubmed/25913414,25913414,,
1011,1527428,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3685,ITGAV,https://ctdbase.org/detail.go?type=gene&acc=3685,,,3685.0,ITGAV,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ITGAV mRNA,,,PMID:20471514,https://www.ncbi.nlm.nih.gov/pubmed/20471514,20471514,,
1012,1527429,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3694,ITGB6,https://ctdbase.org/detail.go?type=gene&acc=3694,,,3694.0,ITGB6,9606.0,Homo sapiens (human),Bortezomib results in increased expression of ITGB6 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1013,1527706,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of JUN mRNA,,,PMID:20471514|PMID:25913414,https://www.ncbi.nlm.nih.gov/pubmed/20471514|https://www.ncbi.nlm.nih.gov/pubmed/25913414,20471514|25913414,,
1014,1527707,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Bortezomib results in increased expression of JUN mrna|bortezomib results in increased expression of JUN protein modified form,,,PMID:17898295,https://www.ncbi.nlm.nih.gov/pubmed/17898295,17898295,,
1015,1527708,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Bortezomib results in increased expression of JUN protein,,,PMID:17351739|PMID:17898295,https://www.ncbi.nlm.nih.gov/pubmed/17351739|https://www.ncbi.nlm.nih.gov/pubmed/17898295,17351739|17898295,,
1016,1527709,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Bortezomib results in increased phosphorylation of JUN protein|pyrazolanthrone inhibits the reaction [bortezomib results in increased phosphorylation of JUN protein],,,PMID:12393500|PMID:16357177,https://www.ncbi.nlm.nih.gov/pubmed/12393500|https://www.ncbi.nlm.nih.gov/pubmed/16357177,12393500|16357177,,
1017,1527710,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10116.0,Rattus norvegicus (Norway rat),Bortezomib results in increased expression of JUN mrna|bortezomib results in increased expression of JUN protein,,,PMID:20830808,https://www.ncbi.nlm.nih.gov/pubmed/20830808,20830808,,
1018,1527711,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3726,JUNB,https://ctdbase.org/detail.go?type=gene&acc=3726,,,3726.0,JUNB,9606.0,Homo sapiens (human),"3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid promotes the reaction [bortezomib results in decreased expression of JUNB protein]|bortezomib results in decreased expression of JUNB protein|bortezomib promotes the reaction [3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid results in decreased expression of JUNB protein]",,,PMID:37657595,https://www.ncbi.nlm.nih.gov/pubmed/37657595,37657595,,
1019,1527712,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,3727,JUND,https://ctdbase.org/detail.go?type=gene&acc=3727,,,3727.0,JUND,9606.0,Homo sapiens (human),Bortezomib results in decreased expression of JUND mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1020,1528551,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,23643,LY96,https://ctdbase.org/detail.go?type=gene&acc=23643,,,23643.0,LY96,9606.0,Homo sapiens (human),[arsenic trioxide co-treated with bortezomib] results in increased expression of LY96 mRNA,,,PMID:25913414,https://www.ncbi.nlm.nih.gov/pubmed/25913414,25913414,,
1021,1528552,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,4067,LYN,https://ctdbase.org/detail.go?type=gene&acc=4067,,,4067.0,LYN,9606.0,Homo sapiens (human),[alvocidib co-treated with bortezomib co-treated with ABL1 protein] results in decreased phosphorylation of LYN protein,,,PMID:15039284,https://www.ncbi.nlm.nih.gov/pubmed/15039284,15039284,,
1022,1528553,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,84232,MAF1,https://ctdbase.org/detail.go?type=gene&acc=84232,,,84232.0,MAF1,9606.0,Homo sapiens (human),Bortezomib inhibits the reaction [cycloheximide results in increased degradation of MAF1 protein],,,PMID:31645432,https://www.ncbi.nlm.nih.gov/pubmed/31645432,31645432,,
1023,1528554,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,4097,MAFG,https://ctdbase.org/detail.go?type=gene&acc=4097,,,4097.0,MAFG,9606.0,Homo sapiens (human),Bortezomib results in increased expression of MAFG mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1024,1528555,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,378938,MALAT1,https://ctdbase.org/detail.go?type=gene&acc=378938,,,378938.0,MALAT1,9606.0,Homo sapiens (human),Bortezomib results in increased expression of MALAT1 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
1025,1528556,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),MAP1LC3B protein affects the reaction [bortezomib results in increased phosphorylation of NFKBIA protein],,,PMID:24085292,https://www.ncbi.nlm.nih.gov/pubmed/24085292,24085292,,
1026,1528557,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606.0,Homo sapiens (human),[bortezomib co-treated with butyrates] results in decreased expression of MAP2K1 protein|[bortezomib co-treated with vorinostat] results in decreased expression of MAP2K1 protein,,,PMID:12893773,https://www.ncbi.nlm.nih.gov/pubmed/12893773,12893773,,
1027,1528959,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Bortezomib results in increased phosphorylation of MAPK3 protein|lapatinib inhibits the reaction [bortezomib results in increased phosphorylation of MAPK3 protein],,,PMID:20701607,https://www.ncbi.nlm.nih.gov/pubmed/20701607,20701607,,
1028,1528960,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [[bortezomib co-treated with butyrates] results in increased phosphorylation of and results in increased activity of MAPK8 protein]|[[bortezomib co-treated with butyrates] results in increased abundance of reactive oxygen species] which results in increased phosphorylation of and results in increased activity of MAPK8 protein|acetylcysteine inhibits the reaction [[bortezomib co-treated with vorinostat] results in increased phosphorylation of and results in increased activity of MAPK8 protein]|[[bortezomib co-treated with vorinostat] results in increased abundance of reactive oxygen species] which results in increased phosphorylation of and results in increased activity of MAPK8 protein,,,PMID:15173093,https://www.ncbi.nlm.nih.gov/pubmed/15173093,15173093,,
1029,1529223,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Bortezomib results in increased phosphorylation of and results in increased activity of MAPK8 protein|alvocidib promotes the reaction [bortezomib results in increased phosphorylation of and results in increased activity of MAPK8 protein],,,PMID:15039284,https://www.ncbi.nlm.nih.gov/pubmed/15039284,15039284,,
1030,1529224,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),[bortezomib co-treated with vorinostat] results in increased phosphorylation of and results in increased activity of MAPK8 protein|[bortezomib co-treated with butyrates] results in increased phosphorylation of and results in increased activity of MAPK8 protein,,,PMID:12893773|PMID:15173093,https://www.ncbi.nlm.nih.gov/pubmed/12893773|https://www.ncbi.nlm.nih.gov/pubmed/15173093,12893773|15173093,,
1031,1529225,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),[bortezomib co-treated with sorafenib] results in increased phosphorylation of MAPK8 protein,,,PMID:16985072,https://www.ncbi.nlm.nih.gov/pubmed/16985072,16985072,,
1032,1529226,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),CGC 11093 promotes the reaction [bortezomib results in increased phosphorylation of MAPK8 protein]|mapk8 results in increased susceptibility to [bortezomib co-treated with CGC 11093]|bortezomib results in increased phosphorylation of MAPK8 protein,,,PMID:18559525,https://www.ncbi.nlm.nih.gov/pubmed/18559525,18559525,,
1033,1529227,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),[bortezomib co-treated with arsenic trioxide] affects the expression of MAPK9 protein,,,PMID:18718063,https://www.ncbi.nlm.nih.gov/pubmed/18718063,18718063,,
1034,1529228,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),[bortezomib co-treated with sorafenib] results in increased phosphorylation of MAPK9 protein,,,PMID:16985072,https://www.ncbi.nlm.nih.gov/pubmed/16985072,16985072,,
1035,1515612,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606.0,Homo sapiens (human),Bardoxolone methyl affects the expression of IL1R1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1036,1515613,400769,Comparative Toxicogenomics Database (CTD),Bardoxolone methyl,C445068,bardoxolone methyl,https://ctdbase.org/detail.go?type=chem&acc=C445068,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Bardoxolone methyl promotes the reaction [lipopolysaccharides results in increased expression of and results in increased secretion of IL6 protein],,,PMID:26918785,https://www.ncbi.nlm.nih.gov/pubmed/26918785,26918785,,
1037,1413926,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9913.0,Bos taurus (cattle),Mevalonic acid inhibits the reaction [simvastatin results in decreased phosphorylation of AKT1 protein],,,PMID:22144680,https://www.ncbi.nlm.nih.gov/pubmed/22144680,22144680,,
1038,1413927,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),"Mevalonic acid inhibits the reaction [asbestos, crocidolite results in increased expression of AKT1 mrna]|mevalonic acid inhibits the reaction [asbestos, crocidolite results in increased activity of AKT1 protein]",,,PMID:17322126,https://www.ncbi.nlm.nih.gov/pubmed/17322126,17322126,,
1039,1413928,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Mevalonic acid inhibits the reaction [simvastatin results in decreased phosphorylation of AKT1 protein],,,PMID:33034787,https://www.ncbi.nlm.nih.gov/pubmed/33034787,33034787,,
1040,1413929,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606.0,Homo sapiens (human),Mevalonic acid inhibits the reaction [simvastatin results in increased expression of BBC3 protein],,,PMID:20045437,https://www.ncbi.nlm.nih.gov/pubmed/20045437,20045437,,
1041,1413930,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,9564,BCAR1,https://ctdbase.org/detail.go?type=gene&acc=9564,,,9564.0,BCAR1,10116.0,Rattus norvegicus (Norway rat),Mevalonic acid inhibits the reaction [lovastatin results in increased cleavage of BCAR1 protein],,,PMID:16367743,https://www.ncbi.nlm.nih.gov/pubmed/16367743,16367743,,
1042,1413931,439230,Comparative Toxicogenomics Database (CTD),Mevalonic acid,D008798,Mevalonic Acid,https://ctdbase.org/detail.go?type=chem&acc=D008798,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Mevalonic acid inhibits the reaction [lovastatin results in decreased expression of BCL2 protein],,,PMID:12094262,https://www.ncbi.nlm.nih.gov/pubmed/12094262,12094262,,
1043,1519619,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,6580,SLC22A1,https://ctdbase.org/detail.go?type=gene&acc=6580,,,6580.0,SLC22A1,9606.0,Homo sapiens (human),[NR1I2 protein results in increased susceptibility to hyperforin] which results in decreased expression of SLC22A1 mrna|hyperforin promotes the reaction [NR1I2 protein results in decreased expression of SLC22A1 mrna]|hyperforin results in decreased expression of SLC22A1 protein|[nr1i2 protein co-treated with hyperforin] results in decreased expression of SLC22A1 mRNA,,,PMID:26920453,https://www.ncbi.nlm.nih.gov/pubmed/26920453,26920453,,
1044,1519620,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,10492,SYNCRIP,https://ctdbase.org/detail.go?type=gene&acc=10492,,,10492.0,SYNCRIP,10026.0,Cricetinae (hamsters),Hyperforin affects the expression of SYNCRIP protein,,,PMID:15095150,https://www.ncbi.nlm.nih.gov/pubmed/15095150,15095150,,
1045,1519621,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,7225,TRPC6,https://ctdbase.org/detail.go?type=gene&acc=7225,,,7225.0,TRPC6,10116.0,Rattus norvegicus (Norway rat),Hyperforin inhibits the reaction [propofol results in decreased expression of TRPC6 protein],,,PMID:36640868,https://www.ncbi.nlm.nih.gov/pubmed/36640868,36640868,,
1046,1519622,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,203068,TUBB,https://ctdbase.org/detail.go?type=gene&acc=203068,,,203068.0,TUBB,10026.0,Cricetinae (hamsters),Hyperforin affects the expression of TUBB protein,,,PMID:15095150,https://www.ncbi.nlm.nih.gov/pubmed/15095150,15095150,,
1047,1520047,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Hyperforin results in increased expression of CXCL8 mrna|u 0126 inhibits the reaction [hyperforin results in increased expression of CXCL8 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hyperforin results in increased secretion of CXCL8 protein]|sb 203580 inhibits the reaction [hyperforin results in increased secretion of CXCL8 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hyperforin results in increased expression of CXCL8 mrna]|u 0126 inhibits the reaction [hyperforin results in increased secretion of CXCL8 protein]|hyperforin results in increased secretion of CXCL8 protein|hyperforin promotes the reaction [JUN protein binds to CXCL8 promoter],,,PMID:15622447,https://www.ncbi.nlm.nih.gov/pubmed/15622447,15622447,,
1048,1520048,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),Hyperforin inhibits the reaction [aluminum maltolate results in increased expression of CYCS protein]|hyperforin results in decreased expression of CYCS protein,,,PMID:30481499,https://www.ncbi.nlm.nih.gov/pubmed/30481499,30481499,,
1049,1520049,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),"Hyperforin inhibits the reaction [CYP1A1 protein affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol]|hyperforin results in decreased activity of CYP1A1 protein",,,PMID:14633740,https://www.ncbi.nlm.nih.gov/pubmed/14633740,14633740,,
1050,1520050,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,1591,CYP24A1,https://ctdbase.org/detail.go?type=gene&acc=1591,,,1591.0,CYP24A1,9606.0,Homo sapiens (human),Hyperforin results in increased expression of CYP24A1 mRNA,,,PMID:15630458,https://www.ncbi.nlm.nih.gov/pubmed/15630458,15630458,,
1051,1520051,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),Hyperforin results in increased expression of CYP2B6 mRNA,,,PMID:24259679,https://www.ncbi.nlm.nih.gov/pubmed/24259679,24259679,,
1052,1520052,441298,Comparative Toxicogenomics Database (CTD),Hyperforin,C001654,hyperforin,https://ctdbase.org/detail.go?type=chem&acc=C001654,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Hyperforin results in increased expression of and results in increased activity of CYP2C9 protein,,,PMID:15100173,https://www.ncbi.nlm.nih.gov/pubmed/15100173,15100173,,
1053,1528856,443119,Comparative Toxicogenomics Database (CTD),Chymostatin,C002101,chymostatin,https://ctdbase.org/detail.go?type=chem&acc=C002101,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Enalapril affects the reaction [chymostatin results in decreased susceptibility to AGT protein modified form]|chymostatin results in decreased susceptibility to AGT protein modified form,,,PMID:21602471,https://www.ncbi.nlm.nih.gov/pubmed/21602471,21602471,,
1054,1528857,443119,Comparative Toxicogenomics Database (CTD),Chymostatin,C002101,chymostatin,https://ctdbase.org/detail.go?type=chem&acc=C002101,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Chymostatin inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN1A protein],,,PMID:33380422,https://www.ncbi.nlm.nih.gov/pubmed/33380422,33380422,,
1055,1528858,443119,Comparative Toxicogenomics Database (CTD),Chymostatin,C002101,chymostatin,https://ctdbase.org/detail.go?type=chem&acc=C002101,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606.0,Homo sapiens (human),Chymostatin inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN2A protein],,,PMID:33380422,https://www.ncbi.nlm.nih.gov/pubmed/33380422,33380422,,
1056,1528859,443119,Comparative Toxicogenomics Database (CTD),Chymostatin,C002101,chymostatin,https://ctdbase.org/detail.go?type=chem&acc=C002101,11202,KLK8,https://ctdbase.org/detail.go?type=gene&acc=11202,,,11202.0,KLK8,9606.0,Homo sapiens (human),Chymostatin results in decreased activity of KLK8 protein,,,PMID:16800733,https://www.ncbi.nlm.nih.gov/pubmed/16800733,16800733,,
1057,1528860,443119,Comparative Toxicogenomics Database (CTD),Chymostatin,C002101,chymostatin,https://ctdbase.org/detail.go?type=chem&acc=C002101,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,9606.0,Homo sapiens (human),Chymostatin inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN2A protein]|chymostatin inhibits the reaction [KRAS protein mutant form results in increased expression of CDKN1A protein]|chymostatin inhibits the reaction [KRAS protein mutant form results in increased expression of AGT protein],,,PMID:33380422,https://www.ncbi.nlm.nih.gov/pubmed/33380422,33380422,,
1058,1513095,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of RPL27A mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
1059,1513096,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of RPL27A mRNA,,,PMID:19072884,https://www.ncbi.nlm.nih.gov/pubmed/19072884,19072884,,
1060,1513097,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6158,RPL28,https://ctdbase.org/detail.go?type=gene&acc=6158,,,6158.0,RPL28,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and results in increased activity of RPL28 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
1061,1513098,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6158,RPL28,https://ctdbase.org/detail.go?type=gene&acc=6158,,,6158.0,RPL28,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RPL28 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
1062,1513099,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,178352,RPL-29,https://ctdbase.org/detail.go?type=gene&acc=178352,,,178352.0,rpl-29,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in increased expression of RPL-29 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
1063,1513601,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,801,CALM1,https://ctdbase.org/detail.go?type=gene&acc=801,,,801.0,CALM1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of CALM1 mRNA,,,PMID:16322246,https://www.ncbi.nlm.nih.gov/pubmed/16322246,16322246,,
1064,1513602,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,801,CALM1,https://ctdbase.org/detail.go?type=gene&acc=801,,,801.0,CALM1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of CALM1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
1065,1513603,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406660,CALM1A,https://ctdbase.org/detail.go?type=gene&acc=406660,,,406660.0,calm1a,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CALM1A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1066,1514078,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,285855,RPL7L1,https://ctdbase.org/detail.go?type=gene&acc=285855,,,285855.0,RPL7L1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RPL7L1 mRNA,,,PMID:20883709,https://www.ncbi.nlm.nih.gov/pubmed/20883709,20883709,,
1067,1514079,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,729677,RPL7P16,https://ctdbase.org/detail.go?type=gene&acc=729677,,,729677.0,RPL7P16,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RPL7P16 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1068,1514080,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6132,RPL8,https://ctdbase.org/detail.go?type=gene&acc=6132,,,6132.0,RPL8,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RPL8 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
1069,1514081,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6132,RPL8,https://ctdbase.org/detail.go?type=gene&acc=6132,,,6132.0,RPL8,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of RPL8 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
1070,1514082,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6133,RPL9,https://ctdbase.org/detail.go?type=gene&acc=6133,,,6133.0,RPL9,9031.0,Gallus gallus (chicken),Sodium arsenite results in increased expression of RPL9 mRNA,,,PMID:20308225,https://www.ncbi.nlm.nih.gov/pubmed/20308225,20308225,,
1071,1514083,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6133,RPL9,https://ctdbase.org/detail.go?type=gene&acc=6133,,,6133.0,RPL9,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RPL9 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
1072,1514084,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6175,RPLP0,https://ctdbase.org/detail.go?type=gene&acc=6175,,,6175.0,RPLP0,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RPLP0 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
1073,1514657,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6217,RPS16,https://ctdbase.org/detail.go?type=gene&acc=6217,,,6217.0,RPS16,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of and results in increased activity of RPS16 protein,,,PMID:30528433,https://www.ncbi.nlm.nih.gov/pubmed/30528433,30528433,,
1074,1517166,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6252,RTN1,https://ctdbase.org/detail.go?type=gene&acc=6252,,,6252.0,RTN1,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of RTN1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
1075,1517362,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,862,RUNX1T1,https://ctdbase.org/detail.go?type=gene&acc=862,,,862.0,RUNX1T1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of RUNX1T1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1076,1517363,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,862,RUNX1T1,https://ctdbase.org/detail.go?type=gene&acc=862,,,862.0,RUNX1T1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RUNX1T1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
1077,1517364,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RUNX2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
1078,1517562,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RUNX2 mRNA,,,PMID:28206643,https://www.ncbi.nlm.nih.gov/pubmed/28206643,28206643,,
1079,1517563,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,864,RUNX3,https://ctdbase.org/detail.go?type=gene&acc=864,,,864.0,RUNX3,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of RUNX3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1080,1517564,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,864,RUNX3,https://ctdbase.org/detail.go?type=gene&acc=864,,,864.0,RUNX3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RUNX3 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
1081,1517565,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23623,RUSC1,https://ctdbase.org/detail.go?type=gene&acc=23623,,,23623.0,RUSC1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RUSC1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1082,1517566,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,284618,RUSC1-AS1,https://ctdbase.org/detail.go?type=gene&acc=284618,,,284618.0,RUSC1-AS1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of RUSC1-AS1 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
1083,1517735,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RUVBL2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1084,1517736,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of RUVBL2 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
1085,1517737,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,449812,RWDD,https://ctdbase.org/detail.go?type=gene&acc=449812,,,449812.0,rwdd,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RWDD mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1086,1517738,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51389,RWDD1,https://ctdbase.org/detail.go?type=gene&acc=51389,,,51389.0,RWDD1,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of RWDD1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1087,1517739,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,112611,RWDD2A,https://ctdbase.org/detail.go?type=gene&acc=112611,,,112611.0,RWDD2A,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RWDD2A mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1088,1517740,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,59350,RXFP1,https://ctdbase.org/detail.go?type=gene&acc=59350,,,59350.0,RXFP1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RXFP1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1089,1517923,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RXRA mRNA,,,PMID:15833926,https://www.ncbi.nlm.nih.gov/pubmed/15833926,15833926,,
1090,1517924,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of RXRA protein,,,PMID:15833926|PMID:30528433|PMID:32201329,https://www.ncbi.nlm.nih.gov/pubmed/15833926|https://www.ncbi.nlm.nih.gov/pubmed/30528433|https://www.ncbi.nlm.nih.gov/pubmed/32201329,15833926|30528433|32201329,,
1091,1517925,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of RXRA mRNA,,,PMID:19084030,https://www.ncbi.nlm.nih.gov/pubmed/19084030,19084030,,
1092,1517926,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,10090.0,Mus musculus (house mouse),Sodium arsenite inhibits the reaction [[alitretinoin co-treated with RXRA protein] results in increased expression of RARB mrna],,,PMID:22310326,https://www.ncbi.nlm.nih.gov/pubmed/22310326,22310326,,
1093,1521007,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [sodium arsenite affects the activity of CAT protein],,,PMID:18434106,https://www.ncbi.nlm.nih.gov/pubmed/18434106,18434106,,
1094,1521008,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:18273903,https://www.ncbi.nlm.nih.gov/pubmed/18273903,18273903,,
1095,1521009,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased activity of CAT protein|biochanin A inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased activity of CAT protein]|[[sodium arsenite results in increased abundance of arsenic] which co-treated with epigallocatechin gallate] results in decreased activity of CAT protein,,,PMID:33410021,https://www.ncbi.nlm.nih.gov/pubmed/33410021,33410021,,
1096,1521010,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Chlorogenic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]|chlorogenic acid inhibits the reaction [sodium arsenite results in decreased expression of CAT mrna],,,PMID:33242462,https://www.ncbi.nlm.nih.gov/pubmed/33242462,33242462,,
1097,1521011,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]|curcumin inhibits the reaction [sodium arsenite results in decreased expression of CAT mrna]|sodium arsenite inhibits the reaction [curcumin results in increased activity of CAT protein],,,PMID:30934151,https://www.ncbi.nlm.nih.gov/pubmed/30934151,30934151,,
1098,1521012,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Curcumin inhibits the reaction [sodium arsenite results in decreased expression of cat]|sodium arsenite results in decreased expression of CAT,,,PMID:20593964,https://www.ncbi.nlm.nih.gov/pubmed/20593964,20593964,,
1099,1521013,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Epigallocatechin gallate inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:28365685,https://www.ncbi.nlm.nih.gov/pubmed/28365685,28365685,,
1100,1525294,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,129607,CMPK2,https://ctdbase.org/detail.go?type=gene&acc=129607,,,129607.0,CMPK2,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of CMPK2 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
1101,1525295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,129607,CMPK2,https://ctdbase.org/detail.go?type=gene&acc=129607,,,129607.0,CMPK2,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CMPK2 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
1102,1525296,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,146223,CMTM4,https://ctdbase.org/detail.go?type=gene&acc=146223,,,146223.0,CMTM4,7955.0,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CMTM4 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1103,1525801,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,337142,CNN3B,https://ctdbase.org/detail.go?type=gene&acc=337142,,,337142.0,cnn3b,7955.0,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of CNN3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
1104,1525802,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26507,CNNM1,https://ctdbase.org/detail.go?type=gene&acc=26507,,,26507.0,CNNM1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of CNNM1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1105,1525803,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26507,CNNM1,https://ctdbase.org/detail.go?type=gene&acc=26507,,,26507.0,CNNM1,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CNNM1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
1106,1525804,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,40620,CNO,https://ctdbase.org/detail.go?type=gene&acc=40620,,,40620.0,cno,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of CNO gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
1107,1525805,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23019,CNOT1,https://ctdbase.org/detail.go?type=gene&acc=23019,,,23019.0,CNOT1,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of CNOT1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
1108,1525806,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23019,CNOT1,https://ctdbase.org/detail.go?type=gene&acc=23019,,,23019.0,CNOT1,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of CNOT1 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
1109,1525807,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55571,CNOT11,https://ctdbase.org/detail.go?type=gene&acc=55571,,,55571.0,CNOT11,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of CNOT11 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
1110,1525808,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4850,CNOT4,https://ctdbase.org/detail.go?type=gene&acc=4850,,,4850.0,CNOT4,9606.0,Homo sapiens (human),Sodium arsenite promotes the reaction [CNOT4 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
1111,1525809,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,729530,CNOT6LP1,https://ctdbase.org/detail.go?type=gene&acc=729530,,,729530.0,CNOT6LP1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of CNOT6LP1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1112,1529220,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,9606.0,Homo sapiens (human),Sodium arsenite affects the methylation of COL6A2 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
1113,1529221,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,9606.0,Homo sapiens (human),[sodium arsenite co-treated with cadmium chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
1114,1529222,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of COL6A2 mRNA,,,PMID:18812580,https://www.ncbi.nlm.nih.gov/pubmed/18812580,18812580,,
1115,1529415,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1293,COL6A3,https://ctdbase.org/detail.go?type=gene&acc=1293,,,1293.0,COL6A3,10090.0,Mus musculus (house mouse),Sodium arsenite results in decreased expression of COL6A3 mRNA,,,PMID:18812580|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/18812580|https://www.ncbi.nlm.nih.gov/pubmed/37682722,18812580|37682722,,
1116,1529416,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,131873,COL6A6,https://ctdbase.org/detail.go?type=gene&acc=131873,,,131873.0,COL6A6,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of COL6A6 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
1117,1529417,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,173989,COL-74,https://ctdbase.org/detail.go?type=gene&acc=173989,,,173989.0,col-74,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-74 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
1118,1529418,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,174336,COL-77,https://ctdbase.org/detail.go?type=gene&acc=174336,,,174336.0,col-77,6239.0,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of COL-77 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
1119,1529419,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1294,COL7A1,https://ctdbase.org/detail.go?type=gene&acc=1294,,,1294.0,COL7A1,9606.0,Homo sapiens (human),Sodium arsenite results in decreased expression of COL7A1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
1120,1530000,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of DDIT3 protein,,,PMID:20654631|PMID:32506763|PMID:33241020,https://www.ncbi.nlm.nih.gov/pubmed/20654631|https://www.ncbi.nlm.nih.gov/pubmed/32506763|https://www.ncbi.nlm.nih.gov/pubmed/33241020,20654631|32506763|33241020,,
1121,1530001,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),EIF2S1 protein mutant form inhibits the reaction [sodium arsenite results in increased expression of DDIT3 protein],,,PMID:16330322,https://www.ncbi.nlm.nih.gov/pubmed/16330322,16330322,,
1122,1530002,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Sodium arsenite affects the localization of DDIT3 protein,,,PMID:21911445,https://www.ncbi.nlm.nih.gov/pubmed/21911445,21911445,,
1123,1530003,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of DDIT3 mRNA,,,PMID:10542372|PMID:11353140|PMID:16330322|PMID:21911445|PMID:23221991,https://www.ncbi.nlm.nih.gov/pubmed/10542372|https://www.ncbi.nlm.nih.gov/pubmed/11353140|https://www.ncbi.nlm.nih.gov/pubmed/16330322|https://www.ncbi.nlm.nih.gov/pubmed/21911445|https://www.ncbi.nlm.nih.gov/pubmed/23221991,10542372|11353140|16330322|21911445|23221991,,
1124,1530004,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of DDIT3 protein,,,PMID:11145585|PMID:12606582|PMID:16330322|PMID:20477944|PMID:21911445|PMID:23221991,https://www.ncbi.nlm.nih.gov/pubmed/11145585|https://www.ncbi.nlm.nih.gov/pubmed/12606582|https://www.ncbi.nlm.nih.gov/pubmed/16330322|https://www.ncbi.nlm.nih.gov/pubmed/20477944|https://www.ncbi.nlm.nih.gov/pubmed/21911445|https://www.ncbi.nlm.nih.gov/pubmed/23221991,11145585|12606582|16330322|20477944|21911445|23221991,,
1125,1530005,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite results in increased activity of DDIT3 protein|melatonin inhibits the reaction [sodium arsenite results in increased activity of DDIT3 protein],,,PMID:18715270,https://www.ncbi.nlm.nih.gov/pubmed/18715270,18715270,,
1126,1522290,444266,Therapeutic Target Database (TTD),Maleic Acid,D0E7UH,Maleic Acid,https://idrblab.net/ttd/data/drug/details/D0E7UH,T33367,Cytoplasmic aspartate aminotransferase (GOT1),https://idrblab.net/ttd/data/target/details/T33367,P17174,"Aspartate aminotransferase, cytoplasmic",2805.0,GOT1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1127,1522291,444289,BindingDB,"2,7-Dibenzyl-1,1-dioxo-3,6-bis-phenoxymethyl-[1,2,7]thiadiazepane-4,5-diol",1163,"(3R,4S,5S,6R)-2,7-Dibenzyl-3,6-bis(phenoxymethyl)-4,5-dihydroxy-1,2,7-thiadiazepan 1,1-Dioxide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1163,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),23,PMID:11170625|DOI:10.1021/jm001024j,https://www.ncbi.nlm.nih.gov/pubmed/11170625|https://doi.org/10.1021/jm001024j,11170625,10.1021/jm001024j,
1128,1513242,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5902,RANBP1,https://ctdbase.org/detail.go?type=gene&acc=5902,,,5902.0,RANBP1,10116.0,Rattus norvegicus (Norway rat),Trichostatin A inhibits the reaction [phenylephrine affects the localization of and affects the expression of RANBP1 protein],,,PMID:25341891,https://www.ncbi.nlm.nih.gov/pubmed/25341891,25341891,,
1129,1513243,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5911,RAP2A,https://ctdbase.org/detail.go?type=gene&acc=5911,,,5911.0,RAP2A,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of RAP2A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1130,1513244,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9693,RAPGEF2,https://ctdbase.org/detail.go?type=gene&acc=9693,,,9693.0,RAPGEF2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAPGEF2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1131,1513415,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5730,PTGDS,https://ctdbase.org/detail.go?type=gene&acc=5730,,,5730.0,PTGDS,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of PTGDS mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1132,1513416,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5733,PTGER3,https://ctdbase.org/detail.go?type=gene&acc=5733,,,5733.0,PTGER3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PTGER3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1133,1513417,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5734,PTGER4,https://ctdbase.org/detail.go?type=gene&acc=5734,,,5734.0,PTGER4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PTGER4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1134,1513418,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5737,PTGFR,https://ctdbase.org/detail.go?type=gene&acc=5737,,,5737.0,PTGFR,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PTGFR mRNA,,,PMID:26705709,https://www.ncbi.nlm.nih.gov/pubmed/26705709,26705709,,
1135,1513419,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5737,PTGFR,https://ctdbase.org/detail.go?type=gene&acc=5737,,,5737.0,PTGFR,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PTGFR mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1136,1513733,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,9606.0,Homo sapiens (human),Trichostatin A promotes the reaction [tretinoin inhibits the reaction [RARG protein binds to FOLR2 promoter]],,,PMID:16740727,https://www.ncbi.nlm.nih.gov/pubmed/16740727,16740727,,
1137,1513734,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606.0,Homo sapiens (human),[[decitabine co-treated with trichostatin A] affects the methylation of RARRES1 promoter] which affects the expression of RARRES1 mRNA,,,PMID:18803327,https://www.ncbi.nlm.nih.gov/pubmed/18803327,18803327|18803327,,
1138,1513735,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RARRES1 mrna|trichostatin A results in increased expression of RARRES1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1139,1513891,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [[lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of dinoprostone]|trichostatin A inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna]|trichostatin A inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 protein]|dusp1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 protein]]|dusp1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [[lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of dinoprostone]],,,PMID:21911040,https://www.ncbi.nlm.nih.gov/pubmed/21911040,21911040,,
1140,1514213,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,644943,RASSF10,https://ctdbase.org/detail.go?type=gene&acc=644943,,,644943.0,RASSF10,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RASSF10 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
1141,1514214,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9770,RASSF2,https://ctdbase.org/detail.go?type=gene&acc=9770,,,9770.0,RASSF2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1142,1514215,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9770,RASSF2,https://ctdbase.org/detail.go?type=gene&acc=9770,,,9770.0,RASSF2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RASSF2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
1143,1514216,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9770,RASSF2,https://ctdbase.org/detail.go?type=gene&acc=9770,,,9770.0,RASSF2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RASSF2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1144,1514217,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,283349,RASSF3,https://ctdbase.org/detail.go?type=gene&acc=283349,,,283349.0,RASSF3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASSF3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1145,1514218,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,283349,RASSF3,https://ctdbase.org/detail.go?type=gene&acc=283349,,,283349.0,RASSF3,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RASSF3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
1146,1514219,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83937,RASSF4,https://ctdbase.org/detail.go?type=gene&acc=83937,,,83937.0,RASSF4,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1147,1514362,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84867,PTPN5,https://ctdbase.org/detail.go?type=gene&acc=84867,,,84867.0,PTPN5,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTPN5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1148,1514363,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84867,PTPN5,https://ctdbase.org/detail.go?type=gene&acc=84867,,,84867.0,PTPN5,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PTPN5 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1149,1514364,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5786,PTPRA,https://ctdbase.org/detail.go?type=gene&acc=5786,,,5786.0,PTPRA,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of PTPRA mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1150,1514365,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5787,PTPRB,https://ctdbase.org/detail.go?type=gene&acc=5787,,,5787.0,PTPRB,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of PTPRB mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1151,1514366,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5789,PTPRD,https://ctdbase.org/detail.go?type=gene&acc=5789,,,5789.0,PTPRD,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTPRD mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1152,1515605,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5947,RBP1,https://ctdbase.org/detail.go?type=gene&acc=5947,,,5947.0,RBP1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RBP1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1153,1515606,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,568032,RBP2A,https://ctdbase.org/detail.go?type=gene&acc=568032,,,568032.0,rbp2a,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of RBP2A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1154,1515607,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5950,RBP4,https://ctdbase.org/detail.go?type=gene&acc=5950,,,5950.0,RBP4,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of RBP4 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1155,1515608,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,335651,RBP4L,https://ctdbase.org/detail.go?type=gene&acc=335651,,,335651.0,rbp4l,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of RBP4L mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1156,1515609,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,116362,RBP7,https://ctdbase.org/detail.go?type=gene&acc=116362,,,116362.0,RBP7,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RBP7 mRNA,,,PMID:17940511|PMID:26705709|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/17940511|https://www.ncbi.nlm.nih.gov/pubmed/26705709|https://www.ncbi.nlm.nih.gov/pubmed/27188386,17940511|26705709|27188386,,
1157,1515610,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,11030,RBPMS,https://ctdbase.org/detail.go?type=gene&acc=11030,,,11030.0,RBPMS,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RBPMS mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1158,1515611,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,348093,RBPMS2,https://ctdbase.org/detail.go?type=gene&acc=348093,,,348093.0,RBPMS2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBPMS2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1159,1515752,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5768,QSOX1,https://ctdbase.org/detail.go?type=gene&acc=5768,,,5768.0,QSOX1,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of QSOX1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1160,1515753,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79691,QTRT2,https://ctdbase.org/detail.go?type=gene&acc=79691,,,79691.0,QTRT2,9606.0,Homo sapiens (human),Trichostatin A affects the expression of QTRT2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1161,1515754,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80223,RAB11FIP1,https://ctdbase.org/detail.go?type=gene&acc=80223,,,80223.0,RAB11FIP1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RAB11FIP1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1162,1515755,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80223,RAB11FIP1,https://ctdbase.org/detail.go?type=gene&acc=80223,,,80223.0,RAB11FIP1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB11FIP1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1163,1515756,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,22841,RAB11FIP2,https://ctdbase.org/detail.go?type=gene&acc=22841,,,22841.0,RAB11FIP2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RAB11FIP2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1164,1516831,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85004,RERG,https://ctdbase.org/detail.go?type=gene&acc=85004,,,85004.0,RERG,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RERG mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1165,1516832,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5978,REST,https://ctdbase.org/detail.go?type=gene&acc=5978,,,5978.0,REST,9606.0,Homo sapiens (human),Trichostatin A results in decreased activity of REST protein,,,PMID:16330548,https://www.ncbi.nlm.nih.gov/pubmed/16330548,16330548,,
1166,1516833,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5979,RET,https://ctdbase.org/detail.go?type=gene&acc=5979,,,5979.0,RET,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RET mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1167,1516834,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54463,RETREG1,https://ctdbase.org/detail.go?type=gene&acc=54463,,,54463.0,RETREG1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RETREG1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1168,1516835,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,162427,RETREG3,https://ctdbase.org/detail.go?type=gene&acc=162427,,,162427.0,RETREG3,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RETREG3 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1169,1519745,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,154214,RNF217,https://ctdbase.org/detail.go?type=gene&acc=154214,,,154214.0,RNF217,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RNF217 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1170,1519746,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55072,RNF31,https://ctdbase.org/detail.go?type=gene&acc=55072,,,55072.0,RNF31,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RNF31 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1171,1519747,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,140545,RNF32,https://ctdbase.org/detail.go?type=gene&acc=140545,,,140545.0,RNF32,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RNF32 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1172,1519748,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100506380,RNF32-DT,https://ctdbase.org/detail.go?type=gene&acc=100506380,,,100506380.0,RNF32-DT,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RNF32-DT mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1173,1519749,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54894,RNF43,https://ctdbase.org/detail.go?type=gene&acc=54894,,,54894.0,RNF43,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF43 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1174,1519750,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54894,RNF43,https://ctdbase.org/detail.go?type=gene&acc=54894,,,54894.0,RNF43,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RNF43 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1175,1519751,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51136,RNFT1,https://ctdbase.org/detail.go?type=gene&acc=51136,,,51136.0,RNFT1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RNFT1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1176,1520361,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79657,RPAP3,https://ctdbase.org/detail.go?type=gene&acc=79657,,,79657.0,RPAP3,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RPAP3 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1177,1520362,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79657,RPAP3,https://ctdbase.org/detail.go?type=gene&acc=79657,,,79657.0,RPAP3,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RPAP3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1178,1520363,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,200916,RPL22L1,https://ctdbase.org/detail.go?type=gene&acc=200916,,,200916.0,RPL22L1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL22L1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1179,1520364,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,200916,RPL22L1,https://ctdbase.org/detail.go?type=gene&acc=200916,,,200916.0,RPL22L1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RPL22L1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1180,1520365,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6160,RPL31,https://ctdbase.org/detail.go?type=gene&acc=6160,,,6160.0,RPL31,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPL31 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1181,1520366,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6160,RPL31,https://ctdbase.org/detail.go?type=gene&acc=6160,,,6160.0,RPL31,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RPL31 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1182,1521014,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6232,RPS27,https://ctdbase.org/detail.go?type=gene&acc=6232,,,6232.0,RPS27,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS27 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1183,1521015,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6232,RPS27,https://ctdbase.org/detail.go?type=gene&acc=6232,,,6232.0,RPS27,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RPS27 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1184,1521871,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RTN3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1185,1521872,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57142,RTN4,https://ctdbase.org/detail.go?type=gene&acc=57142,,,57142.0,RTN4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RTN4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1186,1521873,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84816,RTN4IP1,https://ctdbase.org/detail.go?type=gene&acc=84816,,,84816.0,RTN4IP1,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of RTN4IP1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1187,1521874,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,146760,RTN4RL1,https://ctdbase.org/detail.go?type=gene&acc=146760,,,146760.0,RTN4RL1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RTN4RL1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1188,1521875,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25914,RTTN,https://ctdbase.org/detail.go?type=gene&acc=25914,,,25914.0,RTTN,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RTTN mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1189,1521876,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55680,RUFY2,https://ctdbase.org/detail.go?type=gene&acc=55680,,,55680.0,RUFY2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RUFY2 mrna|trichostatin A results in decreased expression of RUFY2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1190,1522292,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10329,RXYLT1,https://ctdbase.org/detail.go?type=gene&acc=10329,,,10329.0,RXYLT1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of RXYLT1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1191,1522293,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23429,RYBP,https://ctdbase.org/detail.go?type=gene&acc=23429,,,23429.0,RYBP,9606.0,Homo sapiens (human),Trichostatin A affects the expression of RYBP mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1192,1522294,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6263,RYR3,https://ctdbase.org/detail.go?type=gene&acc=6263,,,6263.0,RYR3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RYR3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1193,1522295,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6263,RYR3,https://ctdbase.org/detail.go?type=gene&acc=6263,,,6263.0,RYR3,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of RYR3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1194,1522296,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6271,S100A1,https://ctdbase.org/detail.go?type=gene&acc=6271,,,6271.0,S100A1,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of S100A1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1195,1522297,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1196,1522298,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of S100A10 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1197,1523134,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of KRT19 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1198,1523135,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,125113,KRT222,https://ctdbase.org/detail.go?type=gene&acc=125113,,,125113.0,KRT222,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of KRT222 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1199,1523136,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3856,KRT8,https://ctdbase.org/detail.go?type=gene&acc=3856,,,3856.0,KRT8,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT8 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1200,1523137,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3856,KRT8,https://ctdbase.org/detail.go?type=gene&acc=3856,,,3856.0,KRT8,9606.0,Homo sapiens (human),Trichostatin A affects the expression of KRT8 protein|[trichostatin A co-treated with decitabine] results in decreased expression of KRT8 protein,,,PMID:19294695,https://www.ncbi.nlm.nih.gov/pubmed/19294695,19294695,,
1201,1523429,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6303,SAT1,https://ctdbase.org/detail.go?type=gene&acc=6303,,,6303.0,SAT1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of SAT1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1202,1523430,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6303,SAT1,https://ctdbase.org/detail.go?type=gene&acc=6303,,,6303.0,SAT1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SAT1 mRNA,,,PMID:19606018|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/19606018|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,19606018|24935251|26272509,,
1203,1523431,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6303,SAT1,https://ctdbase.org/detail.go?type=gene&acc=6303,,,6303.0,SAT1,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of SAT1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1204,1523432,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,112483,SAT2,https://ctdbase.org/detail.go?type=gene&acc=112483,,,112483.0,SAT2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAT2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1205,1523433,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,112483,SAT2,https://ctdbase.org/detail.go?type=gene&acc=112483,,,112483.0,SAT2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SAT2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
1206,1523434,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23314,SATB2,https://ctdbase.org/detail.go?type=gene&acc=23314,,,23314.0,SATB2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SATB2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1207,1523435,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,60485,SAV1,https://ctdbase.org/detail.go?type=gene&acc=60485,,,60485.0,SAV1,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of SAV1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1208,1524327,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6322,SCML1,https://ctdbase.org/detail.go?type=gene&acc=6322,,,6322.0,SCML1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SCML1 mRNA,,,PMID:24935251|PMID:26272509|PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28542535,24935251|26272509|28542535,,
1209,1524944,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54549,SDK2,https://ctdbase.org/detail.go?type=gene&acc=54549,,,54549.0,SDK2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SDK2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1210,1524945,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,195814,SDR16C5,https://ctdbase.org/detail.go?type=gene&acc=195814,,,195814.0,SDR16C5,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of SDR16C5 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1211,1527421,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4036,LRP2,https://ctdbase.org/detail.go?type=gene&acc=4036,,,4036.0,LRP2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1212,1527422,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4036,LRP2,https://ctdbase.org/detail.go?type=gene&acc=4036,,,4036.0,LRP2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LRP2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1213,1528096,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80131,LRRC8E,https://ctdbase.org/detail.go?type=gene&acc=80131,,,80131.0,LRRC8E,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRRC8E mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1214,1528097,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,9208,LRRFIP1,https://ctdbase.org/detail.go?type=gene&acc=9208,,,9208.0,LRRFIP1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRRFIP1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1215,1528098,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,407677,LRRFIP1A,https://ctdbase.org/detail.go?type=gene&acc=407677,,,407677.0,lrrfip1a,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of LRRFIP1A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1216,1528099,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,120892,LRRK2,https://ctdbase.org/detail.go?type=gene&acc=120892,,,120892.0,LRRK2,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LRRK2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1217,1528100,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57633,LRRN1,https://ctdbase.org/detail.go?type=gene&acc=57633,,,57633.0,LRRN1,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of LRRN1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1218,1528708,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55337,SHFL,https://ctdbase.org/detail.go?type=gene&acc=55337,,,55337.0,SHFL,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SHFL mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1219,1528709,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6469,SHH,https://ctdbase.org/detail.go?type=gene&acc=6469,,,6469.0,SHH,8355.0,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of SHH mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1220,1528710,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,30269,SHHA,https://ctdbase.org/detail.go?type=gene&acc=30269,,,30269.0,shha,7955.0,Danio rerio (zebrafish),Trichostatin A results in decreased expression of SHHA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1221,1528711,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,387914,SHISA2,https://ctdbase.org/detail.go?type=gene&acc=387914,,,387914.0,SHISA2,7955.0,Danio rerio (zebrafish),Trichostatin A results in increased expression of SHISA2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
1222,1528712,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,387914,SHISA2,https://ctdbase.org/detail.go?type=gene&acc=387914,,,387914.0,SHISA2,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHISA2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1223,1528713,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,387914,SHISA2,https://ctdbase.org/detail.go?type=gene&acc=387914,,,387914.0,SHISA2,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SHISA2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1224,1528714,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,85352,SHISAL1,https://ctdbase.org/detail.go?type=gene&acc=85352,,,85352.0,SHISAL1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SHISAL1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1225,1528861,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7798,LUZP1,https://ctdbase.org/detail.go?type=gene&acc=7798,,,7798.0,LUZP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LUZP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1226,1528862,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7798,LUZP1,https://ctdbase.org/detail.go?type=gene&acc=7798,,,7798.0,LUZP1,9606.0,Homo sapiens (human),Trichostatin A affects the expression of LUZP1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
1227,1528863,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7798,LUZP1,https://ctdbase.org/detail.go?type=gene&acc=7798,,,7798.0,LUZP1,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of LUZP1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
1228,1528864,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,110454,LY6A,https://ctdbase.org/detail.go?type=gene&acc=110454,,,110454.0,Ly6a,9606.0,Homo sapiens (human),Trichostatin A inhibits the reaction [nickel affects the expression of LY6A mrna],,,PMID:14575637,https://www.ncbi.nlm.nih.gov/pubmed/14575637,14575637,,
1229,1528865,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54742,LY6K,https://ctdbase.org/detail.go?type=gene&acc=54742,,,54742.0,LY6K,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of LY6K mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1230,1529095,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),[niacinamide co-treated with trichostatin A] inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:15788402,https://www.ncbi.nlm.nih.gov/pubmed/15788402,15788402,,
1231,1529096,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23409,SIRT4,https://ctdbase.org/detail.go?type=gene&acc=23409,,,23409.0,SIRT4,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SIRT4 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
1232,1529097,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6495,SIX1,https://ctdbase.org/detail.go?type=gene&acc=6495,,,6495.0,SIX1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1233,1529098,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6495,SIX1,https://ctdbase.org/detail.go?type=gene&acc=6495,,,6495.0,SIX1,9606.0,Homo sapiens (human),Trichostatin A results in increased expression of SIX1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1234,1529099,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6496,SIX3,https://ctdbase.org/detail.go?type=gene&acc=6496,,,6496.0,SIX3,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1235,1529100,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6496,SIX3,https://ctdbase.org/detail.go?type=gene&acc=6496,,,6496.0,SIX3,9606.0,Homo sapiens (human),Trichostatin A results in decreased expression of SIX3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
1236,1529101,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,100506108,SIX3-AS1,https://ctdbase.org/detail.go?type=gene&acc=100506108,,,100506108.0,SIX3-AS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX3-AS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
1237,1516525,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5715,PSMD9,https://ctdbase.org/detail.go?type=gene&acc=5715,,,5715.0,PSMD9,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PSMD9 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1238,1516526,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5720,PSME1,https://ctdbase.org/detail.go?type=gene&acc=5720,,,5720.0,PSME1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PSME1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1239,1516527,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5721,PSME2,https://ctdbase.org/detail.go?type=gene&acc=5721,,,5721.0,PSME2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PSME2 mRNA,,,PMID:15498508|PMID:17218384,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/17218384,15498508|17218384,,
1240,1516528,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23198,PSME4,https://ctdbase.org/detail.go?type=gene&acc=23198,,,23198.0,PSME4,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PSME4 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1241,1516529,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9491,PSMF1,https://ctdbase.org/detail.go?type=gene&acc=9491,,,9491.0,PSMF1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PSMF1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1242,1516530,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8624,PSMG1,https://ctdbase.org/detail.go?type=gene&acc=8624,,,8624.0,PSMG1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PSMG1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1243,1516531,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84262,PSMG3,https://ctdbase.org/detail.go?type=gene&acc=84262,,,84262.0,PSMG3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PSMG3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1244,1516532,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,389362,PSMG4,https://ctdbase.org/detail.go?type=gene&acc=389362,,,389362.0,PSMG4,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PSMG4 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
1245,1517918,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5763,PTMS,https://ctdbase.org/detail.go?type=gene&acc=5763,,,5763.0,PTMS,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PTMS mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1246,1517919,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5764,PTN,https://ctdbase.org/detail.go?type=gene&acc=5764,,,5764.0,PTN,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of PTN mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1247,1517920,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5764,PTN,https://ctdbase.org/detail.go?type=gene&acc=5764,,,5764.0,PTN,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PTN mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1248,1517921,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,53635,PTOV1,https://ctdbase.org/detail.go?type=gene&acc=53635,,,53635.0,PTOV1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PTOV1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1249,1517922,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8073,PTP4A2,https://ctdbase.org/detail.go?type=gene&acc=8073,,,8073.0,PTP4A2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of PTP4A2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1250,1518958,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51291,GMIP,https://ctdbase.org/detail.go?type=gene&acc=51291,,,51291.0,GMIP,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of GMIP mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
1251,1518959,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,29926,GMPPA,https://ctdbase.org/detail.go?type=gene&acc=29926,,,29926.0,GMPPA,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GMPPA mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1252,1518960,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2766,GMPR,https://ctdbase.org/detail.go?type=gene&acc=2766,,,2766.0,GMPR,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GMPR mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1253,1518961,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8833,GMPS,https://ctdbase.org/detail.go?type=gene&acc=8833,,,8833.0,GMPS,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GMPS mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1254,1518962,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2768,GNA12,https://ctdbase.org/detail.go?type=gene&acc=2768,,,2768.0,GNA12,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GNA12 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1255,1518963,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10672,GNA13,https://ctdbase.org/detail.go?type=gene&acc=10672,,,10672.0,GNA13,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of GNA13 protein|tretinoin promotes the reaction [SPAG9 protein binds to GNA13 protein],,,PMID:16619266,https://www.ncbi.nlm.nih.gov/pubmed/16619266,16619266,,
1256,1518964,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2771,GNAI2,https://ctdbase.org/detail.go?type=gene&acc=2771,,,2771.0,GNAI2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GNAI2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1257,1518965,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2774,GNAL,https://ctdbase.org/detail.go?type=gene&acc=2774,,,2774.0,GNAL,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GNAL mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1258,1518966,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2775,GNAO1,https://ctdbase.org/detail.go?type=gene&acc=2775,,,2775.0,GNAO1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GNAO1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1259,1519752,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5859,QARS1,https://ctdbase.org/detail.go?type=gene&acc=5859,,,5859.0,QARS1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of QARS1 mRNA,,,PMID:17218384,https://www.ncbi.nlm.nih.gov/pubmed/17218384,17218384,,
1260,1519753,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5860,QDPR,https://ctdbase.org/detail.go?type=gene&acc=5860,,,5860.0,QDPR,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of QDPR mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1261,1521154,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606.0,Homo sapiens (human),Tretinoin results in increased activity of GPX2 protein,,,PMID:10498757,https://www.ncbi.nlm.nih.gov/pubmed/10498757,10498757,,
1262,1521155,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPX2 mRNA,,,PMID:10498757|PMID:17045167,https://www.ncbi.nlm.nih.gov/pubmed/10498757|https://www.ncbi.nlm.nih.gov/pubmed/17045167,10498757|17045167,,
1263,1521156,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of GPX3 mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
1264,1521157,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of GPX4 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1265,1521158,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,10090.0,Mus musculus (house mouse),Tretinoin results in decreased activity of GPX4 protein,,,PMID:16445905,https://www.ncbi.nlm.nih.gov/pubmed/16445905,16445905,,
1266,1521159,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPX7 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1267,1521160,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,493869,GPX8,https://ctdbase.org/detail.go?type=gene&acc=493869,,,493869.0,GPX8,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GPX8 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
1268,1521161,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,57476,GRAMD1B,https://ctdbase.org/detail.go?type=gene&acc=57476,,,57476.0,GRAMD1B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GRAMD1B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1269,1521162,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,54762,GRAMD1C,https://ctdbase.org/detail.go?type=gene&acc=54762,,,54762.0,GRAMD1C,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GRAMD1C mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
1270,1521311,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10111,RAD50,https://ctdbase.org/detail.go?type=gene&acc=10111,,,10111.0,RAD50,7719.0,Ciona intestinalis (vase tunicate),[tretinoin co-treated with puromycin] results in increased expression of RAD50 mRNA,,,PMID:15977162,https://www.ncbi.nlm.nih.gov/pubmed/15977162,15977162,,
1271,1521312,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10111,RAD50,https://ctdbase.org/detail.go?type=gene&acc=10111,,,10111.0,RAD50,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RAD50 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
1272,1521313,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,7955.0,Danio rerio (zebrafish),Tretinoin results in decreased expression of RAD51 mRNA,,,PMID:18230668,https://www.ncbi.nlm.nih.gov/pubmed/18230668,18230668,,
1273,1521314,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,9606.0,Homo sapiens (human),Tretinoin affects the expression of RAD51 mRNA,,,PMID:31600526,https://www.ncbi.nlm.nih.gov/pubmed/31600526,31600526,,
1274,1521315,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10635,RAD51AP1,https://ctdbase.org/detail.go?type=gene&acc=10635,,,10635.0,RAD51AP1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RAD51AP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1275,1521316,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10635,RAD51AP1,https://ctdbase.org/detail.go?type=gene&acc=10635,,,10635.0,RAD51AP1,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of RAD51AP1 protein,,,PMID:20025956,https://www.ncbi.nlm.nih.gov/pubmed/20025956,20025956,,
1276,1521317,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5890,RAD51B,https://ctdbase.org/detail.go?type=gene&acc=5890,,,5890.0,RAD51B,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RAD51B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1277,1521318,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5889,RAD51C,https://ctdbase.org/detail.go?type=gene&acc=5889,,,5889.0,RAD51C,9606.0,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of RAD51C mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1278,1521573,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2894,GRID1,https://ctdbase.org/detail.go?type=gene&acc=2894,,,2894.0,GRID1,10090.0,Mus musculus (house mouse),Tretinoin results in decreased expression of GRID1 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
1279,1521574,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2897,GRIK1,https://ctdbase.org/detail.go?type=gene&acc=2897,,,2897.0,GRIK1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GRIK1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1280,1521575,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2898,GRIK2,https://ctdbase.org/detail.go?type=gene&acc=2898,,,2898.0,GRIK2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GRIK2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1281,1523550,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,2997,GYS1,https://ctdbase.org/detail.go?type=gene&acc=2997,,,2997.0,GYS1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of GYS1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1282,1524048,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of H19 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
1283,1524674,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8357,H3C10,https://ctdbase.org/detail.go?type=gene&acc=8357,,,8357.0,H3C10,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of H3C10 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1284,1524675,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8354,H3C11,https://ctdbase.org/detail.go?type=gene&acc=8354,,,8354.0,H3C11,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of H3C11 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1285,1524937,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,8355.0,Xenopus laevis (African clawed frog),Tretinoin binds to and results in increased activity of RARB protein,,,PMID:16839186,https://www.ncbi.nlm.nih.gov/pubmed/16839186,16839186,,
1286,1524938,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9606.0,Homo sapiens (human),HX 600 promotes the reaction [[tretinoin binds to and results in increased activity of RARB protein] which results in increased expression of TNFRSF10B mrna]|[tretinoin binds to and results in increased activity of RARB protein] which results in increased expression of TNFRSF10B mrna|hx 600 affects the reaction [tretinoin binds to and results in increased activity of RARB protein],,,PMID:9144408,https://www.ncbi.nlm.nih.gov/pubmed/9144408,9144408,,
1287,1524939,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9606.0,Homo sapiens (human),Tretinoin binds to and results in increased activity of RARB protein,,,PMID:16819260|PMID:9144408,https://www.ncbi.nlm.nih.gov/pubmed/16819260|https://www.ncbi.nlm.nih.gov/pubmed/9144408,16819260|9144408,,
1288,1524940,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9606.0,Homo sapiens (human),Tretinoin binds to RARB protein,,,PMID:17387344,https://www.ncbi.nlm.nih.gov/pubmed/17387344,17387344,,
1289,1524941,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9606.0,Homo sapiens (human),Tretinoin results in increased activity of RARB protein,,,PMID:18398471,https://www.ncbi.nlm.nih.gov/pubmed/18398471,18398471,,
1290,1524942,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,7955.0,Danio rerio (zebrafish),Tretinoin binds to and results in increased activity of RARG protein,,,PMID:16839186,https://www.ncbi.nlm.nih.gov/pubmed/16839186,16839186,,
1291,1524943,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,7955.0,Danio rerio (zebrafish),Tretinoin results in increased expression of RARG mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
1292,1525073,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3033,HADH,https://ctdbase.org/detail.go?type=gene&acc=3033,,,3033.0,HADH,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of HADH mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
1293,1525074,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,401022,HAGLR,https://ctdbase.org/detail.go?type=gene&acc=401022,,,401022.0,HAGLR,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HAGLR mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1294,1525075,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HAL mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1295,1525076,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of HAL mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
1296,1525077,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9421,HAND1,https://ctdbase.org/detail.go?type=gene&acc=9421,,,9421.0,HAND1,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of HAND1 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
1297,1525078,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HAND2 mRNA,,,PMID:34742744,https://www.ncbi.nlm.nih.gov/pubmed/34742744,34742744,,
1298,1525079,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,10090.0,Mus musculus (house mouse),Tretinoin results in decreased expression of HAND2 protein,,,PMID:17551590,https://www.ncbi.nlm.nih.gov/pubmed/17551590,17551590,,
1299,1525080,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of HAND2,,,PMID:15069081,https://www.ncbi.nlm.nih.gov/pubmed/15069081,15069081,,
1300,1525081,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,10116.0,Rattus norvegicus (Norway rat),Cyclo(trp-asp-pro-val-leu) inhibits the reaction [tretinoin results in decreased expression of HAND2 mrna]|tretinoin results in decreased expression of HAND2 mrna|cyclo(trp-asp-pro-val-leu) inhibits the reaction [tretinoin results in decreased expression of HAND2 protein]|tretinoin results in decreased expression of HAND2 protein,,,PMID:16619265,https://www.ncbi.nlm.nih.gov/pubmed/16619265,16619265,,
1301,1525288,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3037,HAS2,https://ctdbase.org/detail.go?type=gene&acc=3037,,,3037.0,HAS2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HAS2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1302,1525289,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3037,HAS2,https://ctdbase.org/detail.go?type=gene&acc=3037,,,3037.0,HAS2,10090.0,Mus musculus (house mouse),Tretinoin results in increased expression of HAS2 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
1303,1525290,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3038,HAS3,https://ctdbase.org/detail.go?type=gene&acc=3038,,,3038.0,HAS3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HAS3 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1304,1525291,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,8520,HAT1,https://ctdbase.org/detail.go?type=gene&acc=8520,,,8520.0,HAT1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HAT1 mRNA,,,PMID:16054129|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/16054129|https://www.ncbi.nlm.nih.gov/pubmed/33167477,16054129|33167477,,
1305,1525292,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,115106,HAUS1,https://ctdbase.org/detail.go?type=gene&acc=115106,,,115106.0,HAUS1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HAUS1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1306,1525293,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,54801,HAUS6,https://ctdbase.org/detail.go?type=gene&acc=54801,,,54801.0,HAUS6,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HAUS6 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1307,1525550,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,84868,HAVCR2,https://ctdbase.org/detail.go?type=gene&acc=84868,,,84868.0,HAVCR2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HAVCR2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1308,1525551,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3045,HBD,https://ctdbase.org/detail.go?type=gene&acc=3045,,,3045.0,HBD,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HBD mRNA,,,PMID:16249480,https://www.ncbi.nlm.nih.gov/pubmed/16249480,16249480,,
1309,1525552,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3046,HBE1,https://ctdbase.org/detail.go?type=gene&acc=3046,,,3046.0,HBE1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HBE1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1310,1525553,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1839,HBEGF,https://ctdbase.org/detail.go?type=gene&acc=1839,,,1839.0,HBEGF,9606.0,Homo sapiens (human),Tretinoin metabolite results in increased expression of HBEGF mRNA,,,PMID:15982314,https://www.ncbi.nlm.nih.gov/pubmed/15982314,15982314,,
1311,1525554,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1839,HBEGF,https://ctdbase.org/detail.go?type=gene&acc=1839,,,1839.0,HBEGF,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HBEGF mRNA,,,PMID:15894607|PMID:15982314|PMID:16249480|PMID:16470170|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/15894607|https://www.ncbi.nlm.nih.gov/pubmed/15982314|https://www.ncbi.nlm.nih.gov/pubmed/16249480|https://www.ncbi.nlm.nih.gov/pubmed/16470170|https://www.ncbi.nlm.nih.gov/pubmed/33167477,15894607|15982314|16249480|16470170|33167477,,
1312,1526017,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,91608,RASL10B,https://ctdbase.org/detail.go?type=gene&acc=91608,,,91608.0,RASL10B,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RASL10B mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1313,1526018,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,387496,RASL11A,https://ctdbase.org/detail.go?type=gene&acc=387496,,,387496.0,RASL11A,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RASL11A mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1314,1526019,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,387496,RASL11A,https://ctdbase.org/detail.go?type=gene&acc=387496,,,387496.0,RASL11A,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RASL11A mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
1315,1526020,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,65997,RASL11B,https://ctdbase.org/detail.go?type=gene&acc=65997,,,65997.0,RASL11B,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RASL11B mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1316,1526021,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9770,RASSF2,https://ctdbase.org/detail.go?type=gene&acc=9770,,,9770.0,RASSF2,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RASSF2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1317,1526022,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9770,RASSF2,https://ctdbase.org/detail.go?type=gene&acc=9770,,,9770.0,RASSF2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RASSF2 mRNA,,,PMID:23830798|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23830798|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23830798|33167477,,
1318,1526023,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,9770,RASSF2,https://ctdbase.org/detail.go?type=gene&acc=9770,,,9770.0,RASSF2,10090.0,Mus musculus (house mouse),Tretinoin results in decreased expression of RASSF2 mRNA,,,PMID:16788091,https://www.ncbi.nlm.nih.gov/pubmed/16788091,16788091,,
1319,1526024,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,283349,RASSF3,https://ctdbase.org/detail.go?type=gene&acc=283349,,,283349.0,RASSF3,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RASSF3 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
1320,1526025,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,83937,RASSF4,https://ctdbase.org/detail.go?type=gene&acc=83937,,,83937.0,RASSF4,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RASSF4 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
1321,1526026,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,83937,RASSF4,https://ctdbase.org/detail.go?type=gene&acc=83937,,,83937.0,RASSF4,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of RASSF4 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
1322,1526648,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55008,HERC6,https://ctdbase.org/detail.go?type=gene&acc=55008,,,55008.0,HERC6,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HERC6 mRNA,,,PMID:23830798|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23830798|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23830798|33167477,,
1323,1526649,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64224,HERPUD2,https://ctdbase.org/detail.go?type=gene&acc=64224,,,64224.0,HERPUD2,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HERPUD2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1324,1526650,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HES1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1325,1526651,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HES1 mRNA,,,PMID:22906706|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/22906706|https://www.ncbi.nlm.nih.gov/pubmed/23724009,22906706|23724009,,
1326,1526652,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Tretinoin results in increased expression of HES1 protein,,,PMID:28130038,https://www.ncbi.nlm.nih.gov/pubmed/28130038,28130038,,
1327,1526653,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,390992,HES3,https://ctdbase.org/detail.go?type=gene&acc=390992,,,390992.0,HES3,10116.0,Rattus norvegicus (Norway rat),Tretinoin results in decreased expression of HES3 mRNA,,,PMID:20488242,https://www.ncbi.nlm.nih.gov/pubmed/20488242,20488242,,
1328,1526654,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,388585,HES5,https://ctdbase.org/detail.go?type=gene&acc=388585,,,388585.0,HES5,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of HES5 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1329,1527165,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55131,RBM28,https://ctdbase.org/detail.go?type=gene&acc=55131,,,55131.0,RBM28,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RBM28 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1330,1527166,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5935,RBM3,https://ctdbase.org/detail.go?type=gene&acc=5935,,,5935.0,RBM3,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RBM3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1331,1527167,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23029,RBM34,https://ctdbase.org/detail.go?type=gene&acc=23029,,,23029.0,RBM34,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RBM34 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1332,1527168,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55544,RBM38,https://ctdbase.org/detail.go?type=gene&acc=55544,,,55544.0,RBM38,9606.0,Homo sapiens (human),[tretinoin co-treated with arsenic trioxide] results in increased expression of RBM38 mRNA,,,PMID:15894607,https://www.ncbi.nlm.nih.gov/pubmed/15894607,15894607,,
1333,1527169,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55544,RBM38,https://ctdbase.org/detail.go?type=gene&acc=55544,,,55544.0,RBM38,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RBM38 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1334,1527170,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55544,RBM38,https://ctdbase.org/detail.go?type=gene&acc=55544,,,55544.0,RBM38,10090.0,Mus musculus (house mouse),[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of RBM38 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
1335,1527171,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,375287,RBM43,https://ctdbase.org/detail.go?type=gene&acc=375287,,,375287.0,RBM43,9606.0,Homo sapiens (human),Tretinoin results in increased expression of RBM43 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
1336,1527172,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,129831,RBM45,https://ctdbase.org/detail.go?type=gene&acc=129831,,,129831.0,RBM45,9606.0,Homo sapiens (human),Tretinoin results in decreased expression of RBM45 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
1337,1523427,444913,DrugBank,alpha-CYCLODEXTRIN,DB01909,Alpha-Cyclodextrin (Cyclohexa-Amylose),https://www.drugbank.ca/drugs/DB01909,BE0001243,Cyclomaltodextrin glucanotransferase,https://www.drugbank.ca/bio_entities/BE0001243,P30920,Cyclomaltodextrin glucanotransferase,,,1397.0,Niallia circulans,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1338,1523428,444941,DrugBank,alpha-Ribazole-5'-phosphate,DB02030,Alpha-Ribazole-5'-Phosphate,https://www.drugbank.ca/drugs/DB02030,BE0001229,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,https://www.drugbank.ca/bio_entities/BE0001229,Q05603,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,1253537.0,cobT,99287.0,Salmonella enterica subsp. enterica serovar Typhimurium str. LT2,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1339,1514821,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116.0,Rattus norvegicus (Norway rat),Resveratrol affects the expression of CYP2E1 mRNA,,,PMID:15748624,https://www.ncbi.nlm.nih.gov/pubmed/15748624,15748624,,
1340,1514822,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,120227,CYP2R1,https://ctdbase.org/detail.go?type=gene&acc=120227,,,120227.0,CYP2R1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of CYP2R1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1341,1514823,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [CYP3A11 protein results in increased metabolism of phenacetin]|resveratrol inhibits the reaction [CYP3A11 protein results in increased metabolism of nifedipine],,,PMID:25956474,https://www.ncbi.nlm.nih.gov/pubmed/25956474,25956474,,
1342,1514824,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CYP3A11 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
1343,1514825,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Resveratrol results in decreased activity of CYP3A11 protein,,,PMID:18420780|PMID:25956474,https://www.ncbi.nlm.nih.gov/pubmed/18420780|https://www.ncbi.nlm.nih.gov/pubmed/25956474,18420780|25956474,,
1344,1514826,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of buspirone],,,PMID:20716633,https://www.ncbi.nlm.nih.gov/pubmed/20716633,20716633,,
1345,1514827,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of testosterone],,,PMID:12569440,https://www.ncbi.nlm.nih.gov/pubmed/12569440,12569440,,
1346,1514828,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Resveratrol results in decreased activity of CYP3A4 protein,,,PMID:12569440|PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/12569440|https://www.ncbi.nlm.nih.gov/pubmed/18420780,12569440|18420780,,
1347,1515757,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1612,DAPK1,https://ctdbase.org/detail.go?type=gene&acc=1612,,,1612.0,DAPK1,9606.0,Homo sapiens (human),Resveratrol results in increased activity of DAPK1 protein|resveratrol results in increased expression of DAPK1 mrna|resveratrol results in increased expression of DAPK1 protein,,,PMID:23800064,https://www.ncbi.nlm.nih.gov/pubmed/23800064,23800064,,
1348,1515758,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,92196,DAPL1,https://ctdbase.org/detail.go?type=gene&acc=92196,,,92196.0,DAPL1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DAPL1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1349,1515759,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1615,DARS1,https://ctdbase.org/detail.go?type=gene&acc=1615,,,1615.0,DARS1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of DARS1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1350,1515760,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1615,DARS1,https://ctdbase.org/detail.go?type=gene&acc=1615,,,1615.0,DARS1,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DARS1 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1351,1516052,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51163,DBR1,https://ctdbase.org/detail.go?type=gene&acc=51163,,,51163.0,DBR1,10116.0,Rattus norvegicus (Norway rat),Resveratrol results in decreased expression of DBR1 mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
1352,1516053,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1629,DBT,https://ctdbase.org/detail.go?type=gene&acc=1629,,,1629.0,DBT,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DBT mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
1353,1516054,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,139170,DCAF12L1,https://ctdbase.org/detail.go?type=gene&acc=139170,,,139170.0,DCAF12L1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DCAF12L1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1354,1516055,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,26094,DCAF4,https://ctdbase.org/detail.go?type=gene&acc=26094,,,26094.0,DCAF4,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1355,1516056,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,79877,DCAKD,https://ctdbase.org/detail.go?type=gene&acc=79877,,,79877.0,DCAKD,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DCAKD protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1356,1516057,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,117159,DCD,https://ctdbase.org/detail.go?type=gene&acc=117159,,,117159.0,DCD,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DCD mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1357,1516058,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1633,DCK,https://ctdbase.org/detail.go?type=gene&acc=1633,,,1633.0,DCK,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of DCK mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1358,1516059,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of DCLK1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1359,1516060,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DCLK1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1360,1518782,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1716,DGUOK,https://ctdbase.org/detail.go?type=gene&acc=1716,,,1716.0,DGUOK,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DGUOK mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
1361,1518783,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of DHCR7 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1362,1518784,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of DHCR7 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1363,1518785,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of DHFR mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1364,1522475,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,79075,DSCC1,https://ctdbase.org/detail.go?type=gene&acc=79075,,,79075.0,DSCC1,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of DSCC1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1365,1522476,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,259234,DSCR10,https://ctdbase.org/detail.go?type=gene&acc=259234,,,259234.0,DSCR10,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of DSCR10 mrna|[plant extracts co-treated with resveratrol] results in increased expression of DSCR10 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1366,1524319,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8480,RAE1,https://ctdbase.org/detail.go?type=gene&acc=8480,,,8480.0,RAE1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of RAE1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1367,1524320,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,135250,RAET1E,https://ctdbase.org/detail.go?type=gene&acc=135250,,,135250.0,RAET1E,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [titanium dioxide results in increased expression of RAET1E mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
1368,1524321,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,353091,RAET1G,https://ctdbase.org/detail.go?type=gene&acc=353091,,,353091.0,RAET1G,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of RAET1G mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1369,1524322,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,154064,RAET1L,https://ctdbase.org/detail.go?type=gene&acc=154064,,,154064.0,RAET1L,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of RAET1L mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1370,1524323,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,9606.0,Homo sapiens (human),"Resveratrol inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl promotes the reaction [[AHR protein binds to ARNT protein] which binds to RAF1 promoter]]",,,PMID:18708364,https://www.ncbi.nlm.nih.gov/pubmed/18708364,18708364,,
1371,1524324,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [paclitaxel results in increased phosphorylation of RAF1 protein],,,PMID:12510025,https://www.ncbi.nlm.nih.gov/pubmed/12510025,12510025,,
1372,1524325,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of RAF1 protein,,,PMID:18089832,https://www.ncbi.nlm.nih.gov/pubmed/18089832,18089832,,
1373,1524326,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [dinoprost results in increased expression of RAF1 protein modified form],,,PMID:24333336,https://www.ncbi.nlm.nih.gov/pubmed/24333336,24333336,,
1374,1526393,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9538,EI24,https://ctdbase.org/detail.go?type=gene&acc=9538,,,9538.0,EI24,9606.0,Homo sapiens (human),Resveratrol results in increased expression of EI24 mRNA,,,PMID:12569576|PMID:26341291,https://www.ncbi.nlm.nih.gov/pubmed/12569576|https://www.ncbi.nlm.nih.gov/pubmed/26341291,12569576|26341291,,
1375,1526394,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9538,EI24,https://ctdbase.org/detail.go?type=gene&acc=9538,,,9538.0,EI24,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of EI24 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1376,1526395,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,23741,EID1,https://ctdbase.org/detail.go?type=gene&acc=23741,,,23741.0,EID1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EID1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1377,1526396,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10209,EIF1,https://ctdbase.org/detail.go?type=gene&acc=10209,,,10209.0,EIF1,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of EIF1 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1378,1526397,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1964,EIF1AX,https://ctdbase.org/detail.go?type=gene&acc=1964,,,1964.0,EIF1AX,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF1AX mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1379,1527052,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1973,EIF4A1,https://ctdbase.org/detail.go?type=gene&acc=1973,,,1973.0,EIF4A1,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of EIF4A1 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1380,1527053,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1974,EIF4A2,https://ctdbase.org/detail.go?type=gene&acc=1974,,,1974.0,EIF4A2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EIF4A2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1381,1527054,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1974,EIF4A2,https://ctdbase.org/detail.go?type=gene&acc=1974,,,1974.0,EIF4A2,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of EIF4A2 mRNA,,,PMID:15767336,https://www.ncbi.nlm.nih.gov/pubmed/15767336,15767336,,
1382,1527055,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,9606.0,Homo sapiens (human),Resveratrol results in decreased phosphorylation of EIF4B protein|[resveratrol co-treated with sirolimus] results in decreased phosphorylation of EIF4B protein|[sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein|[resveratrol co-treated with sirolimus] inhibits the reaction [TSC2 gene mutant form results in increased phosphorylation of EIF4B protein],,,PMID:24304514,https://www.ncbi.nlm.nih.gov/pubmed/24304514,24304514,,
1383,1527056,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,9606.0,Homo sapiens (human),Resveratrol results in decreased phosphorylation of EIF4B protein,,,PMID:25311616,https://www.ncbi.nlm.nih.gov/pubmed/25311616,25311616,,
1384,1527057,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,10090.0,Mus musculus (house mouse),Resveratrol results in decreased expression of EIF4B protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
1385,1527058,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4E protein],,,PMID:15297429,https://www.ncbi.nlm.nih.gov/pubmed/15297429,15297429,,
1386,1528338,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10328,EMC8,https://ctdbase.org/detail.go?type=gene&acc=10328,,,10328.0,EMC8,10090.0,Mus musculus (house mouse),Resveratrol results in increased expression of EMC8 mRNA,,,PMID:22610192,https://www.ncbi.nlm.nih.gov/pubmed/22610192,22610192,,
1387,1528339,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51016,EMC9,https://ctdbase.org/detail.go?type=gene&acc=51016,,,51016.0,EMC9,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of EMC9 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1388,1528340,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2010,EMD,https://ctdbase.org/detail.go?type=gene&acc=2010,,,2010.0,EMD,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of EMD mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1389,1528341,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,197342,EME2,https://ctdbase.org/detail.go?type=gene&acc=197342,,,197342.0,EME2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of EME2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1390,1528342,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10436,EMG1,https://ctdbase.org/detail.go?type=gene&acc=10436,,,10436.0,EMG1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EMG1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1391,1528343,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84034,EMILIN2,https://ctdbase.org/detail.go?type=gene&acc=84034,,,84034.0,EMILIN2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of EMILIN2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1392,1528344,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2018,EMX2,https://ctdbase.org/detail.go?type=gene&acc=2018,,,2018.0,EMX2,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of EMX2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1393,1528345,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2019,EN1,https://ctdbase.org/detail.go?type=gene&acc=2019,,,2019.0,EN1,9606.0,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of EN1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
1394,1528346,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,2019,EN1,https://ctdbase.org/detail.go?type=gene&acc=2019,,,2019.0,EN1,9606.0,Homo sapiens (human),Resveratrol results in decreased expression of EN1 mRNA,,,PMID:20878097,https://www.ncbi.nlm.nih.gov/pubmed/20878097,20878097,,
1395,1528558,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8507,ENC1,https://ctdbase.org/detail.go?type=gene&acc=8507,,,8507.0,ENC1,9606.0,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of ENC1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
1396,1528559,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8507,ENC1,https://ctdbase.org/detail.go?type=gene&acc=8507,,,8507.0,ENC1,9606.0,Homo sapiens (human),[lipopolysaccharides co-treated with resveratrol] results in decreased expression of ENC1 mRNA,,,PMID:26667767,https://www.ncbi.nlm.nih.gov/pubmed/26667767,26667767,,
1397,1514085,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,10974,ADIRF,https://ctdbase.org/detail.go?type=gene&acc=10974,,,10974.0,ADIRF,9606.0,Homo sapiens (human),Cyanoginosin LR results in increased expression of ADIRF mRNA,,,PMID:29518473,https://www.ncbi.nlm.nih.gov/pubmed/29518473,29518473,,
1398,1514086,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,173,AFM,https://ctdbase.org/detail.go?type=gene&acc=173,,,173.0,AFM,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in decreased expression of AFM mRNA,,,PMID:17654400,https://www.ncbi.nlm.nih.gov/pubmed/17654400,17654400,,
1399,1516671,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,10116.0,Rattus norvegicus (Norway rat),"[cyanoginosin LR co-treated with dietary fats co-treated with cholesterol, dietary] results in increased expression of BID protein",,,PMID:34740672,https://www.ncbi.nlm.nih.gov/pubmed/34740672,34740672,,
1400,1516672,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,9606.0,Homo sapiens (human),Cyanoginosin LR results in increased expression of BIRC3 protein,,,PMID:22539157,https://www.ncbi.nlm.nih.gov/pubmed/22539157,22539157,,
1401,1516673,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,414899,BLID,https://ctdbase.org/detail.go?type=gene&acc=414899,,,414899.0,BLID,9606.0,Homo sapiens (human),Cyanoginosin LR results in increased expression of BLID mRNA,,,PMID:29518473,https://www.ncbi.nlm.nih.gov/pubmed/29518473,29518473,,
1402,1516674,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,640,BLK,https://ctdbase.org/detail.go?type=gene&acc=640,,,640.0,BLK,9606.0,Homo sapiens (human),BLK protein inhibits the reaction [cyanoginosin LR results in increased mutagenesis of HPRT1 gene]|blk protein inhibits the reaction [cyanoginosin LR affects the localization of CGAS protein]|blk protein inhibits the reaction [cyanoginosin LR inhibits the reaction [PARP1 protein binds to TIMELESS protein]],,,PMID:36435412,https://www.ncbi.nlm.nih.gov/pubmed/36435412,36435412,,
1403,1516675,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,645,BLVRB,https://ctdbase.org/detail.go?type=gene&acc=645,,,645.0,BLVRB,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of BLVRB mRNA,,,PMID:17654400,https://www.ncbi.nlm.nih.gov/pubmed/17654400,17654400,,
1404,1516676,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10116.0,Rattus norvegicus (Norway rat),Cyanoginosin LR results in decreased expression of BMP2 protein,,,PMID:37467923,https://www.ncbi.nlm.nih.gov/pubmed/37467923,37467923,,
1405,1516677,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,653,BMP5,https://ctdbase.org/detail.go?type=gene&acc=653,,,653.0,BMP5,9606.0,Homo sapiens (human),Cyanoginosin LR results in increased expression of BMP5 mRNA,,,PMID:29518473,https://www.ncbi.nlm.nih.gov/pubmed/29518473,29518473,,
1406,1516678,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of BRCA2 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
1407,1518643,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,6352,CCL5,https://ctdbase.org/detail.go?type=gene&acc=6352,,,6352.0,CCL5,10116.0,Rattus norvegicus (Norway rat),"[dietary fats co-treated with cholesterol, dietary co-treated with cyanoginosin LR] results in increased expression of CCL5 protein",,,PMID:34740672,https://www.ncbi.nlm.nih.gov/pubmed/34740672,34740672,,
1408,1518644,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CCL6 mRNA,,,PMID:37342990,https://www.ncbi.nlm.nih.gov/pubmed/37342990,37342990,,
1409,1518645,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CCL7 mRNA,,,PMID:37342990,https://www.ncbi.nlm.nih.gov/pubmed/37342990,37342990,,
1410,1518646,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,20308,CCL9,https://ctdbase.org/detail.go?type=gene&acc=20308,,,20308.0,Ccl9,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CCL9 mRNA,,,PMID:37342990,https://www.ncbi.nlm.nih.gov/pubmed/37342990,37342990,,
1411,1518647,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of CCN1 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
1412,1518648,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CCN1 mRNA,,,PMID:37342990,https://www.ncbi.nlm.nih.gov/pubmed/37342990,37342990,,
1413,1518649,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),MK 2206 inhibits the reaction [cyanoginosin LR results in increased expression of CCND1 protein]|cyanoginosin LR results in increased expression of CCND1 protein,,,PMID:36115647,https://www.ncbi.nlm.nih.gov/pubmed/36115647,36115647,,
1414,1518650,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in decreased expression of CCND1 protein|cyanoginosin LR results in decreased expression of CCND1 mRNA,,,PMID:28414124,https://www.ncbi.nlm.nih.gov/pubmed/28414124,28414124,,
1415,1518651,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CCND1 mRNA,,,PMID:17654400,https://www.ncbi.nlm.nih.gov/pubmed/17654400,17654400,,
1416,1520208,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,187762,CLEC-226,https://ctdbase.org/detail.go?type=gene&acc=187762,,,187762.0,clec-226,6239.0,Caenorhabditis elegans,Cyanoginosin LR results in increased expression of CLEC-226 mRNA,,,PMID:25257166,https://www.ncbi.nlm.nih.gov/pubmed/25257166,25257166,,
1417,1521153,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of CXCL1 mRNA,,,PMID:37342990,https://www.ncbi.nlm.nih.gov/pubmed/37342990,37342990,,
1418,1523270,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,4072,EPCAM,https://ctdbase.org/detail.go?type=gene&acc=4072,,,4072.0,EPCAM,10116.0,Rattus norvegicus (Norway rat),"[dietary fats co-treated with cholesterol, dietary co-treated with cyanoginosin LR] results in increased expression of EPCAM mrna|cyanoginosin LR results in increased expression of EPCAM mRNA",,,PMID:34740672,https://www.ncbi.nlm.nih.gov/pubmed/34740672,34740672,,
1419,1523271,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in decreased expression of EPHX1 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
1420,1523272,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,22905,EPN2,https://ctdbase.org/detail.go?type=gene&acc=22905,,,22905.0,EPN2,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of EPN2 mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
1421,1523273,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,2056,EPO,https://ctdbase.org/detail.go?type=gene&acc=2056,,,2056.0,EPO,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in decreased expression of EPO protein|cyanoginosin LR results in decreased expression of EPO mRNA,,,PMID:23454832,https://www.ncbi.nlm.nih.gov/pubmed/23454832,23454832,,
1422,1523274,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,54821,ERCC6L,https://ctdbase.org/detail.go?type=gene&acc=54821,,,54821.0,ERCC6L,8400.0,Lithobates catesbeianus (American bullfrog),Cyanoginosin LR results in increased expression of ERCC6L mRNA,,,PMID:34863901,https://www.ncbi.nlm.nih.gov/pubmed/34863901,34863901,,
1423,1523275,445434,Comparative Toxicogenomics Database (CTD),Microcystin-LR,C057862,cyanoginosin LR,https://ctdbase.org/detail.go?type=chem&acc=C057862,2069,EREG,https://ctdbase.org/detail.go?type=gene&acc=2069,,,2069.0,EREG,10090.0,Mus musculus (house mouse),Cyanoginosin LR results in increased expression of EREG mRNA,,,PMID:37342990,https://www.ncbi.nlm.nih.gov/pubmed/37342990,37342990,,
1424,1513604,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,132299,OCIAD2,https://ctdbase.org/detail.go?type=gene&acc=132299,,,132299.0,OCIAD2,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of OCIAD2 protein,,,PMID:25100957,https://www.ncbi.nlm.nih.gov/pubmed/25100957,25100957,,
1425,1513605,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4983,OPHN1,https://ctdbase.org/detail.go?type=gene&acc=4983,,,4983.0,OPHN1,9606.0,Homo sapiens (human),Cocaine results in increased expression of OPHN1 mRNA,,,PMID:18000554,https://www.ncbi.nlm.nih.gov/pubmed/18000554,18000554,,
1426,1513606,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the localization of OPRD1 protein,,,PMID:18417105,https://www.ncbi.nlm.nih.gov/pubmed/18417105,18417105,,
1427,1513607,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,10116.0,Rattus norvegicus (Norway rat),"Naltrindole inhibits the reaction [[enkephalin, D-penicillamine (2,5)- binds to and results in increased activity of OPRD1 protein] which results in increased susceptibility to cocaine]|[enkephalin, D-penicillamine (2,5)- binds to and results in increased activity of OPRD1 protein] which results in increased susceptibility to cocaine",,,PMID:19279569,https://www.ncbi.nlm.nih.gov/pubmed/19279569,19279569,,
1428,1513608,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,30509,OPRD1A,https://ctdbase.org/detail.go?type=gene&acc=30509,,,30509.0,oprd1a,7955.0,Danio rerio (zebrafish),Cocaine results in increased expression of OPRD1A mRNA,,,PMID:23226419,https://www.ncbi.nlm.nih.gov/pubmed/23226419,23226419,,
1429,1513609,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,336529,OPRD1B,https://ctdbase.org/detail.go?type=gene&acc=336529,,,336529.0,oprd1b,7955.0,Danio rerio (zebrafish),Cocaine results in increased expression of OPRD1B mRNA,,,PMID:23226419,https://www.ncbi.nlm.nih.gov/pubmed/23226419,23226419,,
1430,1514829,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PDYN protein,,,PMID:14997015,https://www.ncbi.nlm.nih.gov/pubmed/14997015,14997015,,
1431,1515161,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5828,PEX2,https://ctdbase.org/detail.go?type=gene&acc=5828,,,5828.0,PEX2,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PEX2 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1432,1515162,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,51555,PEX5L,https://ctdbase.org/detail.go?type=gene&acc=51555,,,51555.0,PEX5L,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of PEX5L mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
1433,1515163,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5196,PF4,https://ctdbase.org/detail.go?type=gene&acc=5196,,,5196.0,PF4,9606.0,Homo sapiens (human),Cocaine results in increased expression of PF4 protein,,,PMID:10814631,https://www.ncbi.nlm.nih.gov/pubmed/10814631,10814631,,
1434,1515164,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5211,PFKL,https://ctdbase.org/detail.go?type=gene&acc=5211,,,5211.0,PFKL,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PFKL mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1435,1515165,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5216,PFN1,https://ctdbase.org/detail.go?type=gene&acc=5216,,,5216.0,PFN1,9606.0,Homo sapiens (human),Crack cocaine results in decreased expression of PFN1 mrna|cocaine results in increased expression of PFN1 mRNA,,,PMID:12629581,https://www.ncbi.nlm.nih.gov/pubmed/12629581,12629581,,
1436,1515166,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5228,PGF,https://ctdbase.org/detail.go?type=gene&acc=5228,,,5228.0,PGF,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PGF mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1437,1515167,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of PGR mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1438,1520864,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,8671,SLC4A4,https://ctdbase.org/detail.go?type=gene&acc=8671,,,8671.0,SLC4A4,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SLC4A4 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
1439,1520865,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6526,SLC5A3,https://ctdbase.org/detail.go?type=gene&acc=6526,,,6526.0,SLC5A3,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SLC5A3 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1440,1520866,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,80148,SLC66A2,https://ctdbase.org/detail.go?type=gene&acc=80148,,,80148.0,SLC66A2,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SLC66A2 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1441,1522072,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,54221,SNTG2,https://ctdbase.org/detail.go?type=gene&acc=54221,,,54221.0,SNTG2,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SNTG2 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
1442,1522073,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,81609,SNX27,https://ctdbase.org/detail.go?type=gene&acc=81609,,,81609.0,SNX27,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SNX27 mRNA alternative form,,,PMID:12740601,https://www.ncbi.nlm.nih.gov/pubmed/12740601,12740601,,
1443,1522074,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606.0,Homo sapiens (human),Crack cocaine results in increased expression of SOD1 mrna|cocaine results in decreased expression of SOD1 mRNA,,,PMID:12629581,https://www.ncbi.nlm.nih.gov/pubmed/12629581,12629581,,
1444,1522075,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),GPX1 affects the reaction [cocaine results in increased activity of SOD1 protein]|cocaine results in increased activity of SOD1 protein,,,PMID:30027653,https://www.ncbi.nlm.nih.gov/pubmed/30027653,30027653,,
1445,1522076,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),GPX1 affects the reaction [cocaine results in increased activity of SOD2 protein]|cocaine results in increased activity of SOD2 protein,,,PMID:30027653,https://www.ncbi.nlm.nih.gov/pubmed/30027653,30027653,,
1446,1522077,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6651,SON,https://ctdbase.org/detail.go?type=gene&acc=6651,,,6651.0,SON,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SON mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1447,1522078,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,22986,SORCS3,https://ctdbase.org/detail.go?type=gene&acc=22986,,,22986.0,SORCS3,10090.0,Mus musculus (house mouse),[cocaine co-treated with FOS protein mutant form] results in increased expression of SORCS3 mRNA,,,PMID:18355967,https://www.ncbi.nlm.nih.gov/pubmed/18355967,18355967,,
1448,1522079,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6653,SORL1,https://ctdbase.org/detail.go?type=gene&acc=6653,,,6653.0,SORL1,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SORL1 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
1449,1522080,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,11063,SOX30,https://ctdbase.org/detail.go?type=gene&acc=11063,,,11063.0,SOX30,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SOX30 mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
1450,1522783,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,23213,SULF1,https://ctdbase.org/detail.go?type=gene&acc=23213,,,23213.0,SULF1,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SULF1 mRNA,,,PMID:27899881,https://www.ncbi.nlm.nih.gov/pubmed/27899881,27899881,,
1451,1522784,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6829,SUPT5H,https://ctdbase.org/detail.go?type=gene&acc=6829,,,6829.0,SUPT5H,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SUPT5H mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1452,1522785,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6839,SUV39H1,https://ctdbase.org/detail.go?type=gene&acc=6839,,,6839.0,SUV39H1,10090.0,Mus musculus (house mouse),HDAC5 affects the reaction [cocaine affects the expression of SUV39H1 mrna],,,PMID:17988634,https://www.ncbi.nlm.nih.gov/pubmed/17988634,17988634,,
1453,1522786,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,393236,SYBL1,https://ctdbase.org/detail.go?type=gene&acc=393236,,,393236.0,sybl1,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SYBL1 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1454,1522787,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,55638,SYBU,https://ctdbase.org/detail.go?type=gene&acc=55638,,,55638.0,SYBU,10116.0,Rattus norvegicus (Norway rat),Cocaine results in decreased expression of SYBU mRNA,,,PMID:17898221,https://www.ncbi.nlm.nih.gov/pubmed/17898221,17898221,,
1455,1522788,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10090.0,Mus musculus (house mouse),SYN1 protein affects the reaction [cocaine results in increased secretion of dopamine],,,PMID:16554471,https://www.ncbi.nlm.nih.gov/pubmed/16554471,16554471,,
1456,1522789,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SYN1 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1457,1522790,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10116.0,Rattus norvegicus (Norway rat),ILK mutant form inhibits the reaction [cocaine results in increased expression of SYN1 protein]|cocaine results in increased expression of SYN1 protein,,,PMID:19629758,https://www.ncbi.nlm.nih.gov/pubmed/19629758,19629758,,
1458,1523138,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,127833,SYT2,https://ctdbase.org/detail.go?type=gene&acc=127833,,,127833.0,SYT2,10090.0,Mus musculus (house mouse),Cocaine results in increased expression of SYT2 mrna|fos protein mutant form inhibits the reaction [cocaine results in increased expression of SYT2 mrna],,,PMID:18355967,https://www.ncbi.nlm.nih.gov/pubmed/18355967,18355967,,
1459,1523139,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,84258,SYT3,https://ctdbase.org/detail.go?type=gene&acc=84258,,,84258.0,SYT3,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SYT3 mRNA,,,PMID:16076954,https://www.ncbi.nlm.nih.gov/pubmed/16076954,16076954,,
1460,1523140,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6860,SYT4,https://ctdbase.org/detail.go?type=gene&acc=6860,,,6860.0,SYT4,10116.0,Rattus norvegicus (Norway rat),Cocaine results in increased expression of SYT4 mRNA,,,PMID:16459018,https://www.ncbi.nlm.nih.gov/pubmed/16459018,16459018,,
1461,1523141,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,6861,SYT5,https://ctdbase.org/detail.go?type=gene&acc=6861,,,6861.0,SYT5,10116.0,Rattus norvegicus (Norway rat),Cocaine affects the expression of SYT5 mRNA,,,PMID:20187946,https://www.ncbi.nlm.nih.gov/pubmed/20187946,20187946,,
1462,1523142,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,9066,SYT7,https://ctdbase.org/detail.go?type=gene&acc=9066,,,9066.0,SYT7,10090.0,Mus musculus (house mouse),Cocaine promotes the reaction [DRD1 protein results in increased expression of SYT7 protein]|[[cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of SYT7 protein|cocaine promotes the reaction [DRD3 protein results in decreased expression of SYT7 protein],,,PMID:15056714,https://www.ncbi.nlm.nih.gov/pubmed/15056714,15056714,,
1463,1524190,446220,Comparative Toxicogenomics Database (CTD),Cocaine,D003042,Cocaine,https://ctdbase.org/detail.go?type=chem&acc=D003042,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,10090.0,Mus musculus (house mouse),Cocaine affects the expression of TNFRSF10B mRNA,,,PMID:15681117,https://www.ncbi.nlm.nih.gov/pubmed/15681117,15681117,,
1464,1524850,446845,Drug Gene Interaction database (DGIdb),(S)-famoxadone,,FAMOXADONE,https://www.dgidb.org/drugs/chembl:CHEMBL10118,,UQCR10,https://www.dgidb.org/genes/hgnc:30863,,,29796.0,UQCR10,9606.0,Homo sapiens (human),,,,,,,,
1465,1524851,446925,Drug Gene Interaction database (DGIdb),Lycopene,,LYCOPENE,https://www.dgidb.org/drugs/rxcui:29008,,PTH,https://www.dgidb.org/genes/hgnc:9606,,,5741.0,PTH,9606.0,Homo sapiens (human),,,,,,,,
1466,1524852,446925,Comparative Toxicogenomics Database (CTD),Lycopene,D000077276,Lycopene,https://ctdbase.org/detail.go?type=chem&acc=D000077276,488,ATP2A2,https://ctdbase.org/detail.go?type=gene&acc=488,,,488.0,ATP2A2,10090.0,Mus musculus (house mouse),Lycopene inhibits the reaction [atrazine affects the expression of ATP2A2 mrna],,,PMID:27112537,https://www.ncbi.nlm.nih.gov/pubmed/27112537,27112537,,
1467,1525662,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,23678,SGK3,https://ctdbase.org/detail.go?type=gene&acc=23678,,,23678.0,SGK3,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of SGK3 mRNA,,,PMID:26865669,https://www.ncbi.nlm.nih.gov/pubmed/26865669,26865669,,
1468,1525663,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,151246,SGO2,https://ctdbase.org/detail.go?type=gene&acc=151246,,,151246.0,SGO2,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of SGO2 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1469,1525664,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,83699,SH3BGRL2,https://ctdbase.org/detail.go?type=gene&acc=83699,,,83699.0,SH3BGRL2,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of SH3BGRL2 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1470,1525665,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,152503,SH3D19,https://ctdbase.org/detail.go?type=gene&acc=152503,,,152503.0,SH3D19,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of SH3D19 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1471,1525666,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6457,SH3GL3,https://ctdbase.org/detail.go?type=gene&acc=6457,,,6457.0,SH3GL3,10036.0,Mesocricetus auratus (golden hamster),Diethylstilbestrol results in decreased expression of SH3GL3 mRNA,,,PMID:25242112,https://www.ncbi.nlm.nih.gov/pubmed/25242112,25242112,,
1472,1527307,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,4087,SMAD2,https://ctdbase.org/detail.go?type=gene&acc=4087,,,4087.0,SMAD2,10090.0,Mus musculus (house mouse),Diethylstilbestrol results in decreased phosphorylation of SMAD2 protein,,,PMID:17255206,https://www.ncbi.nlm.nih.gov/pubmed/17255206,17255206,,
1473,1527533,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,55234,SMU1,https://ctdbase.org/detail.go?type=gene&acc=55234,,,55234.0,SMU1,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of SMU1 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1474,1527534,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6617,SNAPC1,https://ctdbase.org/detail.go?type=gene&acc=6617,,,6617.0,SNAPC1,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in decreased expression of SNAPC1 mRNA,,,PMID:36653537,https://www.ncbi.nlm.nih.gov/pubmed/36653537,36653537,,
1475,1527535,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in decreased expression of SNCA mRNA,,,PMID:17005392,https://www.ncbi.nlm.nih.gov/pubmed/17005392,17005392,,
1476,1527536,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6642,SNX1,https://ctdbase.org/detail.go?type=gene&acc=6642,,,6642.0,SNX1,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in increased expression of SNX1 mRNA,,,PMID:37077353,https://www.ncbi.nlm.nih.gov/pubmed/37077353,37077353,,
1477,1527537,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6643,SNX2,https://ctdbase.org/detail.go?type=gene&acc=6643,,,6643.0,SNX2,9606.0,Homo sapiens (human),Diethylstilbestrol results in decreased expression of SNX2 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1478,1527538,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6646,SOAT1,https://ctdbase.org/detail.go?type=gene&acc=6646,,,6646.0,SOAT1,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in increased expression of SOAT1 mRNA,,,PMID:17011747,https://www.ncbi.nlm.nih.gov/pubmed/17011747,17011747,,
1479,1527539,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,8651,SOCS1,https://ctdbase.org/detail.go?type=gene&acc=8651,,,8651.0,SOCS1,10090.0,Mus musculus (house mouse),Diethylstilbestrol results in decreased expression of SOCS1 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
1480,1527540,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,8835,SOCS2,https://ctdbase.org/detail.go?type=gene&acc=8835,,,8835.0,SOCS2,10036.0,Mesocricetus auratus (golden hamster),Diethylstilbestrol results in increased expression of SOCS2 mRNA,,,PMID:25242112,https://www.ncbi.nlm.nih.gov/pubmed/25242112,25242112,,
1481,1527963,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6683,SPAST,https://ctdbase.org/detail.go?type=gene&acc=6683,,,6683.0,SPAST,8022.0,Oncorhynchus mykiss (rainbow trout),Diethylstilbestrol results in decreased expression of SPAST mRNA,,,PMID:17823450,https://www.ncbi.nlm.nih.gov/pubmed/17823450,17823450,,
1482,1527964,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,57405,SPC25,https://ctdbase.org/detail.go?type=gene&acc=57405,,,57405.0,SPC25,9606.0,Homo sapiens (human),Diethylstilbestrol results in decreased expression of SPC25 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1483,1527965,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,27290,SPINK4,https://ctdbase.org/detail.go?type=gene&acc=27290,,,27290.0,SPINK4,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in increased expression of SPINK4 mRNA,,,PMID:17005392,https://www.ncbi.nlm.nih.gov/pubmed/17005392,17005392,,
1484,1527966,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,84651,SPINK7,https://ctdbase.org/detail.go?type=gene&acc=84651,,,84651.0,SPINK7,9031.0,Gallus gallus (chicken),Diethylstilbestrol results in increased expression of SPINK7 mrna|[progesterone co-treated with diethylstilbestrol] results in increased expression of SPINK7 mRNA,,,PMID:21715713,https://www.ncbi.nlm.nih.gov/pubmed/21715713,21715713,,
1485,1527967,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,646424,SPINK8,https://ctdbase.org/detail.go?type=gene&acc=646424,,,646424.0,SPINK8,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol affects the expression of SPINK8 mRNA,,,PMID:21658437,https://www.ncbi.nlm.nih.gov/pubmed/21658437,21658437,,
1486,1527968,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,10418,SPON1,https://ctdbase.org/detail.go?type=gene&acc=10418,,,10418.0,SPON1,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in increased expression of SPON1 mRNA,,,PMID:17005392|PMID:36653537,https://www.ncbi.nlm.nih.gov/pubmed/17005392|https://www.ncbi.nlm.nih.gov/pubmed/36653537,17005392|36653537,,
1487,1527969,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,93934.0,Coturnix japonica (Japanese quail),Diethylstilbestrol results in decreased expression of SPP1 mRNA,,,PMID:18597071|PMID:19391684,https://www.ncbi.nlm.nih.gov/pubmed/18597071|https://www.ncbi.nlm.nih.gov/pubmed/19391684,18597071|19391684,,
1488,1530148,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,10915,TCERG1,https://ctdbase.org/detail.go?type=gene&acc=10915,,,10915.0,TCERG1,9606.0,Homo sapiens (human),Diethylstilbestrol results in increased expression of TCERG1 mRNA,,,PMID:36621641,https://www.ncbi.nlm.nih.gov/pubmed/36621641,36621641,,
1489,1530149,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6943,TCF21,https://ctdbase.org/detail.go?type=gene&acc=6943,,,6943.0,TCF21,10090.0,Mus musculus (house mouse),Diethylstilbestrol results in decreased expression of TCF21 mRNA,,,PMID:15289156,https://www.ncbi.nlm.nih.gov/pubmed/15289156,15289156,,
1490,1530150,448537,Comparative Toxicogenomics Database (CTD),Diethylstilbestrol,D004054,Diethylstilbestrol,https://ctdbase.org/detail.go?type=chem&acc=D004054,6943,TCF21,https://ctdbase.org/detail.go?type=gene&acc=6943,,,6943.0,TCF21,10116.0,Rattus norvegicus (Norway rat),Diethylstilbestrol results in decreased expression of TCF21 mrna|diethylstilbestrol results in increased expression of TCF21 mRNA,,,PMID:17011747,https://www.ncbi.nlm.nih.gov/pubmed/17011747,17011747,,
1491,1528961,460995,BindingDB,2-Butanol deriv. 3,3396,2-Butanol deriv. 3,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3396,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),>100000,PMID:7724556|DOI:10.1073/pnas.92.8.3298,https://www.ncbi.nlm.nih.gov/pubmed/7724556|https://doi.org/10.1073/pnas.92.8.3298,7724556,10.1073/pnas.92.8.3298,
1492,1528962,460996,BindingDB,2-Butanol deriv. 4,3397,2-Butanol deriv. 4,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3397,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),83000,PMID:7724556|DOI:10.1073/pnas.92.8.3298,https://www.ncbi.nlm.nih.gov/pubmed/7724556|https://doi.org/10.1073/pnas.92.8.3298,7724556,10.1073/pnas.92.8.3298,
1493,1528963,460996,BindingDB,2-Butanol deriv. 4,3397,2-Butanol deriv. 4,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3397,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),83000,PMID:8709109|DOI:10.1021/jm960093o,https://www.ncbi.nlm.nih.gov/pubmed/8709109|https://doi.org/10.1021/jm960093o,8709109,10.1021/jm960093o,
1494,1528964,460997,BindingDB,2-Butanol deriv. 5,3398,2-Butanol deriv. 5,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3398,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),25000,PMID:8709109|DOI:10.1021/jm960093o,https://www.ncbi.nlm.nih.gov/pubmed/8709109|https://doi.org/10.1021/jm960093o,8709109,10.1021/jm960093o,
1495,1528965,460998,BindingDB,2-Butanol deriv. 6,3399,2-Butanol deriv. 6,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3399,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,IC50 (nM),>200000,PMID:8709109|DOI:10.1021/jm960093o,https://www.ncbi.nlm.nih.gov/pubmed/8709109|https://doi.org/10.1021/jm960093o,8709109,10.1021/jm960093o,
1496,1528966,461000,BindingDB,2-Butanol deriv. 8,3401,2-Butanol deriv. 8,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3401,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),24000,PMID:8709109|DOI:10.1021/jm960093o,https://www.ncbi.nlm.nih.gov/pubmed/8709109|https://doi.org/10.1021/jm960093o,8709109,10.1021/jm960093o,
1497,1528967,461000,BindingDB,2-Butanol deriv. 8,3401,2-Butanol deriv. 8,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=3401,50,Dimer of Gag-Pol polyprotein [489-587],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50,P12497,Gag-Pol polyprotein,,,11698.0,Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE),,Ki (nM),24000,PMID:7724556|DOI:10.1073/pnas.92.8.3298,https://www.ncbi.nlm.nih.gov/pubmed/7724556|https://doi.org/10.1073/pnas.92.8.3298,7724556,10.1073/pnas.92.8.3298,
1498,1513420,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5423,POLB,https://ctdbase.org/detail.go?type=gene&acc=5423,,,5423.0,POLB,8355.0,Xenopus laevis (African clawed frog),Propylthiouracil results in increased expression of POLB mRNA,,,PMID:17403546,https://www.ncbi.nlm.nih.gov/pubmed/17403546,17403546,,
1499,1513421,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5424,POLD1,https://ctdbase.org/detail.go?type=gene&acc=5424,,,5424.0,POLD1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of POLD1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1500,1513422,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10714,POLD3,https://ctdbase.org/detail.go?type=gene&acc=10714,,,10714.0,POLD3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of POLD3 mRNA,,,PMID:22504374,https://www.ncbi.nlm.nih.gov/pubmed/22504374,22504374,,
1501,1513423,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5426,POLE,https://ctdbase.org/detail.go?type=gene&acc=5426,,,5426.0,POLE,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of POLE mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
1502,1513424,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,54107,POLE3,https://ctdbase.org/detail.go?type=gene&acc=54107,,,54107.0,POLE3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of POLE3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1503,1519121,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5837,PYGM,https://ctdbase.org/detail.go?type=gene&acc=5837,,,5837.0,PYGM,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of PYGM mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1504,1519307,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9444,QKI,https://ctdbase.org/detail.go?type=gene&acc=9444,,,9444.0,QKI,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of QKI mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1505,1519308,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,25797,QPCT,https://ctdbase.org/detail.go?type=gene&acc=25797,,,25797.0,QPCT,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of QPCT mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1506,1519309,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,84109,QRFPR,https://ctdbase.org/detail.go?type=gene&acc=84109,,,84109.0,QRFPR,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of QRFPR mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1507,1519310,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,84074,QRICH2,https://ctdbase.org/detail.go?type=gene&acc=84074,,,84074.0,QRICH2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of QRICH2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1508,1519311,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,79832,QSER1,https://ctdbase.org/detail.go?type=gene&acc=79832,,,79832.0,QSER1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of QSER1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1509,1519312,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,79832,QSER1,https://ctdbase.org/detail.go?type=gene&acc=79832,,,79832.0,QSER1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of QSER1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1510,1519313,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5768,QSOX1,https://ctdbase.org/detail.go?type=gene&acc=5768,,,5768.0,QSOX1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of QSOX1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1511,1519314,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,169714,QSOX2,https://ctdbase.org/detail.go?type=gene&acc=169714,,,169714.0,QSOX2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of QSOX2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1512,1519315,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,27291,R3HCC1L,https://ctdbase.org/detail.go?type=gene&acc=27291,,,27291.0,R3HCC1L,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of R3HCC1L mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1513,1522590,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,28954,REM1,https://ctdbase.org/detail.go?type=gene&acc=28954,,,28954.0,REM1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of REM1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1514,1522591,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,161253,REM2,https://ctdbase.org/detail.go?type=gene&acc=161253,,,161253.0,REM2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of REM2 mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
1515,1522592,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,387849,REP15,https://ctdbase.org/detail.go?type=gene&acc=387849,,,387849.0,REP15,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of REP15 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1516,1522593,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,387849,REP15,https://ctdbase.org/detail.go?type=gene&acc=387849,,,387849.0,REP15,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of REP15 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1517,1522594,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,85021,REPS1,https://ctdbase.org/detail.go?type=gene&acc=85021,,,85021.0,REPS1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of REPS1 mRNA,,,PMID:22504374,https://www.ncbi.nlm.nih.gov/pubmed/22504374,22504374,,
1518,1522595,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,11079,RER1,https://ctdbase.org/detail.go?type=gene&acc=11079,,,11079.0,RER1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RER1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1519,1522596,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,473,RERE,https://ctdbase.org/detail.go?type=gene&acc=473,,,473.0,RERE,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RERE mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1520,1522597,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,85004,RERG,https://ctdbase.org/detail.go?type=gene&acc=85004,,,85004.0,RERG,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RERG mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1521,1522598,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,389075,RESP18,https://ctdbase.org/detail.go?type=gene&acc=389075,,,389075.0,RESP18,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RESP18 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1522,1522791,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,389075,RESP18,https://ctdbase.org/detail.go?type=gene&acc=389075,,,389075.0,RESP18,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RESP18 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1523,1522980,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23180,RFTN1,https://ctdbase.org/detail.go?type=gene&acc=23180,,,23180.0,RFTN1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RFTN1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1524,1522981,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,130132,RFTN2,https://ctdbase.org/detail.go?type=gene&acc=130132,,,130132.0,RFTN2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RFTN2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1525,1522982,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5991,RFX3,https://ctdbase.org/detail.go?type=gene&acc=5991,,,5991.0,RFX3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RFX3 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1526,1522983,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5993,RFX5,https://ctdbase.org/detail.go?type=gene&acc=5993,,,5993.0,RFX5,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RFX5 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1527,1522984,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,5993,RFX5,https://ctdbase.org/detail.go?type=gene&acc=5993,,,5993.0,RFX5,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RFX5 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1528,1522985,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,64864,RFX7,https://ctdbase.org/detail.go?type=gene&acc=64864,,,64864.0,RFX7,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RFX7 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1529,1523874,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,10247,RIDA,https://ctdbase.org/detail.go?type=gene&acc=10247,,,10247.0,RIDA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of RIDA mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
1530,1525193,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6093,ROCK1,https://ctdbase.org/detail.go?type=gene&acc=6093,,,6093.0,ROCK1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of ROCK1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1531,1525546,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,22895,RPH3A,https://ctdbase.org/detail.go?type=gene&acc=22895,,,22895.0,RPH3A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RPH3A mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
1532,1525547,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,9501,RPH3AL,https://ctdbase.org/detail.go?type=gene&acc=9501,,,9501.0,RPH3AL,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RPH3AL mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1533,1525548,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,22934,RPIA,https://ctdbase.org/detail.go?type=gene&acc=22934,,,22934.0,RPIA,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RPIA mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1534,1525549,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,100043141,RPL10A-PS1,https://ctdbase.org/detail.go?type=gene&acc=100043141,,,100043141.0,Rpl10a-ps1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RPL10A-PS1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1535,1526268,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,55197,RPRD1A,https://ctdbase.org/detail.go?type=gene&acc=55197,,,55197.0,RPRD1A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RPRD1A mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1536,1526398,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6224,RPS20,https://ctdbase.org/detail.go?type=gene&acc=6224,,,6224.0,RPS20,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of RPS20 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
1537,1526399,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6228,RPS23,https://ctdbase.org/detail.go?type=gene&acc=6228,,,6228.0,RPS23,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RPS23 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1538,1526400,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6230,RPS25,https://ctdbase.org/detail.go?type=gene&acc=6230,,,6230.0,RPS25,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RPS25 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1539,1526401,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,51065,RPS27L,https://ctdbase.org/detail.go?type=gene&acc=51065,,,51065.0,RPS27L,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of RPS27L mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1540,1526919,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,284654,RSPO1,https://ctdbase.org/detail.go?type=gene&acc=284654,,,284654.0,RSPO1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RSPO1 mRNA,,,PMID:24780913|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|30047161,,
1541,1526920,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,340419,RSPO2,https://ctdbase.org/detail.go?type=gene&acc=340419,,,340419.0,RSPO2,10090.0,Mus musculus (house mouse),[propylthiouracil co-treated with iodine deficiency] results in decreased expression of RSPO2 mRNA,,,PMID:36706583,https://www.ncbi.nlm.nih.gov/pubmed/36706583,36706583,,
1542,1527704,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,112611,RWDD2A,https://ctdbase.org/detail.go?type=gene&acc=112611,,,112611.0,RWDD2A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil affects the expression of RWDD2A mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1543,1527705,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,25950,RWDD3,https://ctdbase.org/detail.go?type=gene&acc=25950,,,25950.0,RWDD3,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of RWDD3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1544,1528447,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6295,SAG,https://ctdbase.org/detail.go?type=gene&acc=6295,,,6295.0,SAG,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of SAG mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1545,1528448,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6299,SALL1,https://ctdbase.org/detail.go?type=gene&acc=6299,,,6299.0,SALL1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of SALL1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
1546,1528449,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6299,SALL1,https://ctdbase.org/detail.go?type=gene&acc=6299,,,6299.0,SALL1,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of SALL1 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1547,1528450,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,6297,SALL2,https://ctdbase.org/detail.go?type=gene&acc=6297,,,6297.0,SALL2,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of SALL2 mRNA,,,PMID:24780913|PMID:25825206|PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206|https://www.ncbi.nlm.nih.gov/pubmed/30047161,24780913|25825206|30047161,,
1548,1528451,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,148398,SAMD11,https://ctdbase.org/detail.go?type=gene&acc=148398,,,148398.0,SAMD11,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of SAMD11 mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1549,1528452,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,201191,SAMD14,https://ctdbase.org/detail.go?type=gene&acc=201191,,,201191.0,SAMD14,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of SAMD14 mRNA,,,PMID:24780913|PMID:25825206,https://www.ncbi.nlm.nih.gov/pubmed/24780913|https://www.ncbi.nlm.nih.gov/pubmed/25825206,24780913|25825206,,
1550,1528453,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23034,SAMD4A,https://ctdbase.org/detail.go?type=gene&acc=23034,,,23034.0,SAMD4A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in decreased expression of SAMD4A mRNA,,,PMID:24780913,https://www.ncbi.nlm.nih.gov/pubmed/24780913,24780913,,
1551,1528454,657298,Comparative Toxicogenomics Database (CTD),Propylthiouracil,D011441,Propylthiouracil,https://ctdbase.org/detail.go?type=chem&acc=D011441,23034,SAMD4A,https://ctdbase.org/detail.go?type=gene&acc=23034,,,23034.0,SAMD4A,10116.0,Rattus norvegicus (Norway rat),Propylthiouracil results in increased expression of SAMD4A mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
